Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.16710535426165,0.00314228347251097,0.160946478655528,0.173264229867771,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.165533987151485,0.0030265032662749,0.159602040749586,0.171465933553384,0
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42137,-0.156847512292029,0.00451589768451251,-0.165698671753673,-0.147996352830384,2.81307080737526e-253
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,41843,-0.395386780883783,0.0124483215951279,-0.419785491210234,-0.370988070557333,1.95767000977078e-213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42080,-0.130226504071211,0.00419137814785961,-0.138441605241016,-0.122011402901406,9.26244117746833e-205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42199,0.0833631168079253,0.00286241055644879,0.0777527921172857,0.088973441498565,6.13056225175681e-181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.0842674065498296,0.0029632713276418,0.0784593947476517,0.0900754183520075,7.68336100771432e-173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.110469729099884,0.00394565945439399,-0.118203221630496,-0.102736236569272,7.33193114388137e-167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,39990,0.0709216244203968,0.00262697471456168,0.0657727539798559,0.0760704948609377,1.17713153885084e-155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42123,-0.152620852577342,0.00571509577339742,-0.163822440293201,-0.141419264861483,3.73766820531524e-153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.33969209926762,0.012869839907147,0.314467213049612,0.364916985485629,8.62328192631317e-150
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,39575,-0.25676518356658,0.0101665538461399,-0.276691629105015,-0.236838738028146,7.54035798875409e-137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.161872561547259,0.00645779447088038,-0.174529838710184,-0.149215284384333,1.31594697911841e-135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9,Complement component C9,39990,0.14486335879532,0.00587226230094109,0.133353724685476,0.156372992905165,6.05043187995731e-131
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0876359097074307,0.00357303043705303,-0.0946390493640547,-0.0806327700508068,5.02119706995338e-130
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.214910362331752,0.00875604834332052,-0.23207221708466,-0.197748507578844,1.14834389159437e-129
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,39979,0.161866352051455,0.00702916345811545,0.148089191673548,0.175643512429361,1.00524071683294e-114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.071227627883908,0.00315031270956562,0.0650530149731594,0.0774022407946566,1.05595782004263e-110
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,39468,0.0939430578382532,0.00432083274834408,0.0854742256514988,0.102411890025008,1.24460902406277e-102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0733273102315337,0.00345097588350446,-0.0800912229632025,-0.066563397499865,1.3370479585206e-98
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42145,0.104435767010611,0.00492317925696125,0.0947863356669671,0.114085198354255,2.84757024046359e-98
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42296,-0.110819307698182,0.00528076240534543,-0.121169602012659,-0.100469013383705,2.89521243393897e-96
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.186764806609616,0.00900344944951415,-0.204411567530664,-0.169118045688568,4.10806292136131e-94
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0659410045811534,0.00319107607642398,0.0596864954713624,0.0721955136909444,1.99294607234974e-93
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,41913,-0.172586998875594,0.00844974239708643,-0.189148493973883,-0.156025503777304,2.49565124240238e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.0984319601114905,0.00481377161100474,0.0889969677539212,0.10786695246906,2.69894887005819e-91
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0824682707699417,0.00407076526215372,-0.090446970683763,-0.0744895708561204,6.38059349335824e-90
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42296,-0.06038123049708,0.00298610343545125,-0.0662339932305644,-0.0545284677635955,1.30063011177216e-89
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.185925307933551,0.00929815649395983,-0.204149694661712,-0.167700921205389,1.89295566951595e-87
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.10087792999234,0.005084619417237,0.0909120759345559,0.110843784050125,3.86259063021927e-86
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0741904810117093,0.00378488211653736,0.066772112063296,0.0816088499601225,3.67168496427357e-84
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.161392390754072,0.00824532165866172,-0.177553221205049,-0.145231560303095,3.80121127955807e-84
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.113752262826294,0.00581932931716778,-0.125158148287943,-0.102346377364645,1.0356240163141e-83
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0601697235300359,0.00310678645850945,-0.0662590249887144,-0.0540804220713574,1.94165762411781e-82
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0416405545234873,0.00217763135742648,0.0373723970629314,0.0459087119840432,1.86304647017872e-80
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0713004490745169,0.00377013028230871,0.0639109937211919,0.078689904427842,9.1974812804316e-79
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.074160330945021,0.00396450963613166,0.0663898920582029,0.081930769831839,6.29160560694582e-77
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42089,-0.196840990408448,0.0105621058632485,-0.217542717900415,-0.176139262916481,1.48196177441977e-76
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.155377448936026,0.00838559599547113,-0.171813217087149,-0.138941680784903,1.07603730077103e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42145,-0.119494668989281,0.00646032991604743,-0.132156915624734,-0.106832422353828,1.8610367325551e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0707371661599125,0.00383129773534419,0.0632278225986379,0.0782465097211871,3.42692459288803e-75
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0739732670469309,0.00405798371223209,0.066019618970956,0.0819269151229058,2.29030447596107e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.271296281590377,0.0148862957728558,-0.300473421305175,-0.24211914187558,2.43539848902492e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.102074056290698,0.00560605480280862,-0.113061923704203,-0.0910861888771931,3.44952413486693e-73
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.157508236613243,0.00873024572558577,-0.174619518235391,-0.140396954991095,6.34534137256289e-72
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REN,Renin,42145,-0.146515697964504,0.00835647043128727,-0.162894380009827,-0.130137015919181,4.50662636049733e-68
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0523223029583876,0.00299373984577279,0.046454572860673,0.0581900330561023,1.17047575973671e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.0912524929345863,0.00521691960712877,-0.101477655364559,-0.0810273305046139,1.34865545120251e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0607272194603021,0.00349849049058124,-0.0675842608218413,-0.0538701780987628,8.97108053160076e-67
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.0909182793486147,0.00527471789277686,-0.101256726418457,-0.0805798322787721,6.96851206489436e-66
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0472952435675107,0.00278294017909128,0.0418406808164918,0.0527498063185296,4.14523722964706e-64
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.0771048795384803,0.00460167317404202,0.0680856001173579,0.0861241589596026,2.18328183851196e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.0832984668776205,0.00497442382326929,-0.0930483375712283,-0.0735485961840127,2.56595063071848e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0285900878214965,0.00171204159995108,0.0252344862855923,0.0319456893574006,5.44377955652113e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0553715197699212,0.00331752351868874,-0.0618738658665511,-0.0488691736732913,6.35422516945738e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.0935709662932852,0.00561412145857479,-0.104574644352092,-0.0825672882344786,9.60991088292907e-62
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.111691992511567,0.00670674792380329,-0.124837218442222,-0.098546766580913,1.19679365726776e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.11165709436707,0.00671062558432741,-0.124809920512352,-0.0985042682217883,1.53466080547301e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.0907032663492087,0.00545663927796267,-0.101398279334016,-0.0800082533644019,1.94631810014298e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0435161920717186,0.00262742100351039,0.0383664469048383,0.048665937238599,5.11021743174618e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0576991008100706,0.00348383595073101,-0.0645274192735034,-0.0508707823466378,5.28824627364632e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0643136822419705,0.00389133738616217,0.0566866609650927,0.0719407035188483,9.04865737326041e-61
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.112766471771785,0.00684848617547726,-0.126189504675721,-0.0993434388678497,2.47049497606186e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.146876220438065,0.00893544260297239,-0.164389687939891,-0.129362752936239,5.10803980975545e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.143070927296544,0.00873402217857684,-0.160189610766554,-0.125952243826533,9.84464290403164e-60
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42193,-0.0556492703183294,0.00340006873793313,-0.0623134050446783,-0.0489851355919804,1.22044300747267e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41225,-0.0696197748868997,0.00427309393337931,-0.0779950389963231,-0.0612445107774762,4.45687985043408e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0395831418558651,0.00243648071611533,-0.0443586440594511,-0.034807639652279,8.52250539967007e-59
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42171,0.0645818805462746,0.0040174585864823,0.0567076617167693,0.0724560993757799,1.29288938071593e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0537886278038735,0.00334411692482355,-0.0603430969765276,-0.0472341586312193,1.50537595830593e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0316534106137117,0.00197958504359477,0.027773423928266,0.0355333972991575,4.98632281715576e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,41839,-0.0866132942752943,0.00543030106148799,-0.0972566843558107,-0.0759699041947778,9.61382410382036e-57
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.0872154588464712,0.00555905349176865,0.0763197140026046,0.0981112036903377,5.58350639723213e-55
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0516623505581661,0.00330136692831037,0.0451916713786778,0.0581330297376544,1.01422956179221e-54
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.080754493355197,0.00521814591980003,-0.090982059358005,-0.0705269273523889,1.48925470378179e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42070,-0.123329266113365,0.00803094171501456,-0.139069911874793,-0.107588620351936,8.92960074269262e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0724546484914091,0.00471845606066951,-0.0817028223703213,-0.0632064746124968,8.93012742667127e-53
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD248,Endosialin,39966,0.0636374785589597,0.00418237397866572,0.0554400255607749,0.0718349315571445,9.00236598285413e-52
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0525758265426704,0.0034894881748032,0.0457364297200561,0.0594152233652846,6.91696731908185e-51
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0488729213664291,0.00327366892603797,-0.0552893124614635,-0.0424565302713947,5.28895692864273e-50
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.184067867539468,0.0123868455233451,-0.208346084765225,-0.159789650313712,1.46294824613248e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0491392739043853,0.00333495227569263,-0.0556757803647428,-0.0426027674440277,9.14224308307917e-49
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.115924312338975,0.00787186147650553,-0.131353160832926,-0.100495463845025,1.22701410184679e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.151471162157263,0.0103590503189277,-0.171774900782361,-0.131167423532165,4.83829094059726e-48
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0578969078926112,0.00400541108253339,-0.0657475136143766,-0.0500463021708458,5.19433009505469e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0661054721879583,0.00457663538477978,0.05713526683379,0.0750756775421267,6.1028967692023e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42296,-0.0389391319345877,0.00270211013542209,-0.044235267800015,-0.0336429960691604,9.74312569886776e-47
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.125267990140737,0.00876926477791742,-0.142455749105455,-0.108080231176019,5.88631978444693e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0855901010589222,0.00599716029581043,-0.0973445352387106,-0.0738356668791337,7.10731925093634e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0427317872570235,0.00299432255672111,-0.0486006594681969,-0.0368629150458501,7.1574853627478e-46
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.0772646366477394,0.0054350808855073,-0.0879173951833337,-0.066611878112145,1.55567258999971e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0488092892298401,0.00345580628058922,0.0420359089198852,0.055582669539795,5.59584893667722e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.0871295404894964,0.00618362936542705,-0.0992494540457334,-0.0750096269332594,9.16313400942908e-45
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.211471296377968,0.0150913094516,-0.241050262903104,-0.181892329852832,2.68513458255546e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42239,-0.0291691930590995,0.00208215279332344,-0.0332502125340135,-0.0250881735841856,2.77729782220916e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42134,0.0565481372920754,0.00403905301126439,0.0486315933899972,0.0644646811941536,3.15528858676701e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.105883129757206,0.00756597926597588,0.0910538103958937,0.120712449118519,3.90980548949488e-44
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POSTN,Periostin,39966,0.0544622681118514,0.00391558864745008,0.0467877143628493,0.0621368218608536,1.26970937290289e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0498138878299598,0.003589568617461,-0.0568494423201834,-0.0427783333397363,1.96182888057711e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42137,-0.0405348993933195,0.00292510964485444,-0.0462681142972342,-0.0348016844894048,2.26372348490189e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0566957348763824,0.00410177838180057,-0.0647352205047115,-0.0486562492480533,3.64707443789167e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.0694973047479761,0.00502845407909317,-0.0793530747429987,-0.0596415347529535,3.73190638648172e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0799422770026177,0.00579628197609574,-0.0913029896757653,-0.0685815643294701,6.48798224514357e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FURIN,Furin,42181,-0.046992406116095,0.00341131711670109,-0.0536785876648291,-0.0403062245673608,6.9555477828579e-43
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0386579561404766,0.00281256152828356,0.0331453355450408,0.0441705767359123,1.19821334527334e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0613006649013666,0.00449573357423066,-0.0701123027068587,-0.0524890270958745,4.6438297243573e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42153,0.0714153026781563,0.0052443372667766,0.0611364016352741,0.0816942037210384,5.94119629599025e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42310,-0.0708931376165857,0.0052126645552055,-0.0811099601447885,-0.060676315088383,7.46328629443002e-42
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.116885368019639,0.00864522675653506,-0.133830012462447,-0.09994072357683,2.22846628894436e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42185,0.0570370752940992,0.00423805936948404,0.0487304789299105,0.0653436716582879,5.03922239613346e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0478625479004632,0.00355640322239478,0.0408919975845694,0.0548330982163569,5.04958902043624e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,39736,-0.0535259669032665,0.00397647358384566,-0.061319855127604,-0.045732078678929,5.57022562395398e-41
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0380975185273422,0.00284111629088623,0.0325289305972052,0.0436661064574792,1.08504713153261e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.0778158890216789,0.00581776067253367,-0.0892186999398449,-0.0664130781035129,1.52363260823462e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,39649,-0.115347728419072,0.00862761745226986,-0.132257858625521,-0.0984375982126234,1.87635163227967e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.0703238418046596,0.00527244912004564,-0.0806578420799491,-0.0599898415293702,2.49693207624932e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.079365170868979,0.005955002209652,-0.0910369751998969,-0.0676933665380611,2.88839898108893e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.038902420952029,0.00292236238945236,-0.0446302512353556,-0.0331745906687023,3.50840597266776e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.105693257238971,0.00796566726902235,-0.121305965086255,-0.0900805493916872,6.33007957357445e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0425204463389545,0.00320807187132721,-0.0488082672067558,-0.0362326254711532,7.55226422547536e-40
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42199,-0.0249731094003955,0.00189489834677628,-0.028687110160077,-0.021259108640714,2.01828562058414e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,39638,-0.0856093370304267,0.0065350102764816,-0.0984179571723306,-0.0728007168885227,6.41185122038182e-39
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0466090498867908,0.00358255286523398,-0.0536308535026494,-0.0395872462709322,1.81722096482595e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0655867809458576,0.00503889437736845,-0.0754630139254997,-0.0557105479662154,1.89047964416833e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42296,-0.0410710047966421,0.0031617208590942,-0.0472679776804668,-0.0348740319128175,2.34657962843801e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42152,-0.0440006554453194,0.00338792085101443,-0.0506409803133077,-0.0373603305773311,2.43906118427539e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0327898755018876,0.00252744616873975,-0.0377436699926175,-0.0278360810111577,2.90983440421505e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,39954,0.047760630429753,0.00367944663828554,0.0405489150187134,0.0549723458407927,2.95732428254854e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.165567888880462,0.012779473536556,-0.190615657012111,-0.140520120748812,3.65660743960024e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,41697,-0.0538991813865264,0.00416298493054683,-0.0620586318503982,-0.0457397309226546,4.17164713169561e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,39736,0.0318799690410167,0.00246815772084228,0.0270423799081658,0.0367175581738676,6.79444673968331e-38
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0678131820958402,0.00526991312502958,-0.0781422118208982,-0.0574841523707822,1.13277258019377e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42137,0.0357000891732197,0.00279550861509716,0.0302208922876293,0.0411792860588101,3.92310301502851e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0747739112307949,0.00586361262192266,0.0632812304918265,0.0862665919697633,5.52521506048362e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.0820506382859018,0.00646220682205906,-0.0947165636571376,-0.0693847129146661,9.94730544011843e-37
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,41994,0.0359316091438464,0.00283367340764459,0.030377609264863,0.0414856090228298,1.235836478213e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.0866845287064546,0.00684272304066127,-0.100096265866151,-0.0732727915467585,1.56804542197257e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFM,Afamin,39979,-0.0265135970485831,0.00209637767087019,-0.0306224972834887,-0.0224046968136776,2.03390730806051e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.0948819123962482,0.00752672588584317,-0.109634295132501,-0.0801295296599956,3.41749164066605e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,39943,0.0247883401403613,0.00196711487392132,0.0209327949874755,0.0286438852932471,3.62396327375605e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.036764424467333,0.00291959425120029,-0.0424868291996855,-0.0310420197349804,4.05572258438562e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.020724774302869,0.00165052846097769,0.0174897385193528,0.0239598100863853,5.77848113851288e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0651892579207182,0.00518832022595668,-0.0753583655635933,-0.0550201502778431,5.79294864080149e-36
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0424235814087216,0.00339245185843426,-0.0490727870512527,-0.0357743757661905,1.1021973484264e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42070,-0.050245604516338,0.00405247547746709,-0.0581884564521735,-0.0423027525805025,4.12567515741336e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0342714446229979,0.00277008001694897,-0.0397008014562179,-0.0288420877897779,5.70189610776286e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FST,Follistatin,42166,0.0622777630506573,0.00503677155371794,0.0524056908053702,0.0721498352959445,6.26273741978987e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0421802177860387,0.00341468889644606,-0.0488730080230729,-0.0354874275490044,7.23287199925403e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.11696541349282,0.00947716253635283,-0.135540652064072,-0.0983901749215687,8.36028620625446e-35
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0501598250922891,0.00407170373386054,-0.0581403644106558,-0.0421792857739225,1.20232781969626e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.10182898547849,0.0082756686176907,-0.118049295969164,-0.0856086749878162,1.31207033401652e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0578344420397118,0.00471719538534838,-0.0670801449949946,-0.048588739084429,2.26448910767933e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0858188504667372,0.00700814380270966,-0.0995548123200481,-0.0720828886134262,2.6971426796083e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0715312930250387,0.00584619371647901,-0.0829898327093376,-0.0600727533407399,3.30126656846049e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.120088698106077,0.00983025457040246,-0.139355997064066,-0.100821399148088,3.85259495983803e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42274,0.0677288444289194,0.00556589923420154,0.0568196819298844,0.0786380069279544,6.84374203916583e-34
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,39966,0.0718303221053171,0.00595497788238969,0.0601585654558333,0.0835020787548009,2.66978809569774e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAST,Gastrin,39929,-0.162750589049236,0.013575255010531,-0.189358088869877,-0.136143089228595,6.4350571242226e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0522992098552313,0.00436695260588053,-0.0608584369627571,-0.0437399827477054,6.94731761601172e-33
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42119,-0.0899030366295814,0.00753817034948486,-0.104677850514572,-0.0751282227445911,1.25711721545898e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0459519134473538,0.00385308393988786,-0.053503957969534,-0.0383998689251736,1.26042418733015e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0423983449437913,0.00357010826752408,-0.0493957571481385,-0.0354009327394441,2.27584742376221e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0321709976164876,0.00271846304656334,-0.0374991851877518,-0.0268428100452235,4.0304086226079e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42129,0.216989158749127,0.0183942238369048,0.180936480028794,0.25304183746946,5.82861174871437e-32
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42016,0.0316705485674378,0.00269802516969468,0.0263824192348363,0.0369586779000394,1.1567337033881e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42184,-0.0347840421803975,0.00296601261877246,-0.0405974269131915,-0.0289706574476034,1.30792361387425e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0699816185582065,0.00597103295702655,-0.0816848431539785,-0.0582783939624344,1.54419421617391e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.059330328483295,0.00506585037771814,-0.0692593952236225,-0.0494012617429674,1.58064361638235e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42070,-0.042515007212784,0.00364296920138903,-0.0496552268475065,-0.0353747875780615,2.55393472130912e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0352481950387144,0.00302659289492989,-0.041180317112777,-0.0293160729646518,3.60806984281179e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42119,0.0534973255115972,0.00459602253986913,0.0444891213334537,0.0625055296897407,3.63639866453613e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42145,-0.0821888436341584,0.00706818476654468,-0.0960424857765859,-0.0683352014917308,4.17300859555192e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0658328494878583,0.00567239855824959,-0.0769507506620275,-0.0547149483136891,5.44549441967526e-31
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42145,-0.0754013696299435,0.0065344202316051,-0.0882088332838895,-0.0625939059759975,1.16547729713796e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0577117933275421,0.00506383780668505,-0.0676369154286448,-0.0477866712264394,5.9390752767558e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42016,0.0406493014690155,0.00356697214555125,0.033658036063735,0.0476405668742959,6.00942831743826e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,39862,-0.0292878451036769,0.00257844228127886,-0.0343415919749834,-0.0242340982323703,9.73890698111652e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0418912412784451,0.00369033399531762,0.0346581866476225,0.0491242959092676,9.92527035403126e-30
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0525474448443139,0.00463452091362861,-0.061631105835026,-0.0434637838536018,1.23583417249603e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.0725435250670498,0.00642030195768157,-0.0851273169041056,-0.0599597332299939,1.78985390860197e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0395374383756988,0.00351381142812192,-0.0464245087748178,-0.0326503679765799,3.05166313851421e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELN,Elastin,39958,-0.0405212613711657,0.00360591534705377,-0.0475888554513911,-0.0334536672909403,3.80396529834565e-29
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.0968416169502169,0.00868472564748018,-0.113863679219278,-0.0798195546811557,1.00031094876582e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.058306844022689,0.00523447823240609,-0.0685664213582049,-0.0480472666871731,1.07720245404049e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPN,Asporin,39958,0.0321845060740642,0.00288900890757274,0.0265220486152216,0.0378469635329067,1.12373094822828e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.031902673543756,0.00286880044287457,-0.0375255224117902,-0.0262798246757219,1.40878870257042e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.128837079067763,0.0115901657218314,-0.151553803882553,-0.106120354252974,1.47204997788105e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.0602455160926111,0.0054432475801202,-0.0709142813496467,-0.0495767508355755,2.37562124715778e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42230,-0.0789010427745703,0.00715942962611911,-0.0929335248417638,-0.0648685607073769,3.99715317000084e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.0609470120078792,0.00553554259388252,-0.0717966754918889,-0.0500973485238694,4.73907969525322e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0286171487684411,0.00260304201939401,0.0235151864104288,0.0337191111264534,5.36158484064849e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.0955640845915999,0.00869234399093929,-0.112601078813841,-0.0785270903693589,5.39346031994377e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0411637108588628,0.00376178742672194,-0.0485368142152378,-0.0337906075024878,9.44598928003638e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.0778289126411206,0.00711303317880807,-0.0917704576715844,-0.0638873676106568,9.5249997789307e-28
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0304870770947056,0.00278924501844945,0.0250201568585447,0.0359539973308666,1.07873138390044e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42262,0.05237174802032,0.00479891045249801,0.0429658835334239,0.0617776125072161,1.29509983914617e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEP,Leptin,42145,-0.0786470833584941,0.00720908075344023,-0.0927768816352369,-0.0645172850817512,1.35310835561071e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42047,-0.0804694136533251,0.0074294021968871,-0.0950310419592238,-0.0659077853474264,3.17209219490787e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.077014017438872,0.00712346881768041,-0.0909760163215256,-0.0630520185562184,3.92253055947256e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0619422009383846,0.00576774932921307,-0.0732469896236422,-0.050637412253127,8.55983250843752e-27
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,39736,-0.0719724188985351,0.00670878856406102,-0.0851216444840947,-0.0588231933129755,1.0147670155367e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0731260596732699,0.00682643963494244,-0.0865058813577571,-0.0597462379887827,1.14160619573939e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0667465404320105,0.00626040461883712,0.0544761473790898,0.0790169334849313,1.95248980058415e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.079634483562734,0.00746896130902926,-0.0942736477284314,-0.0649953193970367,1.95503221237737e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0285924751589549,0.00268984281698776,0.0233203832376589,0.0338645670802509,2.75192872101911e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0472948676950495,0.00445508351495106,0.0385629040057454,0.0560268313843536,3.18155502684995e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.0755499822380213,0.00712394512155519,-0.0895129146762694,-0.0615870497997731,3.77657741501379e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0404512862652475,0.00384160075316528,-0.0479808237414515,-0.0329217487890436,7.94446772469037e-26
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.0929107277952603,0.00884672862344088,-0.110250315897204,-0.0755711396933162,1.05989365513862e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0465878878116442,0.00443696074123476,-0.0552843308644643,-0.037891444758824,1.08332857174759e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0244466481038999,0.00232943255792529,-0.0290123359174334,-0.0198809602903663,1.14574614384714e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42249,0.0406642190203057,0.0038819000437814,0.0330556949344942,0.0482727431061173,1.40199749418101e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.025905113106806,0.00248428595579465,0.0210359126334485,0.0307743135801635,2.31186413874235e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.060011538033652,0.00576975531827839,-0.0713202584574777,-0.0487028176098264,3.05224966576612e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0362325487039067,0.00348793936621393,0.0293961875461274,0.043068909861686,3.49114969921783e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42262,-0.0586057916723864,0.00565280829834217,-0.0696852959371371,-0.0475262874076358,4.31539420694756e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0403389344245869,0.00389834501164032,-0.0479796906474019,-0.0326981782017719,5.56182821050586e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42217,-0.0612334428513496,0.00592146569116348,-0.07283951560603,-0.0496273700966692,5.69132639879145e-25
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.038605053052199,0.00375479462286432,-0.045964450513013,-0.0312456555913849,1.05437052460727e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0431796936978628,0.00420512603378233,-0.0514217407240761,-0.0349376466716494,1.20734502921299e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,39958,-0.0297505008100349,0.00289995679609578,-0.0354344161303826,-0.0240665854896872,1.3808931330543e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.0871033787144335,0.0085377221764053,-0.103837314180188,-0.0703694432486791,2.3854086218442e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0375177245478824,0.00368891613162934,-0.0447480001658759,-0.0302874489298889,3.27977060979263e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0375562087508845,0.00369760558883633,-0.0448035157050037,-0.0303089017967653,3.78504326946684e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.111974476528894,0.0110669427358047,-0.133665684291071,-0.0902832687667168,5.60418630279172e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0285837468661128,0.00283487378637975,-0.0341400994874171,-0.0230273942448085,7.98231365313389e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.024088997110292,0.00238988604001744,-0.0287731737487262,-0.0194048204718579,8.26171676814086e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0437851250478033,0.00434275001157453,0.0352733350251172,0.0522969150704894,8.34295342583594e-24
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42145,0.0327868219156533,0.00326052929651149,0.0263961844944908,0.0391774593368159,1.05028144128114e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,39736,-0.0295404792418246,0.00294522625592532,-0.0353131227034382,-0.0237678357802109,1.41726368035256e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42129,-0.0320506141916064,0.00320776593640411,-0.0383378354269585,-0.0257633929562544,2.00039821573636e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0320108823751001,0.0032124079720028,-0.0383072020002256,-0.0257145627499747,2.61529627149871e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0642754996261079,0.00645483443325235,-0.0769269751152825,-0.0516240241369333,2.90814745926336e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0341641985544651,0.00343579041075531,-0.0408983477595455,-0.0274300493493847,3.35345652434241e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00942254245784072,0.000953114254079916,0.00755443851984408,0.0112906463958374,5.71194832857803e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0709967678710706,0.00720458544016194,-0.085117755333788,-0.0568757804083532,8.14632694904025e-23
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42185,-0.0364902089747127,0.00371243237807954,-0.0437665764357486,-0.0292138415136768,1.00361964539768e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.0780835674642617,0.00794662645549832,-0.0936589553170384,-0.0625081796114849,1.07590075041791e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0357775099482709,0.00364581079948723,-0.0429232991152659,-0.0286317207812759,1.17695668983354e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0308903839073765,0.0031529863655697,-0.0370702371838931,-0.0247105306308599,1.37629316603176e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.05420974099009,0.00555820530824705,-0.0651038233942542,-0.0433156585859258,2.2029274833494e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.0774312915172401,0.00796289220122428,-0.0930385602316397,-0.0618240228028405,2.81693192239944e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0550689977559642,0.0056789938933623,-0.0661998257869543,-0.0439381697249741,3.65981784022868e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.0575866115552273,0.00595460248734229,-0.0692576324304181,-0.0459155906800364,4.71556948767791e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OCLN,Occludin,39934,-0.0445600418299751,0.00461079250419527,-0.0535971951381979,-0.0355228885217524,5.1986144860778e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0568740629886448,0.00591186438618436,-0.0684613171855662,-0.0452868087917235,7.69198733563004e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0260948411597797,0.00271320834805964,-0.0314127295219766,-0.0207769527975828,7.89341722963599e-22
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0276308961593573,0.00289604951920095,-0.0333071532169911,-0.0219546391017234,1.71345631134882e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.124160260768071,0.0130441957808634,-0.149726884498563,-0.0985936370375789,2.12317186091939e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.023291077014148,0.00245080800839696,-0.028094660710606,-0.01848749331769,2.4373140603074e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0237254560287722,0.00250969765465942,0.0188064486256397,0.0286444634319046,3.81006187629516e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREH,Trehalase,39966,-0.0738945189820669,0.00782613596790858,-0.0892337454791678,-0.0585552924849661,4.36819760145508e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42194,-0.0303275786447717,0.00321585106259295,-0.0366306467274539,-0.0240245105620895,4.72584588882252e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42167,0.0206225007686863,0.00218727722662362,0.016335437404504,0.0249095641328686,4.82973310499131e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,41843,-0.0466334428501321,0.00495723941311997,-0.0563496320998472,-0.0369172536004169,5.92622183818501e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,41913,-0.0431599312540383,0.0045940326277295,-0.0521642352043881,-0.0341556273036885,6.65448461461524e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.038588832237246,0.0041099135583984,-0.0466442628117068,-0.0305334016627851,6.99762885523943e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0426955897051005,0.00454856132864464,-0.051610769909244,-0.0337804095009571,7.18737894652165e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0749182257733725,0.007985428154948,-0.0905696649570705,-0.0592667865896744,7.50337487845415e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0496813113915262,0.00530279633408439,-0.0600747922063316,-0.0392878305767208,8.46076818490176e-21
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42296,-0.032850350534072,0.00351622146829322,-0.0397421446119267,-0.0259585564562173,1.08386187933952e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,39802,-0.0226693311390644,0.00243552767024234,-0.0274429653727393,-0.0178956969053894,1.548088884453e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0615410830783084,0.00661840127693677,-0.0745131495811044,-0.0485690165755123,1.68500629956349e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42296,-0.0436150733541351,0.00471015597491153,-0.0528469790649617,-0.0343831676433085,2.34842034488066e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.027380577428182,0.00296041210121715,-0.0331829851465676,-0.0215781697097963,2.59995347502366e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0266589373333339,0.0028957155865648,0.0209833347836669,0.0323345398830009,3.87034524966726e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,41992,-0.030775597332106,0.00334525988787653,-0.037332306712344,-0.024218887951868,4.11123683025258e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.050692241186036,0.00551793157702698,-0.0615073870770089,-0.0398770952950631,4.6269177307389e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0313399189436082,0.00341309420005585,0.0246502543114988,0.0380295835757177,4.8255265670132e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0209538922200597,0.00229073425596674,0.0164640530783648,0.0254437313617545,6.67939222833203e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0491466638245472,0.00537349718698542,-0.0596787183110386,-0.0386146093380558,6.73408708018657e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0275794759003079,0.00302074280389233,-0.0335001317959369,-0.021658820004679,7.80529578219368e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0141167534021588,0.00154659970100719,0.0110854179881848,0.0171480888161329,8.18342908411865e-20
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0339878015703325,0.0037408540518981,-0.0413198755120527,-0.0266557276286122,1.17275245825138e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.0565862441858283,0.00622937290198719,-0.0687958150737232,-0.0443766732979334,1.19131913397618e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.06088725357737,0.00670604370200414,-0.0740310992332981,-0.0477434079214419,1.23817699823483e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0251828539338402,0.0027761676637946,0.0197415653128028,0.0306241425548776,1.33952706933718e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,39934,-0.0398114861136602,0.00438992794173359,-0.048415744879458,-0.0312072273478623,1.40068066499489e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0281444676772212,0.00310724616491568,0.0220542651939865,0.0342346701604559,1.51185748674343e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.034763795318338,0.00384040731017064,-0.0422909936462725,-0.0272365969904035,1.59239847133587e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0278993181577033,0.00308783538553443,-0.0339514755133508,-0.0218471608020558,1.85464707164241e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0371471557203806,0.0041281179362318,0.0290560445653663,0.0452382668753949,2.58757155468772e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.032208831884517,0.00359698035625482,0.0251587503862576,0.0392589133827765,3.85620409374154e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.0602640339678465,0.00673435343519257,-0.0734633667008239,-0.047064701234869,4.05567429433323e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.0143351914053713,0.00160342815750286,0.0111924722166657,0.017477910594077,4.47706387312941e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0291597706745069,0.00328299018060752,-0.0355944314284977,-0.0227251099205162,7.38316963628801e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0387376069476088,0.00436978764124311,0.0301728231707723,0.0473023907244453,8.60226258312695e-19
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0289238609045907,0.00327140435808411,-0.0353358134464355,-0.0225119083627458,1.06051074004125e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0346149913242053,0.00392137332306037,-0.0423008830374036,-0.026929099611007,1.20306848244418e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,39638,-0.0576384224364769,0.00654903616706945,-0.0704745333239331,-0.0448023115490208,1.55707192592483e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.0704571845978998,0.00801255968641148,-0.0861618015832663,-0.0547525676125333,1.6611114750981e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0696063775648093,0.00792365626716836,-0.0851367438484593,-0.0540760112811593,1.75554361897935e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0442571402073526,0.00505522299324373,-0.0541653772741103,-0.0343489031405949,2.29135405133999e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0381858037694922,0.00437921832577511,-0.0467690716880114,-0.029602535850973,3.10782127396111e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42137,0.0236048199948224,0.00271068352638252,0.0182918802831127,0.0289177597065322,3.44544469689791e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0323368473062331,0.00371572842322969,-0.0396196750157633,-0.0250540195967029,3.60681027763724e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0766901167547382,0.00880991216171257,-0.0939575445916949,-0.0594226889177816,3.61526106916492e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0332764631248436,0.0038288861934359,-0.040781080063978,-0.0257718461857093,4.00486212301011e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0292306866361499,0.00336434065857746,-0.0358247943269618,-0.0226365789453381,4.17997772247513e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,41900,-0.0481571202360646,0.00554731010902632,-0.0590298480497562,-0.0372843924223731,4.36916400680406e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0274340198180595,0.00316353803503265,0.0212334852693955,0.0336345543667235,4.82591216344472e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0245759617192367,0.00283495474233596,0.0190194504242583,0.0301324730142152,4.85271532192445e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0355084785783162,0.00409547156262848,-0.043535602841068,-0.0274813543155644,4.89870147585941e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42145,-0.0317297679024602,0.00366217463514619,-0.0389076301873467,-0.0245519056175737,5.05783376722617e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0383810399731387,0.00443362446786006,0.029691136016133,0.0470709439301444,5.39732182534844e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0175598942849418,0.00202938247080311,0.0135823046421677,0.0215374839277159,5.58802708291953e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.023918376422718,0.00276727336338848,-0.0293422322149595,-0.0184945206304766,6.06801675062167e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42170,0.0330808056494444,0.00383980522258056,0.0255547874131865,0.0406068238857023,7.74385788971479e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.0587032502796846,0.00681454408135499,-0.0720597566791404,-0.0453467438802288,7.8024898247676e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0369457537281797,0.00429555020872939,-0.0453650321372893,-0.0285264753190701,8.77271837926862e-18
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0460665580489818,0.00537275121807958,-0.0565971504364178,-0.0355359656615459,1.1314637388421e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXN,Paxillin,41839,-0.0455904191846566,0.00532148471349939,-0.0560205292231154,-0.0351603091461977,1.17627344813907e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0461439114398219,0.0054050944201748,0.0355499263762793,0.0567378965033645,1.52151181327095e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0358084702467741,0.00419560119019351,-0.0440318485795534,-0.0275850919139949,1.55279154978197e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0245239801343325,0.00288377045040309,-0.0301761702171225,-0.0188717900515424,2.01995322766178e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0621388634426409,0.00733551730822857,-0.0765164773667689,-0.0477612495185129,2.68714313531549e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0290514914014712,0.00343129256253618,0.0223261579789003,0.0357768248240421,2.83566229144793e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.0735634247233679,0.00869346227870003,-0.0906026107896199,-0.0565242386571158,2.95288252665927e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,41830,-0.0433440053802672,0.0051293122033326,-0.0533974572987991,-0.0332905534617354,3.20808571661009e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.0999159729616105,0.0118447359657746,-0.123131655454529,-0.0767002904686923,3.631924380789e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.032170132145696,0.00381406321603195,-0.0396456960491186,-0.0246945682422733,3.65384292268661e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42119,-0.077895133681881,0.00925816380279405,-0.0960411347353574,-0.0597491326284047,4.36955111946464e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.066710636370181,0.00792907110718168,-0.0822516157402571,-0.0511696570001049,4.45815410891596e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0326273801901598,0.00388171775187574,-0.0402355469838363,-0.0250192133964834,4.68712092338474e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0404677015073801,0.00481887472868128,-0.0499126959755954,-0.0310227070391648,5.10651742695795e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0289759209276564,0.00345848281375881,0.0221972946126891,0.0357545472426237,5.90260985489148e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42249,-0.0324952602453755,0.00387913914268001,-0.0400983729650283,-0.0248921475257226,5.95892939142935e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0519608506591338,0.00621344178978649,0.0397825047511523,0.0641391965671154,6.73570030562522e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0206837429442932,0.00247839797432803,0.0158260829146103,0.0255414029739762,7.76576412406266e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.0845939554199162,0.0101409676898634,-0.104470252092048,-0.064717658747784,8.02265727884786e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.0912972718876935,0.0109494058838569,-0.112758107420053,-0.0698364363553341,8.2771280800806e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42084,-0.0695772398551558,0.00834538071003078,-0.0859341860468162,-0.0532202936634955,8.33752310247138e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.023577146586227,0.00283064302006695,0.0180290862668958,0.0291252069055582,9.06727291935331e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0276983247516022,0.00332632343271618,0.0211787308234785,0.0342179186797259,9.07079665767178e-17
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0525657810194727,0.00633272763064924,-0.0649779271755452,-0.0401536348634002,1.15671484432951e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.0584562013951337,0.00707836651316969,-0.0723297997609463,-0.0445826030293211,1.61509734323244e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0413700093012847,0.00502039633468333,-0.0512099861172641,-0.0315300324853054,1.90527651270635e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0544305174787516,0.00661502616599597,-0.0673959687641037,-0.0414650661933995,2.07162566821136e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0507943471703084,0.00618251302880253,0.0386766216338554,0.0629120727067613,2.29560143218787e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0307588695439597,0.00374989424281657,-0.0381086622598802,-0.0234090768280392,2.61486584880271e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0333335250095664,0.00407710746919956,-0.0413246556491976,-0.0253423943699353,3.20187449148195e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0418476439476817,0.00512257455691756,-0.0518878900792401,-0.0318073978161233,3.37658051783813e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0262139742970554,0.00321162154715587,0.0199191960646299,0.0325087525294809,3.57405327429677e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0316202611682738,0.00387555599609851,-0.0392163509206268,-0.0240241714159207,3.67445856758361e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0439067823163696,0.00538629246039528,-0.0544639155387444,-0.0333496490939949,3.98011894562031e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,39736,0.0398440252848688,0.00489089598034289,0.0302578691633967,0.0494301814063408,4.14364372571593e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0421361122877518,0.00517441376385679,-0.0522779632649112,-0.0319942613105925,4.18634227245272e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42296,-0.0315422349638056,0.0038761626570497,-0.039139513771623,-0.0239449561559882,4.38121069083324e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42145,-0.0315767835178481,0.00389129199116931,-0.0392037158205399,-0.0239498512151562,5.28567550284643e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.031837784070076,0.00393537721900826,-0.0395511234193322,-0.0241244447208198,6.58318202438499e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.027361513199408,0.00339377428293107,-0.0340133107939529,-0.0207097156048631,8.11684317312131e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0369541621833095,0.00459733271004202,-0.0459649342949919,-0.0279433900716271,9.87430810629158e-16
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0253925110061592,0.00316495716219227,-0.0315958270440561,-0.0191891949682624,1.11557808788498e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0531711736263968,0.00663049165134297,-0.066166937263029,-0.0401754099897646,1.15053100149221e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0390568385888227,0.00489219279064222,-0.0486455364584814,-0.0294681407191639,1.53532574416124e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42181,-0.0353727575629419,0.00443171113569706,-0.0440589113889081,-0.0266866037369756,1.55805451460112e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.04569788400846,0.00572585647450047,-0.0569205626984809,-0.0344752053184391,1.57084920396924e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0334067801958289,0.00418815715855657,0.025197992165058,0.0416155682265998,1.62794150196072e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0420899862054982,0.00527956811172587,0.0317420327065155,0.0524379397044809,1.68236476254857e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0517786889437695,0.00649588712042668,0.0390467501877333,0.0645106276998058,1.69972067981224e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.023491559305862,0.00294889117528652,0.0177117326023004,0.0292713860094236,1.79505457919621e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.0667076165564528,0.00838571729797493,-0.0831436224604837,-0.0502716106524219,1.96740699884723e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.035748919499217,0.00450015184024906,-0.0445692171061052,-0.0269286218923288,2.11242069697022e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.0722569666659458,0.00911742418706935,-0.0901271180726017,-0.0543868152592899,2.45763451851884e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0508409906163064,0.00641646721557664,-0.0634172663588366,-0.0382647148737762,2.4885772167406e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0505705738092961,0.00638668535531704,-0.0630884771057175,-0.0380526705128747,2.60136695035236e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.0616996510450663,0.00782995396884539,-0.0770463608240033,-0.0463529412661293,3.5210581833534e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,39713,0.0237979818936666,0.0030205009899925,0.0178777999532813,0.0297181638340519,3.61297978016806e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0269089489325403,0.00341672717767984,-0.0336057342007928,-0.0202121636642879,3.65409800985112e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0442179260168879,0.00562778574526069,-0.0552483860775989,-0.033187465956177,4.22649367418628e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0201564436631675,0.0025670525657682,0.0151250206342619,0.0251878666920732,4.40099199753466e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,39657,-0.0683334563832386,0.00874760266124915,-0.0854787575992869,-0.0511881551671902,6.15373987298911e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.031370681201601,0.00402861227337285,-0.0392667612574118,-0.0234746011457902,7.35510866028323e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,39966,-0.0920984613669305,0.0118251149498564,-0.115275686668649,-0.068921236065212,7.37702426916058e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_E,,42119,-0.0236893125687628,0.00304260017713743,-0.0296528089159521,-0.0177258162215734,7.42488207160913e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.10188374186062,0.0130995929127542,-0.127558943969618,-0.0762085397516216,7.92509147847436e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,39638,-0.0481755585844011,0.00619759576183735,-0.0603228462776023,-0.0360282708911999,8.32822800021979e-15
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,39806,-0.0217268625925051,0.00280393739320401,-0.027222579883185,-0.0162311453018253,1.00853611344292e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELL,L-selectin,39979,0.0187653671189845,0.00242476597724118,0.0140128258035918,0.0235179084343772,1.08634803094935e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0471630928119302,0.00609668431375785,-0.0591125940668956,-0.0352135915569648,1.09958476093196e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.022342242626206,0.00289214215943249,-0.0280108412586937,-0.0166736439937183,1.19522741285878e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0240607115097232,0.00313072742058493,-0.0301969372540696,-0.0179244857653767,1.63064621202555e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0378852532291774,0.00493910198584759,-0.0475658931214387,-0.0282046133369161,1.83041808210245e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0640141871492762,0.00835255878235024,-0.0803852023626827,-0.0476431719358697,1.92453646342467e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39358,-0.0193897029809909,0.00252953441246415,-0.0243475904294206,-0.0144318155325611,1.9374681732702e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.0816816721613743,0.0106744203073988,-0.102603535963876,-0.0607598083588725,2.13762280193308e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0529688854127698,0.00693277695052329,-0.0665571282357954,-0.0393806425897441,2.31480431887296e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,39934,-0.0412614203837476,0.00540328299846406,-0.0518518550607372,-0.0306709857067581,2.4140392579389e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0300742428134164,0.00394202166205278,-0.0378006052710399,-0.022347880355793,2.52091389583981e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0196682791188137,0.00257928313120781,-0.024723674055981,-0.0146128841816464,2.62448700056247e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.034083091098253,0.00448838146821242,-0.0428803187759493,-0.0252858634205566,3.31453595815358e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.0574543281106172,0.00757367881569451,-0.0722987385893784,-0.042609917631856,3.51475946704812e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0193274254145732,0.00255070691614802,0.0143280398589231,0.0243268109702233,3.8023058497595e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.030022266476781,0.00397032635106176,-0.037804106124862,-0.0222404268286999,4.23439271898731e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,39979,-0.015291045820131,0.00202223478532858,-0.019254625999375,-0.011327465640887,4.29215238352622e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.065659369669266,0.00869094996346598,-0.0826936315976593,-0.0486251077408727,4.46123846927315e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.0789436090486536,0.0104808250567239,-0.0994860261598325,-0.0584011919374747,5.36912579221602e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0456231639529766,0.00606029727855651,-0.0575013466189474,-0.0337449812870058,5.46903325624274e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0244871178052319,0.00325361054870037,-0.0308641944806846,-0.0181100411297792,5.55738674452678e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42137,0.0219515837048404,0.00291815120199353,0.0162320073489331,0.0276711600607478,5.71523256313043e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.041136769341431,0.00547803589677819,-0.0518737196991162,-0.0303998189837458,6.31969154021876e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.022842818559926,0.00304243809471209,-0.0288059972255616,-0.0168796398942903,6.45388130028867e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0545709795111494,0.00727427867422982,-0.0688285657126398,-0.0403133933096589,6.75984644783333e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0504080046282971,0.00672128710805471,0.0372342818965098,0.0635817273600843,6.79246795498561e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0300382162798863,0.00400823884793156,-0.0378943644218322,-0.0221820681379405,7.08829866081419e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0283234039813591,0.00378656617923895,0.0209017342700507,0.0357450736926674,7.89547224841869e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0672730360018293,0.00899947840028118,-0.0849120136663804,-0.0496340583372782,8.1813623025965e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.0863615456727469,0.011579112119109,-0.109056605426201,-0.0636664859192933,9.30323484319912e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0284778516032656,0.00382134134743163,-0.0359676806442316,-0.0209880225622996,9.73007330686366e-14
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0578991983222885,0.00777692346681157,-0.0731419683172391,-0.0426564283273378,1.02803921084095e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0496326731262181,0.00667019992290681,-0.0627062649751155,-0.0365590812773208,1.06116034716156e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0852988586115939,0.0114739119896087,0.0628099911119608,0.107787726111227,1.1289425834186e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0220103364530194,0.00296349351986964,0.0162018891540749,0.0278187837519639,1.17588185817226e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0449729788953405,0.00606185321484777,-0.0568542111964422,-0.0330917465942389,1.25001827897197e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0311274665346524,0.0041965107733444,-0.0393526276504074,-0.0229023054188974,1.26475524097185e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0240247539859926,0.00323861796329174,0.0176770627779408,0.0303724451940444,1.26762506300998e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,39736,-0.0358271608162971,0.00482927445964127,-0.045292538757194,-0.0263617828754002,1.2683598428774e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0329495829812559,0.00444608226919067,-0.0416639042288696,-0.0242352617336422,1.32921861305707e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0293662959897182,0.00396476617846384,0.0215953542799291,0.0371372376995073,1.36990094698954e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0250394865631279,0.00338712686569394,0.0184007179063678,0.031678255219888,1.54451093007337e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0402046639711311,0.00544735071484763,0.0295278565700298,0.0508814713722325,1.66786158329934e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0427555033985731,0.00579620886874361,-0.0541160727813105,-0.0313949340158356,1.72018824581167e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0384172896893582,0.00522075853979025,-0.0486499764273471,-0.0281846029513694,1.96463957650496e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.0842677589057494,0.011457280184281,-0.10672402806694,-0.0618114897445587,2.04191474390006e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,39657,-0.0347264255229858,0.00473646531863428,-0.044009897547509,-0.0254429534984626,2.43095049029859e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0556375251735482,0.00759620532695391,-0.0705260876143778,-0.0407489627327185,2.53869656025323e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0300243125653683,0.0041058504010898,-0.0380717793515043,-0.0219768457792323,2.80190555742293e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0238046832296557,0.00325860704179981,-0.0301915530315833,-0.017417813427728,2.92303768309835e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.016727800522409,0.00228973971461798,0.0122399106817577,0.0212156903630602,2.94622415472977e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0574405461981771,0.00786451137578424,-0.0728549884947142,-0.04202610390164,2.95272366445842e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.0805621834651452,0.0110303857409907,-0.102181739517487,-0.0589426274128034,2.95711162643191e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0655980240601294,0.0090242728929675,-0.0832855989303457,-0.047910449189913,3.81813094426252e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.0934710609090752,0.0128740068408146,-0.118704114317072,-0.0682380075010786,4.06867553375203e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0199822434477496,0.00275249275251811,0.0145873576528141,0.0253771292426851,4.13236263362692e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0511453723622124,0.00704664237258285,-0.0649567914124748,-0.03733395331195,4.19032497044738e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.026084240027736,0.00361101433941303,-0.0331618281329856,-0.0190066519224865,5.33639901513626e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0291115007390624,0.00403856571501022,-0.0370270895404824,-0.0211959119376423,6.02247289125687e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0430219328748116,0.0059683555861822,-0.0547199098237287,-0.0313239559258945,6.02314359094568e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0295183383638195,0.00409594482492404,-0.0375463902206706,-0.0214902865069683,6.03379162668359e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0633588638922633,0.00879209379092388,-0.0805913677224741,-0.0461263600620525,6.05089797986368e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0469176523414549,0.00653251834399506,-0.0597213882956852,-0.0341139163872246,7.30311240352533e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42145,-0.0319353854224376,0.00445179248726926,-0.0406608986974853,-0.0232098721473898,7.68441034058834e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0679549252215802,0.00947777107354266,-0.0865313565257238,-0.0493784939174366,7.89348039529752e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0530620984122146,0.0074111451091083,-0.0675879428260669,-0.0385362539983623,8.58184328459283e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0501214726504613,0.00700661809449587,-0.0638544441156732,-0.0363885011852494,8.89959229279938e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,39657,-0.0711113429037608,0.00994087073144927,-0.0905954495374014,-0.0516272362701203,8.99862478408193e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNST,Consortin,42145,-0.0808233045431779,0.0113145863789479,-0.102999893845916,-0.0586467152404401,9.5780087329908e-13
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,39978,-0.0415001678845559,0.00582070403817493,-0.0529087477993788,-0.0300915879697331,1.06642602818247e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.035914118511717,0.00504495829538935,-0.0458022367706801,-0.0260260002527539,1.14445565351555e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,39726,0.0155649778043543,0.00218647718972801,0.0112794825124874,0.0198504730962212,1.15622405197277e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.0675171753339793,0.00949884804246478,-0.0861349174972102,-0.0488994331707483,1.23673735153966e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0554395879952242,0.00779848457726404,-0.0707246177666617,-0.0401545582237867,1.24130745871095e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0333586583301351,0.00469351539771453,-0.0425579485096556,-0.0241593681506146,1.24184294790439e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0175861827001967,0.00247606259337744,-0.0224392653832165,-0.0127331000171769,1.28668010087969e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0416777835375659,0.00587573192089761,-0.0531942181025252,-0.0301613489726066,1.37491089897189e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0342571030344919,0.00483714022154788,0.0247763082002581,0.0437378978687257,1.48937069194509e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0327637031947858,0.00462770571122454,0.0236934000007857,0.0418340063887859,1.51352003586056e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0619571969717022,0.00875090959723898,-0.0791089797822906,-0.0448054141611138,1.5286050763817e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42199,-0.0235923090907409,0.0033393779773306,-0.0301374899263088,-0.0170471282551729,1.68573840797855e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42217,0.0353958637981914,0.00501473507702832,0.0255669830472159,0.045224744549167,1.76619421682161e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0388954184744872,0.0055125559597989,-0.049700028155693,-0.0280908087932813,1.80049270073799e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0476188718195644,0.00675415754399206,-0.0608570206057889,-0.03438072303334,1.87375892153e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.0668842477494395,0.00949985811864413,-0.085503969661982,-0.0482645258368971,2.02525353915965e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0436339894652496,0.00620947161226762,-0.0558045538252941,-0.0314634251052051,2.21158339411931e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,41881,-0.0378142335102162,0.00538383229314567,-0.0483665448047817,-0.0272619222156507,2.26644385270084e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.0230074857819671,0.00327558117529281,-0.029427624885541,-0.0165873466783932,2.28389202747029e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0206821808996688,0.00294560086444189,-0.0264555585939749,-0.0149088032053627,2.32255222157062e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0495570342791294,0.00706381011139726,-0.063402102097468,-0.0357119664607907,2.39713583548012e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42051,-0.0502146711542391,0.00716902024351596,-0.0642659508315304,-0.0361633914769479,2.59839360605036e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0192950729355261,0.00275600721919078,0.0138932987859122,0.02469684708514,2.65824486891735e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.037529018226342,0.00536519436175511,-0.0480447991753821,-0.027013237277302,2.80395646702548e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.0757732753939193,0.0108465523045589,-0.0970325179108547,-0.0545140328769839,2.98831449535368e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0208536974693055,0.00298697472648152,-0.0267081679332093,-0.0149992270054017,3.05667124838128e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0355331105170618,0.00509792701727587,-0.0455250474709225,-0.0255411735632011,3.31183281648702e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0562117635336286,0.00806492340217041,-0.0720190134018826,-0.0404045136653746,3.35347585527319e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0324036036919279,0.00465098603400871,-0.041519536318585,-0.0232876710652709,3.4164263121216e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0427644132692773,0.00614293108105629,-0.0548045581881476,-0.030724268350407,3.52388673866348e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0204824998136176,0.00294316287996742,0.0147139005688815,0.0262510990583537,3.57576813469342e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42262,-0.0282271932722874,0.00406246797387463,-0.0361896305010817,-0.0202647560434931,3.86496242972858e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0143971010060386,0.00207698016509764,-0.01846798212963,-0.0103262198824472,4.34552574569919e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASN,Vasorin,41975,0.019699966799024,0.00284603778753113,0.014121732735463,0.025278200862585,4.65966146533336e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0385931275650904,0.00557559342961207,0.0276649644430507,0.04952129068713,4.6990368671926e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,41992,0.0236589761922165,0.00341976222648568,0.0169562422283045,0.0303617101561284,4.77828371507111e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0626035033949336,0.00905100208506666,-0.0803434674816642,-0.0448635393082029,4.87015499755076e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42181,-0.0289265703813,0.00418533050585216,-0.0371298181727702,-0.0207233225898297,5.01237018959405e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42123,-0.0196048146187101,0.00284078441270883,-0.0251727520676194,-0.0140368771698008,5.38627445429364e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0245256566010457,0.00355691660251686,-0.0314972131419787,-0.0175541000601126,5.61656040254925e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,41900,0.0166359611148197,0.00241270938290293,0.01190705072433,0.0213648715053095,5.62423368046411e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42181,-0.0400902461222796,0.00581580257710498,-0.0514892191734053,-0.0286912730711538,5.69072314193128e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42129,-0.0224654916594783,0.00325902879394151,-0.0288531880956037,-0.016077795223353,5.69251236078232e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.015591442729548,0.00226354054689572,-0.0200279822014636,-0.0111549032576324,5.95301024897707e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.0481892188864577,0.00700779020393731,-0.0619244876861748,-0.0344539500867405,6.45497858027469e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0264476473193717,0.00384736654773551,-0.0339884857529333,-0.0189068088858101,6.50581245454618e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.0175098715907079,0.00255247495584302,0.0125070206772555,0.0225127225041602,7.18728620503121e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0215758735166737,0.003149302151323,0.0154032413000806,0.0277485057332668,7.71184507302939e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.048937741264835,0.00715187135049558,0.0349200734178637,0.0629554091118064,8.11024117560805e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0274426416820802,0.00401103259020491,0.0195810178052786,0.0353042655588818,8.155129906275e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0358508884926048,0.00524377292350399,-0.0461286834226726,-0.025573093562537,8.44250568008132e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0654095704068598,0.00957847457524615,-0.0841833805743423,-0.0466357602393773,8.92800062826034e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0296374470929282,0.00434263803741266,-0.038149017646257,-0.0211258765395994,9.2569486817077e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.0736251894851728,0.0107934254081704,-0.0947803032851867,-0.0524700756851589,9.40573264271485e-12
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.0465770772577251,0.00683874845086915,-0.0599810242214286,-0.0331731302940215,1.01202690352238e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.070546206498419,0.0103764905226989,-0.0908841279229089,-0.0502082850739291,1.10029972024699e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0196618741084034,0.00289425183007154,0.0139891405214632,0.0253346076953437,1.14025504229264e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,39736,-0.0376028397533592,0.00553849231690382,-0.0484582846944906,-0.0267473948122277,1.18358187050279e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.0769423056724627,0.0113358117965461,-0.099160496793693,-0.0547241145512323,1.19753855778238e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0243206904105891,0.00358536669213916,-0.0313480091271818,-0.0172933716939963,1.22329340999111e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0206823020074317,0.00304982653955906,-0.0266599620249675,-0.014704641989896,1.2400911842126e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.021015460100151,0.00310035974350779,-0.0270921651974263,-0.0149387550028757,1.27537803139319e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.044115517767552,0.00652116821974057,-0.0568970074782435,-0.0313340280568605,1.38810280011246e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0551351181078907,0.00817305637186404,-0.0711543085967442,-0.0391159276190371,1.59436368116463e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,39736,-0.0490660247048158,0.00727945226963067,-0.0633337511532919,-0.0347982982563397,1.65817716666617e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0409945655202525,0.00609920348187887,-0.0529490043447351,-0.0290401266957699,1.87489029695972e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0425677838866056,0.00633397844200544,-0.0549823816329362,-0.0301531861402749,1.88252105585796e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0424863561846866,0.00632193549410825,-0.0548773497531387,-0.0300953626162344,1.88556368768241e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.0416793916212238,0.00620822072424362,-0.0538475042407413,-0.0295112790017063,1.97484185223841e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,39958,-0.0226956276513332,0.00338123222838593,-0.0293228428189697,-0.0160684124836968,2.00792127317397e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0592294354864576,0.00883492303915117,-0.0765458846431939,-0.0419129863297213,2.10992398396044e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.058219636264735,0.00870591826943385,-0.0752832360728253,-0.0411560364566447,2.37915887496469e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0272205162964569,0.00407228877516773,-0.0352022022957856,-0.0192388302971281,2.43172185851805e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0423803377317602,0.00635249833926208,-0.0548312344767139,-0.0299294409868065,2.63192989981391e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0487293873360319,0.00730863496339133,-0.0630543118642789,-0.0344044628077849,2.70786419067418e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0400074344145831,0.00601230938923226,-0.0517915608174783,-0.0282233080116879,2.97893076318658e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0169079532677981,0.00254428848782056,0.0119211478316698,0.0218947587039264,3.13701856672044e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.0302615259289016,0.00455620441682032,-0.0391916865858694,-0.0213313652719338,3.216828170909e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.0601232446911502,0.00905264323573221,-0.0778664254331853,-0.042380063949115,3.25045873863925e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0214829121981697,0.00323643664285907,-0.0278263280181734,-0.0151394963781659,3.30363197081082e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0434504840550498,0.00656701690262352,-0.0563218371841919,-0.0305791309259077,3.82023114283746e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0175305510900859,0.00265249216261841,-0.022729435728818,-0.0123316664513538,4.0400706779725e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,41984,-0.024064112497001,0.00364503626854207,-0.0312083835833435,-0.0169198414106585,4.21269527107613e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0457576333712376,0.00693696676396751,-0.0593540882286139,-0.0321611785138612,4.40505707111785e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0203024146894302,0.00308276425343336,0.0142601967527008,0.0263446326261596,4.69145500625647e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.0613675380222455,0.00932650056815645,-0.0796474791358322,-0.0430875969086589,4.8823849095763e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.0684903181120169,0.0104199880644688,-0.0889134947183757,-0.0480671415056581,5.1484355746705e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.0630965587166266,0.00960153302348995,-0.0819155634426669,-0.0442775539905863,5.16338739178736e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,39934,0.0335192460868617,0.00510699185974307,0.0235095420417653,0.0435289501319581,5.48882261357289e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.027794432612409,0.00423749339629771,-0.0360999196691525,-0.0194889455556655,5.64567721598427e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0469088836123243,0.00717739411515243,-0.0609765760780231,-0.0328411911466256,6.6055389458838e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0257280693728777,0.00394609433968562,0.0179937244670939,0.0334624142786615,7.29146715164572e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.030883360744059,0.00473987337506471,-0.0401735125591859,-0.0215932089289322,7.49053106511269e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.025368670506325,0.00390145669566555,-0.0330155256298294,-0.0177218153828205,8.18924015000385e-11
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0532894296767674,0.00824925578771382,-0.0694579710206864,-0.0371208883328483,1.09179119084091e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.0184888680148251,0.00286643251047303,-0.0241070757353522,-0.012870660294298,1.15537031371626e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.057022377056201,0.00884595352627325,-0.0743604459676965,-0.0396843081447054,1.19509991683302e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0475246093405544,0.0073812798356972,-0.0619919178185209,-0.0330573008625879,1.24725254024206e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.0144799423984322,0.00225353056376028,0.0100630224934621,0.0188968623034024,1.36897066395769e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0242176108798824,0.00377508240001021,-0.0316167723839024,-0.0168184493758624,1.45482592477539e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0210100119125108,0.00327880091978134,0.0145835621097393,0.0274364617152822,1.52488349527029e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0258965356123461,0.00405284078139913,-0.0338401035438884,-0.0179529676808038,1.71606165454911e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0184502582309325,0.00288780035141783,-0.0241103469197115,-0.0127901695421536,1.72395202237239e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0253882122516621,0.00398134221258806,-0.0331916429883347,-0.0175847815149895,1.86638306165878e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0435293536142155,0.00683032854865584,0.0301419096588501,0.0569167975695809,1.91420682390006e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42137,0.0327685655213454,0.00515909696413627,0.0226567354716383,0.0428803955710525,2.19886841255138e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0187657899330839,0.00295590701454029,-0.0245593676815829,-0.012972212184585,2.24307587762321e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.0189536114491824,0.00298668210555846,-0.0248075083760769,-0.0130997145222878,2.279586914484e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.02132198827199,0.00335973354014986,0.0147369105332963,0.0279070660106838,2.29074503361227e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.0210733779983383,0.00333200861252233,0.0145426411177945,0.0276041148788821,2.61954886179408e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0267791871725495,0.00423680286288705,-0.0350833207838082,-0.0184750535612909,2.70312342523806e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0337495251392299,0.00537464218690541,-0.0442838238255645,-0.0232152264528953,3.52657563501068e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0339292171680668,0.00540788082706447,-0.0445286635891132,-0.0233297707470205,3.62440430937057e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0280674114886838,0.00447720553133135,0.0192920886472743,0.0368427343300932,3.77043959884308e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,41959,-0.028257962802215,0.00451232694623997,-0.0371021236168453,-0.0194138019875846,3.90729698006231e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0188918165837171,0.00302116054510693,-0.0248132912521267,-0.0129703419153075,4.16950498048756e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0194886791181158,0.00312338158471286,0.0133668512120786,0.025610507024153,4.54598851710284e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0306668055483546,0.00491894896235716,-0.0403079455145747,-0.0210256655821346,4.67217105339038e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0247950439427609,0.00398034274159767,-0.0325965157162923,-0.0169935721692295,4.82208845480549e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.0741959473808353,0.0119135290367952,-0.0975464642929539,-0.0508454304687166,4.89574352296642e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0613166458342551,0.00987932775429946,-0.0806801282326821,-0.0419531634358282,5.57653364512983e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0149919404073014,0.00241559173226411,-0.0197265002025391,-0.0102573806120638,5.58211628356644e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0193996407579826,0.00312960231852303,0.0132656202136775,0.0255336613022878,5.89396461786327e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.036326403273832,0.00586318844072915,-0.0478182526176611,-0.0248345539300028,5.97480645368308e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0260814530007516,0.00421386005473088,-0.0343406187080241,-0.0178222872934791,6.2102852631845e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0403279421536685,0.00652431307816744,-0.0531155957868767,-0.0275402885204603,6.58069362700183e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0252871821329379,0.00409152146595653,0.0172678000596631,0.0333065642062127,6.58110152559498e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0424836780068997,0.00689596518219321,-0.0559997697639984,-0.028967586249801,7.4945382168278e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.0706874571706485,0.0114912254608011,-0.0932102590738185,-0.0481646552674784,7.94053799724953e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0199487312251463,0.00324790902889846,-0.0263146329217873,-0.0135828295285053,8.37594479347092e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0173318433779691,0.00282598928778396,-0.0228707823820256,-0.0117929043739125,8.86187032228735e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0328540365696246,0.00535646242405056,0.0223553702184855,0.0433527029207637,8.8805394345145e-10
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0292288803718781,0.0047828459219101,-0.0386032583788219,-0.0198545023649343,1.01634554218763e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,41839,-0.0518981579093912,0.00850068329586887,-0.0685594971692942,-0.0352368186494882,1.05559316298572e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0607402944848849,0.00995154513748337,-0.0802453229543523,-0.0412352660154175,1.07094199160786e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0420689174505195,0.00689430037077871,-0.0555817461772458,-0.0285560887237932,1.07681296236299e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0227951548972896,0.00374537987354459,-0.030136099449437,-0.0154542103451422,1.18739407001575e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0365362798160521,0.00600557317144658,-0.0483072032320874,-0.0247653564000168,1.20544164356046e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0409307635639165,0.00673101601743238,-0.0541235549580839,-0.027737972169749,1.22686976415409e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0252379427601624,0.00415344397919246,-0.0333786929593796,-0.0170971925609451,1.26866698828419e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0311073577940937,0.00512153415901319,-0.0411455647457596,-0.0210691508424279,1.2831097272865e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42296,-0.0305532418551857,0.00503081364516571,-0.0404136365997105,-0.020692847110661,1.28687446402717e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0323603561381839,0.00533031768271396,-0.0428077787963032,-0.0219129334800645,1.30508771388139e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42249,0.018965048457242,0.00312525150269782,0.0128395555119543,0.0250905414025297,1.32670639585719e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0236035330196303,0.00389188966119302,-0.0312316367555686,-0.015975429283692,1.35611595050672e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.027501745526696,0.00453466038010113,-0.0363896798716942,-0.0186138111816978,1.36417056444171e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.029122152229555,0.00480529676069627,-0.0385405338805197,-0.0197037705785903,1.39365334019959e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,39966,-0.0163781965348525,0.00270383333019617,-0.021677709862037,-0.011078683207668,1.4271645183282e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.0595350099567459,0.00983937367058457,-0.0788201823510917,-0.0402498375624002,1.4798676117795e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.014637095901625,0.00242403799640302,-0.0193882103745749,-0.00988598142867506,1.59759678664724e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0267307060127366,0.0044281379061919,-0.0354098563088728,-0.0180515557166005,1.61553399240783e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0285178134607673,0.00472603063844619,0.0192547934094128,0.0377808335121219,1.64023522661316e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RETN,Resistin,42105,-0.0268411957519166,0.00445411090463045,-0.0355712531249922,-0.0181111383788409,1.72268715713793e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42070,-0.0641298202332711,0.0106469745400807,-0.0849978903318293,-0.043261750134713,1.75358181410111e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.0414717088529471,0.00690708500981868,-0.0550095954721917,-0.0279338222337025,1.97277889532669e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0144685726661689,0.00241331016302405,-0.0191986605856961,-0.00973848474664179,2.09378765789743e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42119,-0.0600373763395548,0.0100161033156122,-0.0796689388381546,-0.0404058138409549,2.09844174193702e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0240140158677867,0.00400666559072104,0.0161609513099734,0.0318670804255999,2.10517574798546e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.0713564710512622,0.0119196315604716,-0.0947189489097864,-0.0479939931927379,2.21047013313651e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0239855537183685,0.00401201385397739,-0.0318491008721642,-0.0161220065645728,2.30964681472687e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0202036829578419,0.00338100692038937,-0.026830456521805,-0.0135769093938787,2.36252656524757e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0500282668788894,0.0083759190268899,-0.0664450681715937,-0.0336114655861852,2.3897000277055e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0357510314230778,0.0059866064732585,-0.0474847801106645,-0.0240172827354911,2.40442129709785e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0514902281529498,0.00863019423763656,-0.0684054088587175,-0.0345750474471822,2.48750415688037e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.050478339711851,0.00846157238193867,-0.0670630215804508,-0.0338936578432512,2.49766818352941e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42025,-0.0448161187945613,0.00751552256459194,-0.0595465430211615,-0.0300856945679611,2.53651384633307e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0478877981577315,0.00805914717772444,-0.0636837266260714,-0.0320918696893916,2.88441998558663e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,39966,0.0307742807644964,0.00518340563526658,0.0206148057193739,0.0409337558096189,2.98626223206321e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0181523968187707,0.00306511147347362,-0.024160015306779,-0.0121447783307624,3.25255799713432e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0521004872347016,0.00881830758649886,-0.0693843701042393,-0.0348166043651638,3.54176251516233e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0363677838203485,0.00615817332269027,-0.0484378035328215,-0.0242977641078756,3.59775738322133e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0240833822852008,0.00408416220365097,-0.0320883402043567,-0.0160784243660449,3.79711161320002e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0550693790424078,0.00936343990184447,-0.073421721250023,-0.0367170368347927,4.16941167205103e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0471818182684365,0.00803496772960446,-0.0629303550184612,-0.0314332815184117,4.42462388378181e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.045729574173888,0.00780435150269115,-0.0610261031191626,-0.0304330452286133,4.75308150318263e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0319009256235942,0.00544900569655404,-0.0425809767888402,-0.0212208744583483,4.89785389220014e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.0485260456461467,0.00829762222214315,-0.0647893852015473,-0.0322627060907462,5.10700698420279e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,39492,-0.0429587491016504,0.00735013628743198,-0.057365016225017,-0.0285524819782837,5.22288193465456e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42249,-0.0147062119090904,0.00252439368597956,-0.0196540235336103,-0.00975840028457041,5.81760496232866e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42083,-0.0212755891427221,0.00365413288325833,-0.0284376895939085,-0.0141134886915358,5.9352020226955e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,39929,-0.0370275416528688,0.00636563098847019,-0.0495041783902704,-0.0245509049154672,6.16106511425373e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0194342314113672,0.00335239384624139,-0.0260049233500003,-0.0128635394727341,6.8963667175949e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0369391413222597,0.00637481122922421,-0.0494337713315391,-0.0244445113129803,7.00325515546602e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.038223904565445,0.00661519614149864,-0.0511896890027823,-0.0252581201281076,7.72045006818757e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0434799636883912,0.00753644238650002,-0.0582513907659312,-0.0287085366108511,8.16899470283502e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0439136542358838,0.00761296667717053,-0.0588350689231381,-0.0289922395486296,8.2189613672045e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0397281033252639,0.0068967997005207,-0.0532458307382845,-0.0262103759122433,8.57324772618538e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.016833989880065,0.00292651947599028,-0.022569968053006,-0.0110980117071241,8.99920173579105e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0206653299060361,0.00359706062347723,-0.0277155687280515,-0.0136150910840207,9.38753486163155e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0174457510411381,0.00303671299984683,-0.0233977085208379,-0.0114937935614383,9.39124862275212e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42016,0.0199039561432037,0.00346548840647467,0.0131115988665133,0.026696313419894,9.47631712338915e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0189475606163345,0.00329937350751001,-0.0254143326910541,-0.0124807885416149,9.55962242229299e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0383210008159857,0.00667363138100531,-0.0514013183227561,-0.0252406833092153,9.58841670891369e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0162047764213535,0.00282235194611991,-0.0217365862357486,-0.0106729666069585,9.61908652134121e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.0506877723263425,0.00883475165993405,-0.0680038855798132,-0.0333716590728718,9.82495291605717e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42070,0.00902467222067799,0.0015732684863292,0.00594106598747276,0.0121082784538832,9.88723530335942e-09
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0205271161115657,0.00358601826221166,-0.0275557119055005,-0.0134985203176308,1.06543842537483e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0204291277580207,0.0035699096852337,-0.0274261507410788,-0.0134321047749627,1.07566453787994e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAYN,Layilin,41997,-0.0212226366735577,0.00371010007572525,-0.0284944328219792,-0.0139508405251363,1.08652173552106e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0170453741790737,0.00298028974311189,-0.022886742075573,-0.0112040062825744,1.09173337852161e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0235654456338379,0.00412156324633981,-0.031643709596664,-0.0154871816710119,1.10374375222356e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0179304813556418,0.00313808605605994,-0.0240811300255193,-0.0117798326857643,1.13271475621164e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0494922951064979,0.0086634505386882,-0.0664726581623268,-0.032511932050669,1.1400137492172e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0154293255517313,0.00270333571042543,-0.0207278635441651,-0.0101307875592974,1.17058625811147e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0232027381046242,0.00407345850246739,-0.0311867167694603,-0.0152187594397881,1.25221699383865e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.010982776767568,0.00192920211610159,0.0072015406200089,0.0147640129151271,1.27986300882511e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0247825716735168,0.00436607058205931,-0.033340070014353,-0.0162250733326805,1.40619079066583e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.0808224664947411,0.0142461339291974,-0.108744888995968,-0.0529000439935143,1.42963193122373e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0503204108067447,0.00887407059336004,-0.0677135891697304,-0.032927232443759,1.45341905072292e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0575226581653151,0.01015152357795,-0.077419644378097,-0.0376256719525332,1.48761079374569e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0302073354036969,0.00534025966502183,-0.0406742443471396,-0.0197404264602541,1.58320137152499e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0335718063202638,0.00594404119669685,-0.0452221270657896,-0.021921485574738,1.65673139159256e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0320942963864811,0.00568279170837821,-0.0432325681349024,-0.0209560246380598,1.65947144285896e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0316097778732998,0.00560493246195063,-0.0425954454987231,-0.0206241102478766,1.74489310599976e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0485922429517865,0.00862840595534872,-0.06550391862427,-0.031680567279303,1.82046101521853e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0166802396148662,0.00296617063427659,-0.0224939340580483,-0.010866545171684,1.9080008729284e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0309641044709198,0.00550654477164241,0.0201712767185007,0.0417569322233389,1.91220573038695e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0246706480065635,0.00439238424550108,-0.0332797211277456,-0.0160615748853814,1.98441638601277e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0402309416833254,0.00716196293736782,-0.0542683890405663,-0.0261934943260845,1.9865190708298e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,39757,-0.0756146366382917,0.0134635480039185,-0.102003190725972,-0.0492260825506114,1.99816806354423e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0193682734602585,0.00345330950803845,-0.0261367600960139,-0.0125997868245031,2.07909495954246e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0147717087974358,0.00263422148547495,-0.0199347829089667,-0.0096086346859049,2.09092523884115e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0306968989453707,0.00547500671436464,-0.0414279121055254,-0.019965885785216,2.1025038170844e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0361859896175706,0.00645531458361783,-0.0488384062014615,-0.0235335730336796,2.12502446407216e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42119,0.0257045876655311,0.00458812220295022,0.0167118681477486,0.0346973071833135,2.1550627894977e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0136345125587752,0.00243400424330069,0.00886386424190584,0.0184051608756446,2.16407502542128e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0523138874145364,0.00935853438482235,-0.0706566148087882,-0.0339711600202846,2.32367570619916e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0402299458990507,0.0072005374997103,-0.0543429993984829,-0.0261168923996185,2.35385595302851e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0302222656536844,0.00541516767680255,-0.0408359943002174,-0.0196085370071514,2.4377990971458e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0196733297815677,0.00352819759127295,0.0127580625026727,0.0265885970604626,2.51858195243767e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0567722929366261,0.0102308309885037,-0.0768247216740933,-0.0367198641991589,2.92593700552106e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0178538097312929,0.00321721324555428,-0.0241595476925793,-0.0115480717700065,2.93253344458495e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0192612243248721,0.00347256777844595,-0.0260674571706262,-0.012454991479118,2.96551905163596e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42119,-0.0462121637424244,0.00835078361054201,-0.0625796996190867,-0.0298446278657621,3.19065917952153e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.035257476899506,0.0063719169776785,-0.0477464341757558,-0.0227685196232561,3.20301896379971e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0497872483570227,0.0089982159544944,-0.0674237516278318,-0.0321507450862137,3.2176934978979e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0263011100240214,0.00475891730459153,-0.0356285879410208,-0.016973632107022,3.32291521166113e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0337543728201627,0.00611060800373063,-0.0457311645074748,-0.0217775811328507,3.37685743872946e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0364260200075284,0.00660071921016149,0.0234886103556118,0.0493634296594449,3.49685101408205e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.038815042809936,0.00704857823403958,-0.0526302561486536,-0.0249998294712185,3.72116732537154e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42310,0.0152326147333404,0.00277380190691309,0.00979596299579073,0.0206692664708901,4.05395488965939e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0477339181041379,0.00869506088042512,-0.0647762374297712,-0.0306915987785047,4.11120389377275e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0501082749168737,0.00913118031717281,-0.0680053883385324,-0.032211161495215,4.16193591769615e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0254517854006446,0.00464732884705821,0.0163430208604105,0.0345605499408786,4.41190057095212e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0479044644306659,0.00876043298772472,-0.0650749130866064,-0.0307340157747255,4.64085415948255e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.028636938858341,0.00523812836271208,-0.0389036704492566,-0.0183702072674253,4.67372874411334e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0157213380962206,0.00288010818938456,-0.0213663501474144,-0.0100763260450269,4.90098340952325e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,41913,-0.0400910973100526,0.00734726034318195,-0.0544917275826892,-0.0256904670374159,4.94003556255157e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.0129481190456115,0.00237498366747361,0.00829315105736326,0.0176030870338598,5.07129668384903e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,41913,-0.0266070484650378,0.00489565891266875,-0.0362025399338685,-0.017011556996207,5.58159858219711e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42119,-0.0185525271426582,0.00341903197325289,-0.0252538298102339,-0.0118512244750826,5.85414068466314e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,39906,-0.0184205697428597,0.00339686065904664,-0.0250784166345911,-0.0117627228511283,5.98727893295557e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0436112306750641,0.00804525604509278,-0.059379932523446,-0.0278425288266823,6.05702722252193e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0436094764019604,0.00804765432993521,-0.0593828788886334,-0.0278360739152873,6.12145805621561e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0325194638443722,0.00600422182952243,-0.0442877386302361,-0.0207511890585082,6.19529714895873e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0375145593999331,0.00692792666363016,-0.0510932956606482,-0.023935823139218,6.23524314047459e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0290000210146856,0.0053707652065442,-0.0395267208195122,-0.0184733212098589,6.79398826963658e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,39966,-0.0158142974603151,0.00292897886750589,-0.0215550960406266,-0.0100734988800035,6.82656833073567e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0239545602827765,0.00444809217889463,-0.03267282095341,-0.015236299612143,7.3502029709525e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0298486616213643,0.0055452344595473,-0.040717321162077,-0.0189800020806516,7.46034412199123e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42070,-0.0300916012053885,0.00559077793098107,-0.0410495259501114,-0.0191336764606655,7.47455055720187e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0241867171804469,0.00449423331838793,-0.0329954144844873,-0.0153780198764066,7.5026415183353e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.0618860839122424,0.0114988372231537,-0.0844238048696237,-0.0393483629548611,7.51583871496917e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.05991413302502,0.0111532423784128,-0.0817744880867091,-0.0380537779633309,7.94515594227181e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0143897697016899,0.00268248901151022,0.00913209123912984,0.0196474481642499,8.28466144229494e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0542257146306988,0.0101121391804798,-0.0740455074244391,-0.0344059218369585,8.37632737576084e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0433901429313985,0.00811710351395305,-0.0592996658187464,-0.0274806200440505,9.19073578360646e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,41647,-0.0341369926275929,0.00638719948462617,-0.0466559036174602,-0.0216180816377257,9.21447538113707e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0261748082261118,0.00490001017171331,-0.0357788281626699,-0.0165707882895537,9.3507099434346e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0404629816384231,0.00758482371421933,-0.055329236118293,-0.0255967271585532,9.75257152401643e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0164906549509604,0.00309167599068564,-0.0225503398927043,-0.0104309700092166,9.77129912018148e-08
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0528478383516292,0.00991996450508798,-0.0722909687816016,-0.0334047079216567,1.01198644466641e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.015033857194259,0.00282293748340416,0.00950089972678685,0.0205668146617312,1.02227537058991e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0151910083732371,0.0028558095809575,-0.0207883951519138,-0.00959362159456038,1.05799765787874e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0272498241486532,0.0051311245441724,0.0171928200420753,0.0373068282552311,1.11317013540784e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,39638,-0.0410315915240393,0.00772732754235619,-0.0561771535070574,-0.0258860295410211,1.11795141970656e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,39930,-0.0580443186571713,0.0109476117367536,-0.0795016376612083,-0.0365869996531343,1.16690006806202e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0363287296775743,0.00685856710789792,-0.0497715212090542,-0.0228859381460943,1.20031552958236e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0150264220836144,0.00283880730959976,-0.02059048441043,-0.0094623597567989,1.22044907286864e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.027681923767586,0.00524617681196209,0.0173994172161403,0.0379644303190317,1.34038848807657e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0165015014327204,0.0031277331836377,0.0103711443927905,0.0226318584726503,1.3417810796893e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42174,0.0143442311387197,0.00271956113536347,0.00901389131340726,0.0196745709640321,1.35188857702564e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0177649612220236,0.00336958165807159,-0.0243693412718439,-0.0111605811722033,1.36987323166523e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.067629981824335,0.0128486201856894,-0.0928132773882862,-0.0424466862603837,1.43910812743187e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0167460582847874,0.00318205513738611,-0.0229828863540642,-0.0105092302155106,1.44583708510162e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0210253665351401,0.00399696015673842,0.0131913246279328,0.0288594084423474,1.46013226180969e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0252106137218604,0.00479321922436939,-0.0346053234016244,-0.0158159040420964,1.47012709722333e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,41997,-0.0377672852445653,0.00720093954569669,-0.0518811267541308,-0.0236534437349998,1.58858428441489e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0250478959597543,0.0047759427407102,-0.0344087437315463,-0.0156870481879623,1.59519247722393e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0338317162540522,0.00645452379469212,-0.0464825828916487,-0.0211808496164556,1.62095689535435e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0325748351893468,0.00621539992434258,-0.0447570190410582,-0.0203926513376353,1.62121364693269e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0307591081597736,0.0058709021856784,-0.0422660764437033,-0.019252139875844,1.63706509846573e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0224355220263477,0.00428620902023829,-0.0308364917060148,-0.0140345523466807,1.68578921061011e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,41900,0.0211687117090633,0.00404794431769333,0.0132347408463843,0.0291026825717422,1.72549754485212e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0203510170633399,0.00389993322538619,-0.0279948861850968,-0.0127071479415829,1.83844609622717e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.0115835331645538,0.00222028080779131,0.00723178278128288,0.0159352835478248,1.84963981362966e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,39657,-0.0267066678014918,0.0051218855591289,-0.0367455634973845,-0.0166677721055992,1.87919707006907e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.032000724454713,0.00613799714723985,-0.0440311988633031,-0.0199702500461229,1.88057775922668e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42249,-0.0329450062304328,0.00632230473432183,-0.0453367235097036,-0.020553288951162,1.90647550316943e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0266140316494157,0.00510812089713272,-0.0366259486077959,-0.0166021146910356,1.92014690314744e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0258359599656187,0.0049596786605082,-0.0355569301402147,-0.0161149897910226,1.92446963779792e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42070,0.0245749383576711,0.0047187436897778,0.0153262007257066,0.0338236759896356,1.93761108386078e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0411822451948629,0.0079104135283226,-0.0566866557103752,-0.0256778346793506,1.96249216103224e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42200,0.0216592455733346,0.00416178624574718,0.0135021445316701,0.029816346614999,1.97547365224016e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,39929,-0.0155610396279155,0.00298994715891645,-0.0214213360593918,-0.00970074319643929,1.97972310790154e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0180709033617429,0.00348320076280464,-0.02489797685684,-0.0112438298666458,2.1558733057618e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42196,-0.015957230178146,0.00307678509895749,-0.0219877289721027,-0.00992673138418937,2.17556266251677e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,39929,-0.0209465099738413,0.00404248107399281,-0.0288697728788672,-0.0130232470688154,2.23776339788763e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0241883461344687,0.00467069789244448,-0.0333429140036599,-0.0150337782652775,2.27277856474412e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0148625787645217,0.00287067392397129,0.00923605787353795,0.0204890996555054,2.28233550270119e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0213672723259209,0.0041311390044965,0.0132702398771078,0.029464304774734,2.34600096492254e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00653289119708045,0.00126345358723156,0.00405652216610659,0.00900926022805431,2.36622143367932e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0356998846981044,0.0069150822107471,-0.0492534458311687,-0.0221463235650401,2.46958146102199e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.016932430057494,0.00328252941433486,-0.0233661877095903,-0.0104986724053977,2.52735476873755e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0175448120075719,0.00340129637206277,0.0108782711183289,0.0242113528968149,2.52738798965999e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0389006358086694,0.0075437371831995,-0.0536863606877404,-0.0241149109295984,2.54945605982308e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0443087887872429,0.0086051022514414,-0.0611747892000681,-0.0274427883744178,2.66077560382138e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0488152716206455,0.00948185396035729,-0.0673997053829458,-0.0302308378583452,2.67398466398839e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDK,Midkine,42129,-0.0273388689513879,0.00531696841913196,-0.0377601270528866,-0.0169176108498893,2.75894659704011e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0195171264864201,0.00379602629293977,-0.026957338020582,-0.0120769149522581,2.77310171195255e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0237681275864577,0.00463337384170487,-0.0328495403161993,-0.0146867148567162,2.95016971565816e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.022451677623545,0.00438150942846179,-0.0310394361033301,-0.0138639191437599,3.02953294798497e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0581702608916673,0.0113589727799912,-0.0804338475404502,-0.0359066742428845,3.08773423438593e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0284111253363717,0.00555546691084446,-0.0392998404816268,-0.0175224101911165,3.20615802083453e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,41997,0.024338724483108,0.0047621658093033,0.0150048794968735,0.0336725694693425,3.25125182134723e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0269124970330055,0.00526659688941629,-0.0372350269362614,-0.0165899671297495,3.27344574894823e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0199783777491506,0.00391114746412127,-0.0276442267788283,-0.0123125287194729,3.29983059729708e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0390100928303453,0.00765478019009946,-0.0540134620029402,-0.0240067236577503,3.5125375147949e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0334206209924384,0.00656875729070962,-0.0462953852822292,-0.0205458567026475,3.68013736490786e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42185,-0.0250609191484532,0.00492809346841484,-0.0347199823465463,-0.0154018559503601,3.71899106185613e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.0575420201609105,0.0113144330704428,-0.0797183089789783,-0.0353657313428426,3.72093263161492e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0144832693475272,0.00284818148696879,-0.020065705061986,-0.00890083363306836,3.72338464350892e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,39919,-0.0330073433898998,0.00650345635372234,-0.0457541178431956,-0.020260568936604,3.92916295183602e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0299859636673249,0.00590859748830058,-0.0415668147443941,-0.0184051125902558,3.93852543696271e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42249,-0.0194014381318194,0.00382763705321446,-0.0269036067561198,-0.0118992695075191,4.05619984799066e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.017659248043096,0.0034850027753957,-0.0244898534828716,-0.0108286426033205,4.08956090717174e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00915772568683364,0.0018088196453457,0.00561243918195607,0.0127030121917112,4.18544256300121e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0415955225970363,0.00822255105880465,-0.0577117226722935,-0.0254793225217792,4.27748617556876e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0211760667801297,0.00419806195408616,-0.0294042682101385,-0.0129478653501208,4.61129055080076e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0335655086805271,0.00665464593387945,-0.0466086147109308,-0.0205224026501234,4.63150183296402e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0329773658752971,0.00654544594596551,-0.0458064399293895,-0.0201482918212047,4.77372370412687e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0260732858960747,0.005184543652822,-0.0362349914556058,-0.0159115803365436,4.99246351520861e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0324971102322127,0.0064746729554784,-0.0451874692249504,-0.019806751239475,5.26994216612602e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0366876922375462,0.00731077339348436,-0.0510168080887756,-0.0223585763863169,5.29409229730396e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0172140329384223,0.00344256020156414,-0.023961450933488,-0.0104666149433566,5.79364196261098e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0281583390258375,0.00565512668630357,-0.0392423873309925,-0.0170742907206825,6.47683676193324e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.037106228150526,0.00745458098752021,-0.0517172068860656,-0.0224952494149864,6.53106008518621e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0296534430029732,0.00596036172361779,-0.0413357519812641,-0.0179711340246823,6.61835092326074e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0216971439368348,0.00436382538085128,-0.0302502416833033,-0.0131440461903663,6.71059094758254e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0146395537317876,0.00294827524823641,0.00886093424524421,0.0204181732183309,6.93614976737955e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.0420760400848069,0.0084742144837364,-0.0586855004729302,-0.0254665796966836,6.96351483023264e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0295332870842158,0.00594946244126349,-0.0411942334690922,-0.0178723406993393,6.98799534067582e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0361607062607181,0.0072848052734159,-0.0504389245966133,-0.0218824879248229,7.01136941596432e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0221296947178957,0.00446166585231465,-0.0308745597884324,-0.013384829647359,7.13698779839697e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0204736894763014,0.0041305431599812,-0.0285695540698645,-0.0123778248827382,7.25727919329272e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0314455224279417,0.00634646348920164,0.0190064539891065,0.0438845908667769,7.34414714413007e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0114694390917015,0.00231508479615237,-0.0160070052921601,-0.00693187289124284,7.36708867369733e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0261298580884639,0.00527884302333916,-0.0364763904142087,-0.0157833257627192,7.51296624125013e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0116968613387003,0.00236310944898278,-0.0163285558587065,-0.00706516681869402,7.51858912716089e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0386731719751135,0.0078146977149016,-0.0539899794963207,-0.0233563644539064,7.5753769588685e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0143518156792994,0.00290060170639272,-0.0200369950238291,-0.00866663633476964,7.59496121894558e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42145,0.02433005560674,0.0049248036784178,0.0146774403970411,0.0339826708164389,7.89297412864338e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0250508005044784,0.00507342247708469,-0.0349947085595644,-0.0151068924493924,8.02243235349129e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42137,-0.0221725330806346,0.00449282036401069,-0.0309784609940955,-0.0133666051671736,8.10613357899588e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0258329783949785,0.00523425181457579,-0.0360921119515471,-0.01557384483841,8.11753027045514e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0468739395146668,0.00950997732588754,0.0282343839559272,0.0655134950734064,8.36929201606555e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0160494688198402,0.00325620427790387,-0.0224316292045318,-0.00966730843514863,8.38643977562454e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0154474179505726,0.00313590740552465,-0.0215937964654009,-0.00930103943574427,8.51241596985119e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0245625851987065,0.00498871684957202,-0.0343404702238676,-0.0147847001735453,8.61521443776148e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0380401502258666,0.00774729680992955,-0.0532248519733285,-0.0228554484784046,9.23246257150389e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0303649568610761,0.00618537425730471,-0.0424882904053933,-0.0182416233167589,9.25542077711857e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0317167883121568,0.00646177593310846,-0.0443818691410494,-0.0190517074832642,9.29053358032541e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0336934269587962,0.00687222065463881,-0.0471629794418883,-0.0202238744757042,9.57686238218133e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0373095038310448,0.00761108153316776,-0.0522272236360536,-0.022391784026036,9.62169029482239e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0272019842557495,0.00555646638158528,-0.0380926583636567,-0.0163113101478424,9.91814243969518e-07
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0173783424200391,0.00355174132486779,0.0104169294232982,0.0243397554167799,1.00499722947486e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0492751114584328,0.0100829233796067,-0.0690376412824619,-0.0295125816344037,1.03576161891547e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42137,-0.0228361216874115,0.00467291119214785,-0.0319950276240213,-0.0136772157508017,1.03601227088984e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0450404670254229,0.0092169865854836,-0.0631057607329708,-0.0269751733178751,1.03954848730458e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0174629582698775,0.00357834762019476,-0.0244765196054592,-0.0104493969342957,1.074616797364e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0112355768430365,0.0023050813955103,-0.0157535363782367,-0.00671761730783635,1.10721340795103e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0297540904104151,0.0061067123910199,-0.0417232466968141,-0.0177849341240161,1.11766475408237e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0480432840791398,0.0098626280846567,-0.0673740351250669,-0.0287125330332127,1.12147241856004e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42137,-0.0322291443903717,0.00661899498379201,-0.0452023745586041,-0.0192559142221394,1.13322120971062e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.0157761009413082,0.00324028769291728,0.00942513706319035,0.0221270648194261,1.13858090236804e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.015282162917857,0.00314008844684774,-0.0214367362736785,-0.00912758956203539,1.1470178323049e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0121248352983771,0.00249288422723433,-0.0170108883837564,-0.00723878221299784,1.16462897857166e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0197435326392862,0.00405978537685349,-0.027700711977919,-0.0117863533006534,1.16833600229942e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0252499885874586,0.00519204133724862,-0.0354263896084659,-0.0150735875664513,1.17124554666688e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0214976342817993,0.00442384758403088,-0.0301683755464998,-0.0128268930170988,1.18993249559415e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0341211850230717,0.00702401081459778,-0.0478882462196834,-0.0203541238264601,1.20318318138658e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0155005208116453,0.0031919936594999,0.00924421323902545,0.021756828384265,1.21343380643055e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0494871039578794,0.0102057029315286,-0.0694902817036755,-0.0294839262120834,1.25487914483981e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0256373498089232,0.00528817502554782,-0.0360021728589969,-0.0152725267588494,1.26088811573103e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,39930,-0.0292192512617668,0.00603251179272166,-0.0410429743755013,-0.0173955281480324,1.29175685221651e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42299,-0.0170892999531729,0.00352908663819315,-0.0240063097640314,-0.0101722901423143,1.2967212694345e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0167226790500174,0.00346040717606959,-0.0235050771151138,-0.009940280984921,1.36255411422465e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39418,-0.0118272327802508,0.0024526624246398,-0.0166344511325448,-0.00702001442795676,1.43917059508102e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0399128877893344,0.00827993210226292,-0.0561415547097697,-0.0236842208688991,1.45152597590502e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,39929,0.0191619452789597,0.00398234267341509,0.0113565536390661,0.0269673369188532,1.51561993823088e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.0139787506503283,0.00290545092495501,-0.0196734344632401,-0.00828406683741644,1.51613929055136e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0238453898938115,0.00496387794189227,-0.0335745906599204,-0.0141161891277027,1.57386844489335e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.013329370612892,0.00277502377988286,0.00789032400432156,0.0187684172214624,1.58034584633921e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0432084876918724,0.00899649148510585,-0.0608416110026798,-0.0255753643810649,1.58127940609819e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0145260673702043,0.00303105170311048,-0.0204669287083008,-0.00858520603210773,1.66877725087097e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,39929,-0.0112057718629847,0.00233843378795909,-0.0157891020873845,-0.00662244163858492,1.67224485288894e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0327820268684983,0.00684362403315145,-0.0461955299734751,-0.0193685237635214,1.68412146188551e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.0108260087376545,0.00226088736343624,0.00639466950531945,0.0152573479699895,1.69917757868735e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0247627830740433,0.0051734712819066,-0.0349027867865802,-0.0146227793615063,1.71555536950861e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0339565650488663,0.0070938163350029,-0.0478604450654719,-0.0200526850322606,1.71617784230326e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42185,0.0330643627308274,0.00691613057089241,0.0195087468118783,0.0466199786497765,1.76464297809173e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0169029114175522,0.00353583455143002,-0.023833147138355,-0.00997267569674936,1.7672928714017e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,39948,-0.0220130834767055,0.00460845362390411,-0.0310456525795576,-0.0129805143738535,1.80448971731557e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0195877447089367,0.00410414579241508,-0.0276318704620703,-0.0115436189558031,1.84143194481641e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,41960,0.0199802029492571,0.00419677561536626,0.0117545227431392,0.028205883155375,1.94805443571059e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0171140338281402,0.00359667597626211,0.0100645489146664,0.0241635187416139,1.97701421507945e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0265277662128039,0.00557866371156554,-0.0374619470874723,-0.0155935853381354,2.00284834555592e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,39990,-0.0372121293537731,0.00783400996759957,-0.0525667888902683,-0.021857469817278,2.05824082692076e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0343958831349183,0.00724632860958714,-0.0485986872097091,-0.0201930790601275,2.09397661593684e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.015547376134429,0.00327581525262154,-0.0219679740295672,-0.00912677823929077,2.09971023199008e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COCH,Cochlin,39958,-0.022726892439816,0.00478908249599757,-0.0321134941319713,-0.0133402907476608,2.10463223591831e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0327460977583054,0.00690115248513552,-0.0462723566291711,-0.0192198388874398,2.11034144503302e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.0352944074858168,0.00744235929042762,-0.0498814316950549,-0.0207073832765786,2.13374873748368e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.028612164314559,0.00604227597313602,-0.0404550252219055,-0.0167693034072124,2.20967278284369e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0117414422010298,0.00248402259031647,-0.01661012647805,-0.00687275792400948,2.30419723192143e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0325483739841757,0.0068897985649591,-0.0460523791714955,-0.0190443687968559,2.33419006642418e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0610782796634179,0.0129296401748448,-0.0864203744061137,-0.0357361849207222,2.3429927052715e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0533320124032587,0.0113037095464693,-0.0754872831143385,-0.0311767416921788,2.40905709369182e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,41992,-0.0246618190530302,0.00523159746555129,-0.0349157500855107,-0.0144078880205497,2.45331845665069e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.0117533355941407,0.00249450020166005,0.00686411519888704,0.0166425559893945,2.48139830423621e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0227540593481582,0.00482972447288489,-0.0322203193150125,-0.0132877993813038,2.4864317586494e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42145,-0.0267874289770355,0.00568651145696989,-0.0379329914326965,-0.0156418665213745,2.49323899778139e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0272434158498471,0.00578285749495888,-0.0385778165399665,-0.0159090151597277,2.49427954852186e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0274376814374389,0.00582531993403257,-0.0388553085081427,-0.016020054366735,2.50110336895388e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0477027578917247,0.0101274470965185,-0.0675525542009008,-0.0278529615825485,2.50431143454381e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0196818720030922,0.00417992752382048,-0.0278745299497804,-0.0114892140564041,2.51797685974417e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0183973531068234,0.00390863925980109,-0.0260582860560335,-0.0107364201576132,2.54119057694758e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0101595820907733,0.00216127454562104,-0.0143956802001906,-0.0059234839813561,2.61793037368136e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0370678280760635,0.00789903124042775,-0.0525499293073019,-0.0215857268448251,2.72856312291624e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0333754575757029,0.00712630835474556,-0.0473430219510042,-0.0194078932004016,2.84880462802759e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0198446150855577,0.00423833022152287,-0.0281517423197426,-0.0115374878513729,2.87241939187559e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,39757,-0.0263116872971169,0.00563535237193176,-0.0373569779461032,-0.0152663966481307,3.06139125726105e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0147935932892771,0.00317015439572101,-0.0210070959048903,-0.00858009067366392,3.09852283653778e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0159944297343493,0.00343575531704965,-0.0227285101557666,-0.009260349312932,3.26615951264004e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,39929,0.0436752049072645,0.00939203611399891,0.0252668141238267,0.0620835956907024,3.35300793221003e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0238119131903717,0.00512110789567278,0.013774541714853,0.0338492846658904,3.35496281954446e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0159731425381235,0.00343612614895039,-0.0227079497900663,-0.00923833528618073,3.37968514730264e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0146668081147406,0.00315644516825845,-0.0208534406445272,-0.00848017558495404,3.40575004105638e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0565515349675546,0.012191622494298,-0.0804471150563787,-0.0326559548787305,3.54178920471595e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42119,-0.0166215042864325,0.00358362166545038,-0.0236454027507152,-0.00959760582214971,3.5477516018233e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,39736,-0.0150167303276698,0.00324019883572304,-0.021367520045687,-0.00866594060965269,3.61848391598355e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0353539868100885,0.00763284188518975,-0.0503143569050604,-0.0203936167151166,3.66491066100413e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0149073402304809,0.00322852468230868,0.00857943185315587,0.0212352486078059,3.9287123983435e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0282436173493873,0.00612448218386418,-0.0402476024297611,-0.0162396322690135,4.03224372659566e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0280464327659167,0.00609449996798999,-0.0399916527031771,-0.0161012128286563,4.22381612384695e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0223025056651467,0.00485467053690554,-0.0318176599174816,-0.0127873514128119,4.38652441330376e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00917141195751237,0.0019991177969273,0.00525314107553487,0.0130896828394899,4.52087018496877e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0445380807540323,0.00971896851673198,-0.063587259046827,-0.0254889024612376,4.63352688989934e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42296,-0.0226612100308993,0.00494626925677763,-0.0323558977741834,-0.0129665222876151,4.65781948768269e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0266211122399104,0.0058145945224671,-0.0380177175039459,-0.0152245069758749,4.7369946253815e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,39979,0.0100454309915795,0.00220055449281849,0.00573234418565525,0.0143585177975037,5.04840038346335e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0165035519447988,0.00361562247162325,-0.0235901719891804,-0.00941693190041727,5.06057417571517e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0449677215569656,0.00986709957975166,-0.0643072367332788,-0.0256282063806523,5.23474161800133e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0195182909556863,0.0042892178389791,-0.0279251579200853,-0.0111114239912872,5.40726751195696e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0131669620449016,0.00289608152155207,0.0074906422626595,0.0188432818271436,5.50271737567291e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0344423510800427,0.0075828577810079,-0.0493047523308182,-0.0195799498292672,5.61657475090759e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0408744868842539,0.00900592893270869,-0.0585261075923629,-0.0232228661761449,5.72072343775153e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0488897049946947,0.0107984126182263,-0.0700545937264183,-0.0277248162629711,6.01958528755043e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0123102094471914,0.00272551655371213,0.00696819700191558,0.0176522218924671,6.34757283975592e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0265526542215674,0.00588034782851769,-0.0380781359654621,-0.0150271724776727,6.37157579425814e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0296154550407253,0.00655905286644012,-0.0424711986589479,-0.0167597114225027,6.3911601857373e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,41654,0.0147748495530992,0.00327478448690965,0.00835627195875629,0.0211934271474421,6.48711379057201e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0143003922701144,0.00317422908348884,-0.0205218812737526,-0.0080789032664763,6.69855782705164e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0282884352462332,0.00629080490721966,-0.0406184128643837,-0.0159584576280826,6.95652881707378e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0117938168456445,0.00262318737611882,0.00665236958845166,0.0169352641028374,6.98227188283278e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0443972220065282,0.00987731686828204,-0.0637567630683609,-0.0250376809446954,7.02015294423335e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.0165165930563597,0.00367644877181712,0.00931075346359818,0.0237224326491213,7.09611869207122e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0309349797718983,0.00689356077516887,-0.0444463588912293,-0.0174236006525673,7.27861281122489e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0477060714749457,0.0106425091919045,-0.0685653894910785,-0.0268467534588128,7.43425249500369e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0191042411607132,0.0042624098502019,0.0107499178543175,0.027458564467109,7.46631359328159e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0178172524705003,0.00398192845648958,-0.0256218322452199,-0.0100126726957807,7.72186850093535e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,39990,-0.0135501821379116,0.00303017666612161,-0.01948932840351,-0.00761103587231328,7.83338979447396e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42070,-0.0144511380473141,0.00323842754345554,-0.020798456032487,-0.00810382006214125,8.17065485625641e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0438870252422884,0.00984321395416917,-0.06317972459246,-0.0245943258921168,8.31634848778713e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0251409764010316,0.00564150058532105,-0.0361983175482609,-0.0140836352538023,8.41464757169584e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0249796721675433,0.00560835086341964,-0.0359720398598458,-0.0139873044752408,8.4967006850532e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0130803519624404,0.00294073501066293,-0.0188441925833398,-0.00731651134154106,8.75314188409898e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0314834363041175,0.00708568995216243,-0.0453713886103559,-0.0175954839978792,8.94689701970065e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42310,0.0140071177128561,0.00315621398066846,0.00782093831074592,0.0201932971149663,9.1528557670896e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0247278998203292,0.00557722839759319,-0.0356592674796118,-0.0137965321610465,9.33513633477264e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0475133273025303,0.0107194846886161,-0.0685235172922178,-0.0265031373128427,9.40545235706184e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0263391071739372,0.00594338281152542,0.0146900768633474,0.037988137484527,9.42499296091416e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,41839,-0.032853370175081,0.00741413333765068,-0.0473850715168763,-0.0183216688332857,9.44710314869401e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0205380009208552,0.00463609611335469,-0.0296247493030304,-0.01145125253868,9.51316043095963e-06
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.0646676482460126,0.0146479822571622,-0.0933776934700505,-0.0359576030219747,1.020480149796e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0241499773643324,0.00547637406249173,-0.0348836705268162,-0.0134162842018486,1.04413526146043e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.0117289189973775,0.00266102849758705,0.00651330314210692,0.0169445348526482,1.05450016919242e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0297518944743295,0.00675315805600098,-0.0429880842640915,-0.0165157046845676,1.0647199611599e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0271635294109002,0.00616838518490855,-0.0392535643733209,-0.0150734944484794,1.07265262326769e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0154533311545758,0.0035098961835354,-0.0223327276743052,-0.0085739346348464,1.07705848663471e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0155158400700347,0.00352390041439415,-0.0224226848822473,-0.00860899525782218,1.0772769425787e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0213248169556313,0.00484331583924569,-0.0308177160005529,-0.0118319179107097,1.07771181023413e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0123148227599674,0.00280433222470335,-0.017811313920386,-0.00681833159954886,1.13498374040703e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0106978575848406,0.00243961132037195,0.00591621939691155,0.0154794957727696,1.1681443183749e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0179984206251342,0.00410463102997637,-0.0260434974438878,-0.00995334380638049,1.16911372394247e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.021720795381695,0.00495378507698143,-0.0314302141325786,-0.0120113766308114,1.17050246864383e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0551550670176228,0.0125891955333401,-0.0798298902629694,-0.0304802437722763,1.19154261487107e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42166,-0.0139807309636425,0.00319375553226178,-0.0202404918068755,-0.00772097012040938,1.20935010679786e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0253573697906652,0.00579471596681128,-0.0367150130856153,-0.0139997264957151,1.21804340146429e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42016,0.0154559566221818,0.00353632146399919,0.00852476655274334,0.0223871466916202,1.24819553139168e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.011075937522744,0.00253590495504405,-0.0160463112346303,-0.00610556381085767,1.26528386955484e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0181538680279265,0.00416012698405105,-0.0263077169166665,-0.0100000191391864,1.28968831117618e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0207457811487589,0.00475975402887865,-0.030074899045361,-0.0114166632521567,1.32064153317279e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0224849471547143,0.00516021406348564,-0.0325989667191461,-0.0123709275902824,1.32795529583266e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0129639577219161,0.00297747607647754,-0.0187998108318121,-0.00712810461202013,1.34654128381108e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0223073792394168,0.00512571830226123,-0.0323537871118488,-0.0122609713669847,1.36082261122393e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0301732776657595,0.00693616455232234,-0.0437681601883113,-0.0165783951432078,1.37241499909922e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.0169538382831724,0.0039112671769377,0.00928775461637451,0.0246199219499703,1.47074797777563e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0389384440222256,0.00899069387082285,-0.0565602040090384,-0.0213166840354128,1.49508486579988e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,41749,0.0303255896683857,0.00700431322300629,0.0165971357512934,0.0440540435854781,1.50513735494348e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0300209608631956,0.00693451260784977,-0.0436126055745811,-0.01642931615181,1.50972399302026e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0493432518440463,0.0114096802141538,0.0269802786243048,0.0717062250637878,1.53840949222036e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0282166050766477,0.00653286945990726,-0.0410210292180659,-0.0154121809352295,1.57719978533706e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0235115545894573,0.00545082991997328,-0.0341951812326049,-0.0128279279463097,1.62153227134268e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.020921405353095,0.00486129791776773,0.0113932614342702,0.0304495492719197,1.69450979568869e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0345521428182077,0.00803154492476776,-0.0502939708707525,-0.0188103147656629,1.70435291423461e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0504713539005358,0.0117373790978953,-0.0734766169324107,-0.027466090868661,1.71954477177994e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.00895942558925313,0.00208359022039306,-0.0130432624212235,-0.00487558875728274,1.72003375647083e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0357341875820324,0.00832110798709508,0.0194248159273261,0.0520435592367388,1.76384093607771e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0258106355850468,0.00601551436308527,-0.037601043736694,-0.0140202274333997,1.7963290078692e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0296523241413346,0.0069183588603714,-0.0432123075076625,-0.0160923407750067,1.83393966270626e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0185106916867159,0.00435982665807696,-0.0270559519365468,-0.00996543143688509,2.19314379666365e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0170956052029368,0.00402773465672324,-0.0249899651301143,-0.00920124527575921,2.20601575112393e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0618320066706179,0.0145706787383839,-0.0903905369978503,-0.0332734763433855,2.21461413364159e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0134560553729179,0.00317157911974478,-0.0196723504476176,-0.00723976029821811,2.22304700282195e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0159933760225297,0.00377660332447407,-0.0233955185384989,-0.00859123350656051,2.30561316128047e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.012089425178901,0.00285940248684416,0.00648499630468641,0.0176938540531155,2.37353409878154e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0159020107759709,0.00376584142802694,-0.0232830599749037,-0.00852096157703812,2.43008008264883e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.0549005317481066,0.0130194230321992,-0.0804186008912171,-0.0293824626049961,2.49378821724219e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0243640819051271,0.00578447173154773,-0.0357016464989606,-0.0130265173112936,2.54789159246639e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,41756,-0.0321799524723597,0.00764698485151249,-0.0471680427813242,-0.0171918621633952,2.59134425364677e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,39946,-0.0208554221811874,0.0049704749893109,-0.0305975531602367,-0.011113291202138,2.73905978523334e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42137,0.019495114272938,0.00464737473800977,0.0103862597864388,0.0286039687594371,2.74772395595985e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0238012318653724,0.00567470807047167,-0.0349236596834969,-0.012678804047248,2.75884362235144e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0364341969516909,0.00868896886561599,-0.0534645759282982,-0.0194038179750835,2.77278084247932e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LXN,Latexin,41960,0.0297723391597127,0.00711127181112104,0.0158342464099155,0.04371043190951,2.84927598919792e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.028030118476227,0.00670300393851935,-0.0411680061957249,-0.0148922307567291,2.91482821333796e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.033906272182142,0.00811411014307176,-0.0498099280625627,-0.0180026163017214,2.9503100424325e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42217,-0.0202679157150816,0.00485064836050242,-0.0297751865016663,-0.0107606449284968,2.95407533993044e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0258261549964976,0.00618713698340345,0.0136993665090269,0.0379529434839684,3.01310959636212e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.0121431850488799,0.00291835515601191,0.00642320894309653,0.0178631611546632,3.19234224147373e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.01821719041379,0.00438254602289748,0.00962740020891096,0.0268069806186691,3.25166549493713e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42187,0.0117645798241157,0.00283587056949891,0.00620627350789784,0.0173228861403336,3.36712107089234e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0313068638307852,0.00754726217173137,0.0165142299741917,0.0460994976873787,3.37679340529513e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0115759330474756,0.00280225301109221,-0.0170683489492163,-0.0060835171457349,3.63949468575334e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.032502459033938,0.00787044981671945,-0.0479285406747081,-0.0170763773931679,3.6545940603582e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.02894584106482,0.00702120989694777,-0.0427074124628377,-0.0151842696668024,3.77329640006392e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0225303081075881,0.00546838263212172,-0.0332483380665466,-0.0118122781486295,3.81396051295561e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0215512243325399,0.00523331382208809,-0.0318085194238325,-0.0112939292412472,3.84355645388764e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0115362006000817,0.00280464795117473,-0.0170333105843842,-0.00603909061577928,3.92436215287699e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42145,-0.052516693731418,0.0127803480602606,-0.0775661759295288,-0.0274672115333071,3.99411241090202e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0243549142998832,0.00592849431008347,-0.0359747631476468,-0.0127350654521196,4.01307087141399e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0301604046796105,0.00734328599581685,0.0157675641278095,0.0445532452314115,4.02822951243719e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0176744986159657,0.00430618636553214,-0.0261146238924087,-0.00923437333952273,4.08130049896607e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.021788880849451,0.00531596145774706,-0.0322081653066353,-0.0113695963922668,4.18305455508637e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,41913,0.0130505462251197,0.00318598949116116,0.00680600682244386,0.0192950856277956,4.22417239534796e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0309781857818714,0.00756709805687663,-0.0458096979733496,-0.0161466735903932,4.26868228164492e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0446462850056676,0.0109073390427982,-0.0660246695295521,-0.0232679004817831,4.27889863821125e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0296353248620974,0.00725184896649514,-0.0438489488364279,-0.0154217008877669,4.40329131501096e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0155822318720083,0.00382161044352692,-0.023072588341321,-0.0080918754026955,4.58039426437522e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42082,-0.037148290463209,0.00911562277298173,-0.0550149110982532,-0.0192816698281648,4.623160218229e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,39970,0.0151042028639984,0.00370842799504864,0.0078356839937031,0.0223727217342938,4.67383348220019e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.029627702992094,0.00727649983106423,0.0153657633232081,0.0438896426609799,4.69449453304037e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLU,Clusterin,39979,0.0127818282770398,0.00313958256724216,0.00662824644524515,0.0189354101088344,4.70906028343246e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0211374625834875,0.00519391698585671,-0.0313175398757666,-0.0109573852912083,4.74099375171883e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42129,-0.016106577430322,0.00396562599586839,-0.0238792043822241,-0.00833395047842,4.90233528948726e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.011389380883259,0.00280661605677462,-0.0168903483545373,-0.00588841341198075,4.97626147608994e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0154082675606601,0.00379733606866018,-0.0228510462552341,-0.00796548886608616,4.99010585806683e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0192400553178211,0.00475133972345391,-0.0285526811757908,-0.00992742945985145,5.16929634521449e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2,Brorin,41973,-0.0171695628017724,0.0042449661377104,-0.0254896964316848,-0.00884942917186006,5.26870126977263e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0268119341716243,0.00663780065529592,-0.0398220234560043,-0.0138018448872443,5.3912099101892e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0181404205446757,0.00449201650520769,-0.0269447728948828,-0.00933606819446867,5.41190934973043e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0184009720136553,0.00456472632444872,-0.0273478356095748,-0.00945410841773577,5.58861091566517e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0240900050923424,0.00598520985503795,-0.0358210164082168,-0.012358993776468,5.73112540723168e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.0279391913895037,0.00694343400849262,-0.0415483220461492,-0.0143300607328582,5.7643713536356e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.016221647354165,0.00403354950532755,-0.024127404384607,-0.00831589032372303,5.81592457936667e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0329823479074023,0.00821210037284707,-0.0490780646381826,-0.0168866311766221,5.95072152272711e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0205054173470538,0.00511156922305686,-0.0305240930242452,-0.0104867416698623,6.07140911441125e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,41846,-0.0233922423598064,0.00583348327103024,-0.0348258695710257,-0.0119586151485871,6.10529425532006e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0299805626167573,0.00748090468677737,-0.0446431358028409,-0.0153179894306737,6.17287714376633e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.00999424221427084,0.00249433110208705,-0.0148831311743615,-0.00510535325418023,6.18808493831518e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0190278633225433,0.00474894224408352,-0.028335790120947,-0.00971993652413965,6.19525581277938e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,41751,-0.031319669692748,0.00781732266615552,-0.0466416221184128,-0.0159977172670831,6.19790081189057e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42217,-0.0232014002041603,0.0057986791713273,-0.0345668113799618,-0.0118359890283588,6.33682122645853e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0169073797560782,0.00422718455020456,-0.0251926614744791,-0.00862209803767724,6.38318848660088e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,39979,-0.00894112803839502,0.00223580230548937,-0.0133233005571542,-0.00455895551963586,6.3994099386737e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.011507591366782,0.00288331288834133,-0.017158884627931,-0.00585629810563303,6.61125490503496e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,39934,-0.0229893378313876,0.00576306174699849,-0.0342849388555046,-0.0116937368072705,6.67459078687533e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0461904672940483,0.011592335796316,-0.0689114454548277,-0.0234694891332688,6.79604729862237e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0111370932758638,0.00279536279692764,-0.0166160043578419,-0.00565818219388557,6.80837387795136e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0238560824109598,0.00598894426579904,-0.0355944131719259,-0.0121177516499937,6.83083562642683e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,41839,-0.0140502685905426,0.0035285690562896,-0.0209662639408702,-0.00713427324021502,6.87433892769748e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42070,-0.0187414898704358,0.00470687363427096,-0.0279669621936069,-0.0095160175472647,6.87753508519036e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0158501321572691,0.00398284271914233,-0.0236565038867881,-0.00804376042775013,6.93985756528031e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0184010850564308,0.00462450286509799,-0.0274651106720229,-0.00933705944083872,6.96249586467363e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0219168348064484,0.00550873444834414,-0.0327139543252029,-0.0111197152876939,6.97768286734591e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.026037468758768,0.00656369506411094,-0.0389023110844254,-0.0131726264331105,7.3199467212697e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0253845675652536,0.00640384890566166,-0.0379361114203504,-0.0128330237101567,7.41053490660671e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0140010068327879,0.00353272240863576,-0.020925142753714,-0.00707687091186181,7.4406049405194e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,41976,0.0267608710296818,0.00676382185738326,0.0135037801892106,0.040017961870153,7.64574883981052e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42145,-0.0100699323786267,0.0025463984505201,-0.0150608733416461,-0.0050789914156073,7.70598404925041e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0231812750977805,0.00586314394656313,-0.0346730372330443,-0.0116895129625168,7.73416571837334e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0312339242094323,0.0079082995316563,-0.0467341912914786,-0.0157336571273859,7.870659735824e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42018,0.0196929306576206,0.00498694400858906,0.009918520400786,0.0294673409144551,7.89130554799375e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,39575,0.0287583082098235,0.00729801686826743,0.0144541951480194,0.0430624212716277,8.17938741356333e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0264950867945364,0.00673240174922412,-0.0396905942230156,-0.0132995793660571,8.3449732046497e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0195330458403723,0.00496550342566362,-0.029265432554673,-0.00980065912607164,8.41282443636366e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGN,Biglycan,41820,0.0481864326350144,0.0122656779328961,0.0241457038865381,0.0722271613834906,8.58911226695571e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0276247061283988,0.00703295175664982,-0.0414092915714325,-0.0138401206853652,8.61170876009783e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0460999591423475,0.0117375993149889,-0.0691056537997257,-0.0230942644849692,8.62392957659096e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0168749710690691,0.0043041293442509,-0.0253110645838009,-0.00843887755433738,8.87566106865208e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0226530455584922,0.0057885483964727,-0.0339986004155787,-0.0113074907014057,9.15418503052649e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0236923553120684,0.00605423781354313,-0.035558661426613,-0.0118260491975239,9.1557080599726e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00986048293827169,0.00252377925153148,0.00491387560527,0.0148070902712734,9.39775550055555e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.018044267703968,0.0046309133847166,0.00896767746992351,0.0271208579380126,9.80707828881222e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,41839,-0.0275566615234706,0.00707943443084896,-0.0414323530079345,-0.0136809700390066,9.97051530747769e-05
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0410674362367566,0.0105696931132975,-0.0617840347388198,-0.0203508377346934,0.000102650692159215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0173643540118833,0.00448126513415737,-0.0261476336748317,-0.00858107434893485,0.000107192492825558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0336972038185653,0.00871302136000923,-0.0507747256841834,-0.0166196819529472,0.000110506965655801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0194305928905246,0.00502484177152946,-0.0292792827627223,-0.00958190301832687,0.000110841469462518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAT,Catalase,39827,-0.0211268084398187,0.00547049792764647,-0.0318489843780058,-0.0104046325016316,0.000113115505398057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.00665912196199811,0.00172448928088852,-0.0100391209525396,-0.00327912297145661,0.00011331517830831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0136403455158709,0.00353299507097989,-0.0205650158549915,-0.00671567517675032,0.000113529117929867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00904545864063786,0.00234451747656401,0.0044502043865724,0.0136407128947033,0.000114888419366454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42286,0.0176083634218985,0.00457215285441066,0.00864694382725359,0.0265697830165434,0.000118066622916333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0196792302144504,0.00511718672963439,-0.0297089162045338,-0.00964954422436697,0.000120860419733387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0426489976646765,0.0110987345527875,-0.0644025173881399,-0.0208954779412131,0.000122246950698666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0147034627319175,0.00382616411565635,-0.022202744398604,-0.00720418106523109,0.000122266995951779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0218327407862414,0.00568223771759195,-0.0329699267127216,-0.0106955548597611,0.000122463249258829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0310411136708659,0.00808771436644338,-0.0468930338290949,-0.0151891935126368,0.00012457742481158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.0096053906464588,0.00250270015319873,0.0047000983461893,0.0145106829467283,0.000124598878484138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0238243314511471,0.00621187739589515,-0.0359996111471016,-0.0116490517551926,0.000126097294803748
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0195494208884784,0.0051017096733836,-0.0295487718483103,-0.00955006992864654,0.000127848225144834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0240340644239729,0.00627265599844873,-0.0363284701809324,-0.0117396586670134,0.0001280200553381
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0188115034800318,0.00491189520869863,-0.0284388180890811,-0.00918418887098248,0.000128964087390734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0303491000306616,0.00792636946708492,-0.0458847841861481,-0.0148134158751752,0.000129422200314853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0145833353914369,0.00381012927110495,-0.0220511887628025,-0.00711548202007116,0.000130162018081548
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0178888422092318,0.00467755001161037,-0.0270568402319881,-0.0087208441864755,0.000131679670081435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0191774912146619,0.00503051818561874,-0.0290373068584747,-0.0093176755708492,0.000138448045449173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0209878154930869,0.00552237627682615,0.0101639579905077,0.0318116729956662,0.000145028692293973
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0128446089056131,0.00338167485114893,-0.019472691613865,-0.00621652619736118,0.000146321944853672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,39966,0.0126989757923206,0.00335022929182626,0.00613252638034117,0.0192654252043001,0.000151133690416192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,39979,-0.0162986432582927,0.00430400275836497,-0.0247344886646881,-0.0078627978518974,0.000153349484753605
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0260921574760502,0.00689917314859396,-0.0396145368472943,-0.012569778104806,0.000156445912159971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0143407458169012,0.00379892054692211,-0.0217866300888685,-0.00689486154493386,0.000160727675978409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0311373039208456,0.00825898497187333,-0.0473249144657173,-0.0149496933759738,0.000163883186211894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0247140508716138,0.00655533655211899,-0.037562510513767,-0.0118655912294606,0.000164037748716313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0204416751567005,0.00542293287728851,-0.0310706235961859,-0.009812726717215,0.000164276807775857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0344595368170946,0.00914506355685582,-0.052383861388532,-0.0165352122456572,0.000165349208103519
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.019041756391457,0.00506458013831666,0.00911517932035636,0.0289683334625577,0.000170769421011462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0184786740995953,0.00491458921275925,-0.0281112689566034,-0.00884607924258714,0.000170793052624044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0568889095249939,0.0151552826021148,0.0271845556248489,0.0865932634251389,0.000175085319974297
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0373140588291145,0.00994639688809001,-0.0568089967297709,-0.0178191209284581,0.000176503422985689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.0156001566416753,0.00416104294782424,0.0074445124639398,0.0237558008194108,0.000178201978685205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0129261595553583,0.00344974736028784,-0.0196876643815225,-0.00616465472919414,0.00017987497796121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0127341829107815,0.00340227766248777,-0.0194026471292575,-0.00606571869230547,0.000182694697754004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,41913,-0.0298185539508525,0.00797582891777489,-0.0454511786296913,-0.0141859292720138,0.000185811705544268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0391862776177284,0.0104840734422541,-0.0597350615645465,-0.0186374936709103,0.000186474063817886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0211795525704127,0.00567217527520861,-0.0322970161098216,-0.0100620890310038,0.000189429866871922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0305303087472639,0.00818051444294295,-0.0465641170554321,-0.0144965004390957,0.000190835766985204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0282781418511921,0.00758013494199138,-0.0431352063374952,-0.013421077364889,0.000191849671977543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.00918451529829602,0.00246323784352377,-0.0140124614716026,-0.00435656912498944,0.000193298101394341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0141871565655329,0.00380486197520403,-0.0216446860369328,-0.00672962709413304,0.000193414605108541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0177038804845208,0.0047535671995049,0.00838688877349124,0.0270208721955504,0.000196622513338126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0234533945389177,0.00629880519672583,-0.0357990527245003,-0.011107736353335,0.000197467355502479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0173123760451297,0.00465230286164459,-0.0264308896539531,-0.00819386243630628,0.000199222550925955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0280007645630698,0.00752749368583848,-0.0427546521873132,-0.0132468769388264,0.000200344235135818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0302523992105092,0.00816178529141837,0.0142553000393292,0.0462494983816892,0.000210903638583853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,39870,0.0125664828245192,0.00339707411399341,0.0059082175610921,0.0192247480879463,0.000217301858532196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0256363069313305,0.00694649556376619,-0.0392514382363122,-0.0120211756263488,0.000224847496801243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,41839,-0.0281545933485169,0.00763349873844965,-0.0431162508758782,-0.0131929358211556,0.000226665515598529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0367551500137874,0.00998106236234726,-0.056318032243988,-0.0171922677835868,0.000231886633679455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0164386470743053,0.00446587411595512,-0.0251917603415773,-0.00768553380703325,0.000233482758162143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0132586439689451,0.00361018689555749,-0.0203346102842378,-0.00618267765365242,0.000241052929517444
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0262438550356875,0.00715029401869013,-0.0402584313123202,-0.0122292787590548,0.000243171813755693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0248843195522707,0.00679150151127834,0.0115729765901652,0.0381956625143762,0.00024921885781198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0110848872119393,0.00302665610885394,-0.017017133185293,-0.00515264123858557,0.000250796427046096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.0168789211779036,0.00460990071253252,0.00784351578133983,0.0259143265744673,0.000251963261774049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0171640716289264,0.00468839436910849,-0.026353324592379,-0.00797481866547372,0.000252218357448057
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0156659037816778,0.00427992120683692,-0.0240545493470782,-0.00727725821627745,0.000252854604337164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0162772417046256,0.00444878327160033,-0.0249968569169623,-0.00755762649228895,0.000254355084243938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,39958,-0.0206015419035219,0.00563973822412472,-0.0316554288228064,-0.00954765498423748,0.000260436439561107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.039983359639933,0.0109526245675315,-0.0614505037922947,-0.0185162154875714,0.000262853555600488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,39859,0.0115891289638085,0.00319514025631097,0.00532665406143899,0.017851603866178,0.000287876775178798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42077,-0.00944956653471836,0.00260905881255214,-0.0145633218073206,-0.00433581126211616,0.000293600833344687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.0030798827955748,0.000850325344640227,0.00141324512007995,0.00474652047106964,0.000293620978259532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42146,-0.0212257116524429,0.00586773956921109,-0.0327264812080966,-0.00972494209678916,0.000298708318943024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,39979,-0.00773903098656776,0.00214056329069092,-0.011934535036322,-0.00354352693681357,0.000301159092827598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.0104833020628417,0.00290552922986208,0.00478846477231204,0.0161781393533714,0.000309606638492443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0253198394463185,0.00702354549503695,-0.0390859886165909,-0.0115536902760461,0.000313545494164652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.013165800517152,0.00365528211274275,-0.0203301534581278,-0.00600144757617624,0.000317071246639434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0228172853037939,0.00633509319975974,-0.035234067975323,-0.0104005026322648,0.000317241657105106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0235291590903319,0.00653434485449946,-0.0363364750051508,-0.0107218431755129,0.000318331710512916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0182140348761923,0.00505974202484795,-0.0281311292448943,-0.00829694050749032,0.000319607285946017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42070,-0.013074121430851,0.00363256170144397,-0.0201939423656812,-0.00595430049602087,0.000320408972225612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42069,-0.01655315378104,0.00460202115048014,-0.0255731152359811,-0.00753319232609892,0.000323146305537189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0201034427388507,0.00559054994472253,-0.0310609206305069,-0.00914596484719453,0.000324561178331888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0102261300790814,0.00284960431328324,0.00464090562504623,0.0158113545331165,0.000333848632562783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.031621582425845,0.00882006129098901,-0.0489089025561834,-0.0143342622955065,0.000338250751858042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42119,-0.014668562015386,0.00410184546029406,-0.0227081791175624,-0.0066289449132097,0.000349990995657306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.0309032367195616,0.00864438997579938,0.0139602323669948,0.0478462410721283,0.000351517511555851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.01496327339446,0.00418541313744969,0.00675986364505858,0.0231666831438614,0.000351546276348397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0184565930932463,0.00516486527374998,0.00833345715669636,0.0285797290297963,0.000353710588684752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0330709896638925,0.00925864590001115,-0.0512179356279144,-0.0149240436998707,0.000355631961473994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0489224661233908,0.0137262049734472,-0.0758258278713473,-0.0220191043754342,0.000366555362819396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0230676418955798,0.00647398513247486,-0.0357566527552305,-0.010378631035929,0.00036772045478577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.00765355975861051,0.00215040218456455,-0.011868348040357,-0.00343877147686399,0.000373399255713633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0128639432267248,0.00361680647887083,0.00577500252813795,0.0199528839253116,0.000377106109573167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42016,0.0154338264136997,0.00434580746562919,0.00691604378106645,0.0239516090463329,0.000384458480925317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0270143248978387,0.00761444989985635,-0.0419386467015571,-0.0120900030941202,0.000389821859949572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.0126637585294072,0.00356945802899317,0.00566762079258061,0.0196598962662339,0.000390014130609159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,39875,0.0269881654007201,0.00761126457974385,0.0120700868244221,0.041906243977018,0.000392982110171915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0216230866102383,0.00610191026103221,-0.0335828307218614,-0.00966334249861513,0.00039620395747969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0297552642560904,0.00842256003730852,-0.0462634819292151,-0.0132470465829657,0.000412567628544541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0126281662720404,0.0035754691605198,-0.0196360858266592,-0.00562024671742162,0.000413974411921119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0189914379792316,0.00538111932828463,-0.0295384318626695,-0.00844444409579373,0.000418100892297021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,39736,0.0127567280537556,0.00361835334470834,0.00566475549812725,0.019848700609384,0.000424283735207388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0159381552656701,0.00452139320336132,-0.0248000859442583,-0.00707622458708193,0.000425062386205392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.045718544878828,0.0129758779427667,-0.0711512656466508,-0.0202858241110053,0.000427863412714512
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0155534561693599,0.00441468684368448,-0.0242062423829815,-0.00690066995573827,0.000427891894851518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0116165744290755,0.00329826856973451,-0.0180811808257551,-0.00515196803239583,0.000429685670507788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0280055603364195,0.00796897932063574,-0.0436247598048656,-0.0123863608679735,0.000442318831656845
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0380392472572111,0.0108305575063353,-0.0592671399696282,-0.0168113545447939,0.00044583810013076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.018141178374639,0.00516533490654107,-0.0282652347914596,-0.00801712195781854,0.000446024566602237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.010045991317957,0.00286045551411892,-0.0156524841256301,-0.00443949851028393,0.000446137988838537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,39866,-0.0349458633705825,0.00995842917622214,-0.0544643845559779,-0.0154273421851871,0.000451254796928295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.011305368143513,0.00322213560056035,-0.0176207539206112,-0.00498998236641468,0.000452122760612969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0189054265213888,0.00539131620365167,-0.0294724062805461,-0.00833844676223154,0.000455298372972217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,39934,-0.0222290421849075,0.00634009717835021,-0.0346556326544739,-0.0098024517153411,0.000456475395331674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42035,-0.0247222997832942,0.00705735666204941,-0.038554718840911,-0.0108898807256773,0.00046145202187049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.0100188187109277,0.00286135536381907,0.00441056219784231,0.0156270752240131,0.000464264517476003
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0193706803048806,0.00553295181153873,-0.0302152658554966,-0.00852609475426473,0.000465404466011808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0207689370832317,0.00593850669327777,-0.0324084102020561,-0.00912946396440727,0.000471735519790021
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0263814065237085,0.00754507025918752,-0.041169744231716,-0.0115930688157009,0.000473224968704555
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0143415798751257,0.00410254243040927,-0.0223825630387279,-0.00630059671152357,0.000474486134557738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0282429695258917,0.00808875188820237,-0.0440969232267683,-0.0123890158250151,0.000481950862977732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0176092411084517,0.00504597446997196,-0.0274993510695968,-0.00771913114730666,0.000485287428346064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0116456968663176,0.00333852128699804,-0.0181891985888338,-0.00510219514380145,0.000487682837071046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0132670200721786,0.00380782758364702,-0.0207303621361268,-0.00580367800823044,0.000495625331041234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0227065265943083,0.00652445777069964,-0.0354944638248796,-0.00991858936373705,0.000502893050867731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0229725273751067,0.00661083608637898,-0.0359297661044095,-0.0100152886458039,0.000512801230419282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSG,Basigin,42284,-0.00754282341919906,0.0021708863568933,-0.0117977606787099,-0.0032878861596882,0.000513321509369973
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0136465954543793,0.00392751608405283,-0.0213445269791229,-0.0059486639296358,0.000513567804261063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0188017020846273,0.00541370964734048,-0.0294125729934146,-0.00819083117583994,0.00051630577964543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,41900,-0.0179575557927829,0.00517369288415204,-0.0280979938457208,-0.00781711773984486,0.000520293795980817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42137,0.0071818090540535,0.00207150993648617,0.0031216495785406,0.0112419685295664,0.000528045569269649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0252976804316976,0.00729811914971396,-0.0396019939651369,-0.0109933668982582,0.000529251432715032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0231351072015749,0.00669748778680699,-0.0362621832637166,-0.0100080311394332,0.000553458473449752
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0105590252507825,0.00306399139251885,0.00455360212144554,0.0165644483801194,0.00057030356714449
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0396579428182499,0.0115112339338609,-0.0622199613286173,-0.0170959243078824,0.000572469328737855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42119,-0.0171160625661806,0.00496907317493897,-0.026855445989061,-0.00737667914330025,0.000573814053357434
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0197824820702147,0.00574417030118444,-0.0310410558605362,-0.00852390827989317,0.000575054245657948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0118939945383579,0.00345645458441873,-0.0186686455238186,-0.00511934355289719,0.000581453531620824
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0151939099694182,0.00442614917195889,-0.0238691623464576,-0.00651865759237876,0.000599662267418614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42144,-0.011628351135889,0.00338999207748571,-0.018272735607761,-0.00498396666401704,0.000604934789130902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0260653941054695,0.00760667133243641,-0.0409744699170448,-0.0111563182938941,0.000613303489256603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0140091676094766,0.00409278736595151,0.00598730437221166,0.0220310308467416,0.000621430745110336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0197587444185621,0.00579594001536222,-0.0311187868486721,-0.00839870198845218,0.000653756629888735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0133122347190376,0.00390593529712759,-0.0209678679014077,-0.00565660153666753,0.000656245927661488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0258088992699406,0.00757672062815827,-0.0406592717011308,-0.0109585268387504,0.000660758427322214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0183444431979982,0.00538763091039442,-0.0289041997823713,-0.00778468661362514,0.000663780345282853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0242160358979999,0.00711252198695897,-0.0381565789924395,-0.0102754928035603,0.000664653727342389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,39929,-0.0135396406601987,0.00397807124507044,-0.0213366603005368,-0.00574262101986066,0.000667419372220475
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0110318127962875,0.00324659102712186,-0.0173951312094463,-0.00466849438312865,0.000681221139783707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,41843,0.0191686897072214,0.00564474697612566,0.00810498563401506,0.0302323937804277,0.000686178994460995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0235244119126019,0.00694172198963849,-0.0371301870122933,-0.00991863681291043,0.000703858001591948
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0310381743492026,0.00917237504570904,-0.0490160294387923,-0.0130603192596129,0.000717133716271736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.0106238543734545,0.00314131209667959,0.00446688266396249,0.0167808260829465,0.000721736236856424
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0293270442142861,0.00867633463771048,-0.0463326601041987,-0.0123214283243736,0.000726652737199314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2,Complement C2,42199,-0.00793951291990047,0.0023493094767589,-0.0125441594943479,-0.00333486634545303,0.00072819419631599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,39586,-0.0226222777378876,0.00671472738965484,-0.0357831434216111,-0.00946141205416415,0.000756860999099744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0337617004249347,0.0100266201787409,-0.0534138759752668,-0.0141095248746025,0.000761471725758047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0242491557361985,0.00720765554739273,-0.0383761606090882,-0.0101221508633087,0.000769756244580282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PI3,Elafin,41966,-0.0196602703576036,0.00584470928078033,-0.0311159005479331,-0.0082046401672742,0.000771010093829514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0164424602563854,0.00488799109485419,-0.0260229228022996,-0.00686199771047119,0.000771186498702738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0151600535331177,0.00450944680471703,-0.0239985692703631,-0.0063215377958723,0.000776869504277642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0190389889267311,0.00568375037340655,-0.030179139658608,-0.00789883819485432,0.00081161067023627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0152380445894598,0.00455296148115811,-0.0241618490925297,-0.00631424008638989,0.000820103698227988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0213904074882195,0.00639309641617772,0.00885993851251117,0.0339208764639278,0.00082294373154069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0227684663956158,0.00680540336117087,-0.0361070569835107,-0.00942987580772085,0.000823635497385985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0146817797169727,0.00439097464131613,-0.0232880900139524,-0.00607546941999314,0.000829134759479619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0270578048244087,0.00810637459328556,0.011169310621569,0.0429462990272483,0.000846602003518156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0108467430250402,0.00325181925421921,0.00447317728677052,0.0172203087633098,0.000854002666726252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0200983638534457,0.00604841147904956,-0.0319532503523829,-0.00824347735450857,0.000893190500906356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0195577698919666,0.00588619413977074,0.00802082937801591,0.0310947104059172,0.000894038405917079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.0111212739132338,0.00335493880454537,0.00454559385632484,0.0176969539701427,0.000919178990169261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.026501760059815,0.00800917641057508,-0.0421997458245422,-0.0108037742950879,0.00093947086322453
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0410603119413076,0.0124125443096709,-0.0653888987882625,-0.0167317250943527,0.000942678897890349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0504463804523868,0.0152540428335613,-0.080344304406167,-0.0205484564986067,0.000945664937765073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0244151097239123,0.00738684903785001,-0.0388933338380983,-0.00993688560972627,0.000951501077611274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,39736,-0.0407422382972876,0.0123292967701184,-0.0649076599667196,-0.0165768166278556,0.000954442802250175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,39657,-0.0198445576456615,0.00600609140265502,-0.0316164967948653,-0.00807261849645764,0.000955942978203285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0192095735835428,0.00582368677826508,-0.0306239996689424,-0.00779514749814328,0.000975036064182428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0143689518017912,0.00436413249787361,-0.0229226514976234,-0.00581525210595887,0.000995498740387159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0215903826252421,0.00657691775916487,-0.0344811414332053,-0.008699623817279,0.00103056705420386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,41751,-0.0368712139625634,0.0112792646177916,-0.058978572613435,-0.0147638553116918,0.00108229312674088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0285553660110096,0.00873909278930531,-0.045683987878048,-0.0114267441439712,0.00108755803669119
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0103958274680419,0.00319127254471251,-0.0166507216556785,-0.00414093328040543,0.0011264223605743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0140297281279601,0.00432047080134676,-0.0224978508985997,-0.0055616053573204,0.00116801131635922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,39930,-0.014833843965457,0.00456799061535267,-0.0237871055715482,-0.00588058235936571,0.00116825778346078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0190443473711317,0.00587268170721373,-0.0305548035172706,-0.00753389122499274,0.00118685518379269
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42113,-0.00992295156418251,0.00306015731591924,-0.0159208599033842,-0.00392504322498079,0.00118720083561894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0178912362487622,0.00553067774097866,-0.0287313646210803,-0.00705110787644399,0.00121973824379499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.0125250775878797,0.00388260338840627,0.00491517494660339,0.020134980229156,0.00125918069371745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0292230441640144,0.0090655219145277,-0.0469914671164887,-0.0114546212115402,0.00126917367777156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0448292830693202,0.0139139110222192,-0.0721005486728697,-0.0175580174657706,0.00127644538205942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0157321258251445,0.00488395681841207,-0.0253046811892321,-0.00615957046105683,0.00127966665402953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NBN,Nibrin,41913,-0.0181534816685952,0.00563676449104894,-0.0292015400710511,-0.00710542326613923,0.00128252097737385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.00889050963205988,0.00276384100137497,0.00347338126936493,0.0143076379947548,0.00130026280685593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0207369932202279,0.00646743058271055,-0.0334131571623406,-0.00806082927811521,0.00134739058651971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0256181040798111,0.00798951498518656,-0.0412775534507768,-0.00995865470884543,0.0013474937473402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42137,0.00783170337327603,0.00244291937943719,0.00304358138957914,0.0126198253569729,0.0013496334832959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.0171987951130368,0.00538747887267185,0.0066393365226,0.0277582537034737,0.00141442993619506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42262,-0.00932664875256271,0.00292273972074951,-0.0150552186052317,-0.00359807889989367,0.00142070594421978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0240913707806469,0.00754970978548046,-0.0388888019601886,-0.00929393960110524,0.00142089243579578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0126618753193798,0.00396834569311101,0.00488391776088225,0.0204398328778774,0.0014224301313584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,41913,-0.0377783979698733,0.0118446081354305,-0.0609938299153172,-0.0145629660244295,0.00142848481205834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.0134200846605283,0.00421044591966828,0.00516761065797846,0.0216725586630781,0.00143922245508815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0260453274250515,0.00819451514644081,-0.0421065771120755,-0.00998407773802756,0.00148433868518487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0147690827473748,0.00464816172500274,-0.0238794797283802,-0.00565868576636948,0.00148941704711321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42143,-0.0347937197619978,0.0109560595323114,-0.0562675964453282,-0.0133198430786675,0.00149784026192052
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0360506922199001,0.01135334241078,-0.058303243345029,-0.0137981410947713,0.00149996661795552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.00904186510771552,0.00285195512085807,-0.0146316971445973,-0.0034520330708337,0.00152628714937564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,39979,0.00621732292090782,0.00196196892003342,0.00237186383764232,0.0100627820041733,0.00153411409532828
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.010456741423848,0.00330435452863602,0.00398020654772143,0.0169332762999746,0.00155683099603474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0113545480935366,0.00359292790043173,-0.0183966867783828,-0.00431240940869042,0.00158055456806275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0192886173947131,0.0061164132499607,-0.031276787364636,-0.00730044742479007,0.00161639701528005
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.033414206134959,0.0106254626581375,-0.0542401129449084,-0.0125882993250095,0.00166684206325459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,39966,0.015706673187922,0.00499529419822066,0.00591589655940948,0.0254974498164345,0.00166916832305596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0182748009053203,0.00581227992024776,-0.029666869549006,-0.00688273226163473,0.00166921442960332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0115036780077559,0.00366085163971148,-0.0186789472215904,-0.00432840879392144,0.00167958699479979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.0132305957449428,0.00421038922836681,-0.0214829586325417,-0.00497823285734382,0.00168019153305376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0148327356638309,0.00473172119958221,-0.0241069092150121,-0.0055585621126498,0.00172379995208677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0232104571568348,0.007415429251519,-0.037744698489812,-0.00867621582385754,0.00175244095361313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0336034727373099,0.0107379714768558,-0.0546498968319473,-0.0125570486426726,0.00175616496297098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0113990505625605,0.00366355533322111,-0.0185796190156738,-0.00421848210944708,0.00186541027160843
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.0968186314522219,0.031118128049444,-0.157810162429132,-0.0358271004753117,0.00186637121181435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0161898558257055,0.00521199218088444,-0.026405360500239,-0.00597435115117197,0.00189938802005406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0260001323113609,0.00838250645628475,-0.042429844965679,-0.00957041965704278,0.00192799534272729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0129732554307964,0.00418362848355403,-0.0211731672585623,-0.0047733436030305,0.00193377531957738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42070,0.0092712403470614,0.00299186519808906,0.00340718455880683,0.015135296135316,0.00194695625311346
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.0164635052762979,0.00533062402969858,0.00601548217808866,0.0269115283745071,0.00201602097780944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0133301390961722,0.00431703442443343,-0.0217915265680617,-0.0048687516242827,0.00202048186238616
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0268047069900412,0.00868088948033156,-0.0438192503714911,-0.00979016360859135,0.00202064759362058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0277974182925206,0.00900689935270835,-0.0454509410238289,-0.0101438955612122,0.00203206300033293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,41830,-0.0274436178154864,0.00890633372395697,-0.044900031914442,-0.00998720371653074,0.00206480730415214
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00965322723846568,0.00313790153231426,-0.0158035142418016,-0.00350294023512973,0.00210063700368322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGN,Cingulin,39649,-0.0120067080662622,0.00390491547483914,-0.019660342396947,-0.00435307373557754,0.00211180592991766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0187230262494591,0.00609647972738955,-0.0306721265151426,-0.00677392598377563,0.00213774516075086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0262393510714699,0.00857190288395131,-0.0430402807240145,-0.00943842141892533,0.0022106349074329
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.0112489243746392,0.00367656435819759,0.00404285823257187,0.0184549905167064,0.00222054193917753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0179134435816095,0.00586045404163418,-0.0293999335032125,-0.00642695366000651,0.00224352447116774
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0174118424402717,0.00569739717588014,-0.0285787409049968,-0.00624494397554665,0.00224771062471771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0216684688537159,0.00710359895317084,-0.0355915228019307,-0.007745414905501,0.00229026231827791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42148,-0.0298846651773068,0.00981154667637604,-0.0491152966630039,-0.0106540336916098,0.00232456466379428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0236030958101436,0.00776144056658496,-0.0388155193206502,-0.00839067229963712,0.00236284941220626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0289773318594222,0.00953610357462424,-0.0476680948656857,-0.0102865688531587,0.00238143616315419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0151990430522512,0.00500221003287041,-0.0250033747166772,-0.00539471138782516,0.00238325133081401
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0117904702944145,0.00388173777678912,0.00418226425190777,0.0193986763369211,0.00239172754959944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0131888143096737,0.00434669018676489,-0.0217083270757329,-0.00466930154361455,0.00241612752531497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0131840999673013,0.00434539411840574,-0.0217010724393765,-0.00466712749522602,0.00241865795103657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0407218317029217,0.0134336974399175,-0.06705187868516,-0.0143917847206834,0.00243947267434641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0141641206845212,0.00467324757311933,-0.0233236859278351,-0.00500455544120733,0.00244395496774472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0205159382281432,0.00676922340711204,-0.0337836161060828,-0.00724826035020362,0.00244482729869913
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,39934,0.0109866209086502,0.00362736349606099,0.00387698845637061,0.0180962533609297,0.0024606586389569
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.032835335954071,0.0108427231603502,-0.0540870733483575,-0.0115835985597846,0.00246375442055275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.025240158873185,0.00834463506635765,-0.041595643603246,-0.00888467414312403,0.00249336829721666
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.0137859938674297,0.00455788721203359,0.00485253493184387,0.0227194528030155,0.00249482331685254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0168515673524408,0.00557683184818642,-0.0277821577748862,-0.0059209769299954,0.00251816736969861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.009844183743855,0.0032598537990124,-0.0162334971899193,-0.00345487029779069,0.00253401290632216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0090513199652896,0.00299959947653737,-0.0149305349393028,-0.00317210499127636,0.00255425757463395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.00720144382608454,0.00239164341220127,-0.011889064913999,-0.00251382273817004,0.00260800351741232
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,39657,-0.0133929650680287,0.00444916906421414,-0.0221133364338885,-0.00467259370216904,0.00261649945316081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0123758877655622,0.00411259722876122,-0.0204365783339342,-0.00431519719719022,0.00262458053211253
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42123,-0.011231719222712,0.00373260236350681,-0.0185476198551853,-0.00391581859023861,0.00262518118964596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0278974505760752,0.00927178409179386,-0.0460701473959911,-0.00972475375615919,0.00262810960217661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0111186617903285,0.00369749963758264,-0.0183657610799905,-0.00387156250066654,0.00264353061178511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0168796099614458,0.00562555778882033,0.00585351669535796,0.0279057032275336,0.00270018965766276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0238046816960471,0.00794728977908333,-0.0393813696630505,-0.00822799372904382,0.00274769213747884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.0159353973538198,0.00532225212466916,0.00550378318946823,0.0263670115181713,0.00275744443964626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.00841566494630579,0.00281440884670606,0.00289942360676192,0.0139319062858497,0.00279283478110789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2,Prothrombin,39979,0.0046396078900981,0.00155166926493967,0.00159833613081635,0.00768087964937985,0.00279505333977858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0189445702165323,0.00635438680744136,-0.0313991683591174,-0.00648997207394725,0.00287497117430737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42137,-0.0117568964827981,0.00394580507261321,-0.01949067442512,-0.00402311854047624,0.00289143147798529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0137175596249749,0.0046211761799859,-0.0227750649377473,-0.00466005431220257,0.0029987754812779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0193239129671169,0.00651215718896097,-0.0320877410574804,-0.00656008487675338,0.00301012881010482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,41877,-0.0132074763220613,0.00445357864224391,-0.0219364904608594,-0.00447846218326324,0.00302643025630109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0173074535997231,0.0058366274209109,-0.0287472433447084,-0.00586766385473769,0.00302898773403762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7,Complement component C7,39722,-0.0102892980332698,0.00347210654689692,-0.0170946268651878,-0.00348396920135183,0.00304889000163815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0107738076160087,0.0036419420120552,-0.0179120139596369,-0.00363560127238051,0.00310042015565165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0205763006964748,0.00696567636673425,-0.0342290263752739,-0.00692357501767567,0.00314373412296425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0147257574298538,0.00498510158584876,-0.0244965565381174,-0.00495495832159024,0.00314376012995999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,39929,-0.0421603426104933,0.014325957505068,-0.0702392193204267,-0.01408146590056,0.00325777296090146
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0327449357475994,0.0111386621301681,-0.0545767135227288,-0.0109131579724699,0.00329135159327199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.0115832836741757,0.00394529746138125,0.00385050064986843,0.0193160666984829,0.00333172527410211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0222860758761887,0.00760603128736495,-0.0371938971994241,-0.00737825455295343,0.00339483813606564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0123661041489777,0.00423108504574584,-0.0206590308386396,-0.00407317745931589,0.00347602857326337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.00672707524473684,0.00230225836493938,-0.011239501640018,-0.00221464884945566,0.00348421330227204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFP,Properdin,39979,0.00720749585347467,0.0024708682531505,0.00236459407729968,0.0120503976296497,0.00354118935576167
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0147260045344135,0.00505377902003037,0.00482059765515394,0.024631411413673,0.00357711649861198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,39649,-0.0131208676547995,0.0045055219416419,-0.0219516906604176,-0.00429004464918139,0.00359639900238412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,39966,-0.013120113343629,0.00450876072451306,-0.0219572843636746,-0.0042829423235834,0.00362227601825312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0322879625569591,0.0111004685017277,-0.0540448808203453,-0.0105310442935729,0.00363654421187942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0219267780576456,0.00755878585238648,-0.0367419983283231,-0.00711155778696808,0.00372771807699248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0264376157005957,0.00912489774193157,0.00855281612640977,0.0443224152747815,0.00377121896986676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0169606717822839,0.00585596093001513,-0.0284383552051136,-0.00548298835945426,0.00378310801222829
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0175607210049791,0.00606389385255398,-0.0294459529559849,-0.00567548905397326,0.00378751524791293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0139401743813466,0.00481606214079067,-0.0233796561772963,-0.00450069258539691,0.00380343830373306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42079,0.00863520680151463,0.00298367320196708,0.00278720732565916,0.0144832062773701,0.00380792504955077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0145673598832641,0.00504126051932079,0.00468648926539536,0.0244482305011328,0.00386313047199997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0142102653298029,0.00492111392074935,-0.0238556486144716,-0.00456488204513415,0.00388797357791983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.029307915720216,0.0101566985330129,-0.0492150448449213,-0.00940078659551076,0.00391330181836266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0270908411265877,0.0094197635846803,-0.0455535777525611,-0.00862810450061432,0.0040344633554482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0141471914271629,0.00492704152291377,-0.0238041928120739,-0.00449019004225193,0.00409387629763727
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0159996354068519,0.00557449964400506,-0.0269256547091018,-0.00507361610460199,0.0041104003376557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.00897918426881802,0.00313254240146589,-0.0151189673756912,-0.00283940116194488,0.00415788096498144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0143219361543468,0.00500347246392516,-0.0241287421836401,-0.00451513012505352,0.00421093649490826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0202454784296088,0.00707291263657845,-0.0341083871973026,-0.00638256966191505,0.00421095555805109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0137952241903442,0.00482201980113511,-0.023246383000569,-0.00434406538011938,0.00423263706993647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0225531996902805,0.00788960317041205,-0.0380168219042882,-0.00708957747627292,0.00426294616019971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0177176712084622,0.00621005453972202,-0.0298893781063174,-0.00554596431060709,0.00433784049152772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0253845107136944,0.00892508304532629,-0.0428776734825339,-0.0078913479448549,0.00446062183878721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0205397421608011,0.00722227473758134,-0.0346954006464605,-0.00638408367514165,0.00446413024304716
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.00579843995288607,0.00204026576131998,-0.00979736084507323,-0.00179951906069891,0.00448975261139219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0251444872666392,0.0088501854420127,0.00779812380029436,0.0424908507329841,0.00450232604846883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0158034692683046,0.00557865426076326,-0.0267376316194006,-0.00486930691720858,0.00462168347036866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0123706106498172,0.00437267958221129,0.00380015866868309,0.0209410626309514,0.00467671378672154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0191472004140397,0.00677691148696463,-0.0324299469284904,-0.00586445389958905,0.0047298481941855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0330493794807065,0.0116988100037663,0.0101197118733245,0.0559790470880886,0.00473473566754742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0117589932465629,0.00416406939073278,-0.0199205692523991,-0.00359741724072661,0.00475233078452847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0166037028510763,0.00589993117103834,-0.0281675679463115,-0.00503983775584119,0.00489663696943405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0222185965753708,0.00789873178657464,-0.0377001108770571,-0.0067370822736845,0.0049162717849984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0173926252881642,0.00618431233916531,-0.0295138774729282,-0.00527137310340015,0.00492466005939397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,39979,-0.0204788690751724,0.00728577832028016,-0.0347589945829215,-0.00619874356742326,0.00495028751888673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0138687041527115,0.00493443364413895,-0.0235401940952238,-0.00419721421019916,0.00495349437896305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0138197135692751,0.00492060641825975,-0.0234641021490642,-0.00417532498948599,0.00498385322025538
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0105165460057102,0.00374706715576097,-0.0178607976310017,-0.00317229438041867,0.00501517035179204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,41913,0.0137400416828867,0.00492075353973733,0.00409536474500159,0.0233847186207719,0.0052415318066042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.010890491601375,0.00390478896015496,-0.0185438779632787,-0.00323710523947124,0.00529575875300144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0180544511302209,0.00647681472674269,0.00535989426580521,0.0307490079946366,0.00531993290266369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0170407893435272,0.00611429301583447,-0.0290248036545628,-0.00505677503249169,0.00532649273297043
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0199072825773579,0.00715962970762702,-0.0339401568043068,-0.00587440835040889,0.00543678143678953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.0103151365959806,0.00371167873879208,0.00304024626794809,0.017590026924013,0.00545988615754747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.00907575851736119,0.00326728566780597,-0.0154796384262609,-0.00267187860846149,0.00548105196294158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,39966,0.033173482895075,0.0119429065402392,0.00976538607620627,0.0565815797139438,0.00548395197850799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0175875481081856,0.00633437128072037,-0.0300029158183975,-0.00517218039797366,0.00550200478189919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42262,-0.0319738283608668,0.0115284073394885,-0.0545695067462644,-0.00937814997546929,0.00555351538198463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.00988657486789062,0.00356502569522058,-0.0168740252305229,-0.00289912450525828,0.00555819349770841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.0106588672084328,0.00384415099347068,0.00312433126123031,0.0181934031556354,0.00556773204434954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0151788500562095,0.00548103902388302,-0.0259216865430202,-0.00443601356939878,0.00562641087360111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,38503,-0.0309062201721133,0.0111660045006729,-0.0527915889934323,-0.00902085135079434,0.00565261163626481
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0117949325611546,0.00426541058642782,-0.0201551373105531,-0.00343472781175608,0.00569562194252151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0114634449876768,0.00414599666584512,-0.0195895984527333,-0.00333729152262039,0.00570248957262771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0145398185809799,0.0052616763390622,-0.0248527042055418,-0.00422693295641798,0.00572898239035912
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0113545127937602,0.00411413485119676,-0.0194182171021058,-0.00329080848541454,0.00579187576597691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.0107692523027351,0.00390269526850683,0.00311996957646174,0.0184185350290085,0.00579951712603885
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.020600460170945,0.00746703954166933,-0.0352358576726169,-0.00596506266927317,0.00580816364479184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.019245670067008,0.00698917924939432,-0.0329444613958208,-0.00554687873819508,0.00590154702537181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0067672107929261,0.00245855373737682,-0.0115859761181847,-0.00194844546766754,0.00592208699574728
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.0138486727192447,0.00503734689162738,0.00397547281165505,0.0237218726268344,0.00598202999562797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0128270834419076,0.00466856377683929,-0.0219774684445127,-0.00367669843930262,0.00601222893542261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42296,-0.0166924162338438,0.00607601208909921,-0.0286013999284782,-0.00478343253920932,0.00601730983986415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,39958,0.00861982503433799,0.00313853112350427,0.00246830403226962,0.0147713460364064,0.00603385841342369
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.00916238760258243,0.0033394761656003,-0.015707760887159,-0.00261701431800585,0.0060838795808827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0338339820090035,0.0123355208136047,-0.0580116028036687,-0.00965636121433826,0.00610142905065767
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0284816323218731,0.0103855051899616,-0.0488372224941977,-0.00812604214954845,0.00610800002729759
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,39886,-0.00815617397383639,0.00297825346520801,-0.0139935507656441,-0.00231879718202869,0.00618026629625557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0172231404609279,0.00631407328149709,-0.0295987240926622,-0.00484755682919361,0.00638541921984024
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00928325610037498,0.00340580267280953,-0.0159586293390817,-0.00260788286166829,0.00642447917750478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42181,0.0108885233124226,0.00399550674373296,0.00305733009470599,0.0187197165301392,0.00643463985239695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.00661429435509555,0.0024271925371041,-0.0113715917278196,-0.00185699698237151,0.0064387165036936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0107475805699561,0.00394529871188099,-0.0184803660452429,-0.0030147950946694,0.00645696447107518
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0119016586480352,0.00437585769629598,-0.0204783397327753,-0.00332497756329512,0.00654150352210373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42070,-0.0166838978017088,0.00613719664993509,-0.0287128032355815,-0.00465499236783599,0.0065664900694359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,39649,-0.0129475504799125,0.00476617591737993,-0.0222892552779772,-0.00360584568184784,0.00660691070376486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.00773631387458391,0.00284925163228299,-0.0133208470738586,-0.00215178067530926,0.00663342674929201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0146565226372223,0.00539812238304568,-0.0252368425079918,-0.00407620276645271,0.00663358795284088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0232355819931997,0.0085668230797803,-0.040026555229569,-0.00644460875683028,0.0066927104659486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0165404233569633,0.00610162319611009,-0.0284996048213391,-0.00458124189258751,0.00672017256380314
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0222621394702835,0.00822808818147954,-0.0383891923059834,-0.00613508663458362,0.00682802254368816
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0145324928618206,0.00538441477846474,-0.0250859458276115,-0.00397903989602972,0.00696557041924097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0127463559858499,0.00473072772802181,-0.0220185823327727,-0.00347412963892719,0.00706272183658284
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0201596173033887,0.00748994446338958,-0.0348399084516323,-0.00547932615514517,0.00712252592962921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0237243515777986,0.00882715704701323,0.00642312376565271,0.0410255793899446,0.00720641336297365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.00961792413472547,0.00358218617847306,-0.0166390090445327,-0.00259683922491827,0.00726335055870861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0120720235206136,0.00449751702786443,0.00325689014599927,0.0208871568952278,0.00728221737762182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00836136598948,0.00311981998793855,0.00224651881312045,0.0144762131658396,0.00737137189409848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0076489700453964,0.00285647823392249,-0.0132476673838845,-0.00205027270690832,0.00742252186725173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0164572342025852,0.00614717548016278,-0.0285056981437042,-0.0044087702614661,0.0074329233738287
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.00934867708859445,0.0034950489416213,-0.0161989730141722,-0.0024983811630167,0.00748735487582795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,41814,-0.0101712889825496,0.00380352050065185,-0.0176261891638273,-0.00271638880127203,0.00750049400202473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0161853793340737,0.00606662415700067,0.00429479598635236,0.028075962681795,0.00764303566269946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCT,Secretin,39649,-0.0133589532344453,0.00502413160089513,-0.0232062511721997,-0.0035116552966908,0.00784958008899609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0121179529034656,0.00455850192413632,0.00318328913215845,0.0210526166747728,0.00786417896548195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00842812706013179,0.0031821170291969,-0.0146650764373577,-0.00219117768290586,0.00809418311940198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0178648185374573,0.00674567102859174,-0.0310863337534971,-0.0046433033214175,0.00810008317618863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0124160089853225,0.00468825897324925,-0.021604996572891,-0.00322702139775397,0.00810051725042276
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.00808431881581714,0.00305436968116019,-0.0140708833908911,-0.00209775424074317,0.00813706897780285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0184934257712902,0.00699632701037785,-0.0322062267116308,-0.00478062483094965,0.00822169338348386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.0080667081082024,0.00306062231454839,0.00206788837168755,0.0140655278447172,0.0084075452602388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,41997,-0.0218807491831529,0.00832247457656364,-0.0381927993532176,-0.00556869901308817,0.00857049597865237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0209990297920463,0.00798986077364263,-0.0366591569083858,-0.00533890267570675,0.00859341807485134
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.00847237048697919,0.00323135094135819,-0.0148058183320412,-0.00213892264191715,0.00875304297300423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,41913,0.012667163433748,0.00483982149451921,0.00318111330449035,0.0221532135630056,0.0088734065500269
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,39757,0.0454159254392342,0.0173586182030107,0.0113930337613333,0.0794388171171351,0.00889995999022001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,39575,-0.0107191931637584,0.00409750014267985,-0.0187502934434109,-0.00268809288410586,0.00890799248859734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0100979515763021,0.00386722053580488,-0.0176777038264796,-0.0025181993261245,0.00903360158061812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0187896724528422,0.0072022151325614,-0.0329060141126626,-0.00467333079302185,0.00909410184759934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,39657,0.00466803491942941,0.00178994371857372,0.00115974523102493,0.0081763246078339,0.0091215960655788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,39966,-0.0230957790938538,0.00886882902541782,-0.0404786839836728,-0.00571287420403492,0.00922217096817451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.00996043742630868,0.00382732484906333,0.00245888072214455,0.0174619941304728,0.00926588822482968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0108339706861312,0.00416813110372104,0.00266443372283796,0.0190035076494244,0.00935549023627684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0171098063315914,0.00658958068441677,-0.0300253844730483,-0.00419422819013454,0.00943061301793487
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42016,0.01515408379924,0.00584685710960026,0.00369424386442354,0.0266139237340565,0.00955692387579985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0214664115921895,0.00829420807150724,-0.0377230594123437,-0.0052097637720353,0.00966060063353489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0279621697259534,0.010810987067248,-0.0491517043777595,-0.0067726350741473,0.0097071640411535
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00580942236661553,0.00224620375438016,-0.0102119817252006,-0.00140686300803043,0.00971277716074796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0149000461327617,0.00576326233226288,-0.026196040303997,-0.00360405196152646,0.00974037254529955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0140805744323078,0.00544699799969914,-0.0247566905117181,-0.00340445835289745,0.0097498517851294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,39914,-0.0262534005617336,0.0101787886768467,-0.0462038263683531,-0.00630297475511402,0.00991469203826593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00802357842558104,0.00311255865400221,0.00192296346373671,0.0141241933874254,0.00995393122275817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.028970192622369,0.0112396232380737,-0.0509998541689935,-0.00694053107574447,0.00996411476571659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,39575,-0.0204170377529244,0.00792166432571771,-0.0359434998313311,-0.00489057567451769,0.00996854156482525
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0394059900344261,0.0153280347532112,-0.06944893815072,-0.00936304191813217,0.0101581685049171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0142164123197831,0.00554303690848276,0.00335205997915687,0.0250807646604093,0.0103382051581096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42249,-0.0196257296545963,0.00765267063533259,-0.0346249640998482,-0.00462649520934441,0.0103412822649797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0160117940452877,0.00624618985147568,0.00376926193639534,0.02825432615418,0.0103743741679164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0165716563547242,0.00647463701264957,-0.0292619448995174,-0.00388136780993104,0.0104937888542531
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0121035918871444,0.00473172738349425,0.00282940621549567,0.0213777775587931,0.0105418881700179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.031477721088758,0.0123285942241811,-0.055641765768153,-0.00731367640936298,0.0106859177733614
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),39775,0.0485555619935557,0.0190207161621208,0.0112749583157989,0.0858361656713124,0.0107000997217376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,39990,-0.00580309292558984,0.0022772024916153,-0.0102664098091558,-0.00133977604202386,0.0108366105181846
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.023590605347295,0.00925958935796641,-0.0417394004889092,-0.00544181020568085,0.0108571515239098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42296,-0.00940286093615941,0.00369109456091829,-0.0166374062755593,-0.00216831559675956,0.0108623242739704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0241964245042509,0.00950167620406466,-0.0428197098642177,-0.00557313914428421,0.0108904787230855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0148663893449328,0.00584354977344862,-0.0263197469008921,-0.00341303178897355,0.0109704541685534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0214223057886784,0.00844455759824187,-0.0379736386812325,-0.00487097289612434,0.0112001393654884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0205983886449421,0.00812168518395753,-0.0365168916054989,-0.00467988568438537,0.011218912146638
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0196652212222197,0.00775439144311319,-0.0348638284507215,-0.0044666139937178,0.0112258739069557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,39934,-0.00676001607115973,0.00266630416175273,-0.0119859722281951,-0.00153405991412438,0.0112468063683546
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.00798294631715241,0.00315712106932056,0.00179498902128412,0.0141709036130207,0.0114668599173683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,39930,-0.00920869986869428,0.00364521895054849,-0.0163533290117693,-0.00206407072561924,0.0115425592668235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.019928325720743,0.00790711421667534,-0.0354262695854266,-0.00443038185605934,0.011739427120032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0240362470611865,0.00955242268363938,-0.0427589955211197,-0.00531349860125335,0.0118729793599395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0230679522610705,0.00916769894799795,-0.0410366421991465,-0.00509926232299451,0.011876160009078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0103003474415847,0.00409652772103532,-0.0183295417748139,-0.00227115310835548,0.0119369309206499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42070,-0.0195256777482876,0.0077708902524479,-0.0347566226430855,-0.00429473285348975,0.0119937429968932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0174407817290331,0.00694421440594908,-0.0310514419646933,-0.00383012149337288,0.0120338199049025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0241607815590034,0.00963100636703786,-0.0430375540383977,-0.00528400907960923,0.0121310545364638
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.0122747337439297,0.00491295450656689,0.00264534291105864,0.0219041245768008,0.0124859317931023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PALLD,Palladin,39657,0.00994208485280102,0.00398227254225794,0.00213683066997546,0.0177473390356266,0.0125539738293933
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00899890083286712,0.00361213538770842,0.00191911547295861,0.0160786861927756,0.0127395107274875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0158767888579828,0.00637414925355097,-0.0283701213949427,-0.00338345632102294,0.0127598398139597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.0184816225888958,0.007421918823679,0.00393466169448501,0.0330285834833067,0.0127834710809646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0213288424149661,0.00858532505608345,-0.0381560795248896,-0.00450160530504249,0.0129912736120869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0169247963639658,0.00682800971529963,-0.0303076954059531,-0.00354189732197856,0.0131998996738733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42286,-0.00779474322287214,0.003145366352084,-0.0139596612729568,-0.00162982517278749,0.0132178982154923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42113,-0.00616958474487371,0.00249525379470001,-0.0110602821824857,-0.00127888730726169,0.0134283378575751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0104737033086525,0.0042382457610501,0.00216674161699434,0.0187806650003107,0.0134767735937855
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.0107106856330919,0.0043411870963581,0.00220195892423003,0.0192194123419538,0.0136287568340304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0191381420627109,0.00776199842993965,-0.0343516589853926,-0.00392462514002921,0.0136925540586762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,39657,0.0140714612459779,0.00571183850768949,0.00287625777090655,0.0252666647210493,0.0137715710064008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0123576394951042,0.0050311020021622,-0.0222185994193421,-0.00249667957086626,0.0140544783632316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0429768014949832,0.0175315222720731,0.00861501784171999,0.0773385851482464,0.0142428473348476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0232319566324077,0.00948428198509587,-0.0418211493231957,-0.00464276394161984,0.0143200295041393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,39638,-0.0131078457490969,0.00537317075587463,-0.0236392604306111,-0.0025764310675826,0.014723272311259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.024055049961819,0.00987195883513335,-0.0434040892786804,-0.00470601064495763,0.0148346325330204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0169377524437427,0.0069577955469042,-0.0305750317156749,-0.00330047317181046,0.0149311753024362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0112838942740942,0.00463919285397382,-0.0203767122678829,-0.00219107628030548,0.0150165056207004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0116886923063194,0.00480667261353546,0.00226761398378988,0.0211097706288489,0.0150408886051103
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.00620342568626466,0.0025520270318893,0.00120145270376164,0.0112053986687677,0.0150791038100331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0154990670492458,0.00639570028154755,0.00296349449741261,0.028034639601079,0.0153906974657411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.00848729571834774,0.00350339187725251,-0.0153539437977627,-0.00162064763893281,0.0154232977277779
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.00557621554655361,0.00230190251707663,-0.0100879444800238,-0.00106448661308341,0.015429764025118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0135327365345215,0.0055978138729244,-0.0245044517254533,-0.00256102134358962,0.015640783699145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.00729693082850541,0.00302458121876283,-0.0132251100172806,-0.00136875163973025,0.0158574853275991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42138,0.0102564230110374,0.00425205527033425,0.00192239468118229,0.0185904513408925,0.015873730436702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,39736,0.0131664832705791,0.00546068757943153,0.00246353561489326,0.0238694309262649,0.015918819548786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0192368844720591,0.00798396489259889,-0.0348854556615529,-0.00358831328256524,0.0159902829498755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0301995598616524,0.0125367529508432,-0.0547715956453051,-0.00562752407799972,0.0160173214761017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00560231564870154,0.00232594595925031,-0.0101611697288321,-0.00104346156857093,0.0160262263652443
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,39638,-0.00738648463587307,0.00306795160139755,-0.0133996697746123,-0.00137329949713388,0.0160728558514337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0147671311101618,0.00614832975411885,-0.0268178574282348,-0.00271640479208886,0.0163305988422143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.015253237010104,0.00635508623859422,-0.0277092060377486,-0.00279726798245928,0.0164043658407463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42129,-0.00966685484165568,0.0040299856824653,-0.0175656267792877,-0.00176808290402369,0.0164654108522317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0116665173916902,0.00486433652826142,-0.0212006169870826,-0.00213241779629782,0.0164843308139231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.00989916981044745,0.00412842914809228,-0.0179908909407083,-0.00180744868018658,0.0165071793832142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,39979,0.00564998918200789,0.00235979028124049,0.00102480023077654,0.0102751781332392,0.0166692970644744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0172987364245471,0.00722928915748273,0.00312932967588098,0.0314681431732133,0.016730909087028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0117853980071163,0.00493492020010122,-0.0214578415993147,-0.00211295441491787,0.0169493217872098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.00904766352143459,0.00379239338713827,-0.0164807545602256,-0.00161457248264359,0.0170611697139807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0212309708983746,0.00890349285853699,-0.0386818169011071,-0.00378012489564211,0.0171128941703142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.00738539886912199,0.00309813181893222,-0.0134577372342292,-0.00131306050401483,0.0171501935903291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0134401269401648,0.00564266237672503,-0.0244997451985459,-0.00238050868178374,0.0172413492088783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00854278119429989,0.00358709176908074,0.00151208132690165,0.0155734810616981,0.0172575162072034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0215375195969065,0.0090459777262509,-0.0392676359403582,-0.00380740325345469,0.017287073743164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0247040715077065,0.0103823039310656,-0.0450533872125951,-0.00435475580281781,0.0173528531773001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,39822,0.00778579448161064,0.00328063484779999,0.00135575017992266,0.0142158387832986,0.0176486632569199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0098541674370188,0.00415952187434926,-0.0180068303107433,-0.00170150456329426,0.0178472080725177
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0109049870950783,0.00461243874683757,-0.0199453670388799,-0.00186460715127667,0.0180836226989368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0150921716119731,0.00638616138712423,-0.0276090479307366,-0.0025752952932096,0.0181290428530931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0169535836990713,0.00717858013077541,-0.0310236007553911,-0.00288356664275146,0.0182059250432429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0194276808842008,0.00823575270672796,-0.0355697561893876,-0.00328560557901399,0.0183412651975741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,39929,-0.0207955556981907,0.00882478252342945,-0.0380921294441124,-0.00349898195226898,0.0184652460956302
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.0078062399237788,0.00331330611407683,0.00131215994018821,0.0143003199073694,0.0184890411784871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERVV_1,,39575,0.010715486284714,0.004552220939886,0.00179313324253742,0.0196378393268905,0.0185949908801076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.00985779516633052,0.00419412628380291,-0.0180782826825842,-0.00163730765007681,0.0187712091021497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0122273185249447,0.00520370952725088,-0.0224265891983564,-0.00202804785153297,0.0188011608833595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42310,-0.01369644016945,0.00583150664584819,-0.0251261931953124,-0.00226668714358756,0.0188533686647028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0217339176372196,0.00925491461042661,-0.0398735502736557,-0.0035942850007834,0.0188730850196186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0363303268032544,0.0154842040120722,-0.0666793666669159,-0.0059812869395929,0.0189763627079887
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0124119682826443,0.00530468321252721,0.00201478918609095,0.0228091473791976,0.0193112111352412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0182142023562098,0.00781069907990351,-0.0335231725528207,-0.00290523215959895,0.019720422921763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.0137782812880393,0.00591232257084918,0.00219012904917494,0.0253664335269037,0.0197981308563942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0122623795057347,0.00526202682679757,-0.022575952086258,-0.0019488069252115,0.0198054152376387
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0125307847947488,0.00538533720243134,-0.0230860457115142,-0.00197552387798334,0.0199919965856547
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0150801864390406,0.00652346755433356,-0.0278661828455344,-0.00229419003254682,0.0208130286518294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0275715057910779,0.0119327504178098,0.00418331497217071,0.0509596966099851,0.0208713309788413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0190877259644234,0.0082616246281217,0.0028949416933049,0.035280510235542,0.0208837120538991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0146887304644529,0.00637324658544349,-0.0271802937719222,-0.0021971671569837,0.0211956711744593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.0100320189949833,0.00436159065775693,0.00148330130577974,0.0185807366841869,0.0214622088219949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.00957153824153354,0.00416862042573332,-0.0177420342759708,-0.00140104220709624,0.021689220588543
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.00924796014037679,0.00402852371680487,-0.0171438666253143,-0.00135205365543925,0.0217163759203918
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.00592493922045457,0.00258467172159157,-0.010990895794774,-0.000858982646135099,0.0219014605638468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.020122281087772,0.00878779067812168,-0.0373463508168905,-0.00289821135865349,0.0220515415637808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0153957093861642,0.0067291129154028,-0.0285847707003536,-0.00220664807197467,0.0221601916923753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.00976383265965699,0.00426816531377328,-0.0181294366746526,-0.00139822864466137,0.0221793754988707
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,39575,0.00842611372473658,0.0036858393223219,0.00120186865298565,0.0156503587964875,0.0222687017826286
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0113231472547238,0.00496086805380816,-0.0210464486401878,-0.00159984586925977,0.0224786527406709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,41839,-0.00698080030003153,0.00306148874376779,-0.0129813182378164,-0.000980282362246662,0.0226117779789168
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.00788373773563563,0.00345860935152373,0.00110486340664912,0.0146626120646221,0.022655494704549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0156616014340394,0.00687419350740531,-0.0291350207085538,-0.00218818215952502,0.0227231536242169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.00641131528733734,0.00281755237484917,0.000888912632632955,0.0119337179420417,0.0228950175256884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0161970823884053,0.0071271950311905,-0.0301663846495386,-0.00222778012727187,0.0230673360683593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0132440216493259,0.00582922395853262,-0.0246693006080498,-0.00181874269060193,0.0231055434934953
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0106799068394059,0.00470157738395125,-0.0198949985119504,-0.00146481516686145,0.0231291779057552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0122924247336373,0.00541354720179205,-0.0229029772491497,-0.00168187221812486,0.0231819288458124
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0149655277123014,0.00659231337578175,-0.0278864619288336,-0.00204459349576917,0.023214600183137
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.00935940579512478,0.00412330996514645,0.00127771826343774,0.0174410933268118,0.0232343654177936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.00838533084983283,0.00370700793498165,-0.0156510664023969,-0.0011195952972688,0.023712157769289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0119633192482549,0.0052889981393924,-0.022329755601464,-0.00159688289504583,0.023721344236041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.00951340830558207,0.00420650204178394,-0.0177581523074786,-0.00126866430368555,0.0237412779280114
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0201408600780792,0.00890909205233362,-0.0376026805006531,-0.00267903965550526,0.0237967027702672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.00907522024747559,0.0040171921168455,-0.0169489167964928,-0.0012015236984584,0.023893640608197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,39966,-0.0200603380675379,0.008887509810409,-0.0374798572959395,-0.00264081883913628,0.0240183425787014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.00909239891687756,0.00402895180958646,-0.016989144463667,-0.00119565337008809,0.0240386080506607
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00626737249508015,0.00277787490031153,0.00082273769046955,0.0117120072996907,0.0240793181117285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.014679379336644,0.00651969874886146,-0.0274579888844124,-0.00190076978887549,0.0243709143930622
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,39908,-0.0201136332003507,0.00894419658449288,-0.0376442585059567,-0.00258300789474463,0.02454493497163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.00952144710763926,0.00423566687533906,-0.0178233541833038,-0.00121954003197471,0.0245973314410142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42181,-0.00785437069775298,0.00349592101603102,-0.0147063758891738,-0.00100236550633218,0.0246736487102952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.0119628854289895,0.00532467103403759,0.00152653020227586,0.0223992406557032,0.0246760364091647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00910719587587247,0.00408010231982681,0.00111019532901192,0.017104196422733,0.0256283543406427
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.00710316067021892,0.00318602761024412,-0.0133477747862974,-0.000858546554140439,0.0257986977030438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0127858528796579,0.00573891091943977,-0.0240341182817598,-0.00153758747755594,0.0259058033840198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00855460634456782,0.00384035160184695,-0.0160816954841878,-0.00102751720494781,0.025926645448916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00899444460768773,0.00404091427125101,0.00107425263603575,0.0169146365793397,0.0260414065803803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0103637568711145,0.00466220515817582,0.00122583476108989,0.0195016789811391,0.0262401527582333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00972738772015437,0.00437865611500201,0.00114522173475042,0.0183095537055583,0.0263341456640513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0174695351237259,0.00788000876436181,-0.032914352301875,-0.00202471794557671,0.0266473404713992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0165891554558173,0.00748489757081457,-0.0312595546946138,-0.00191875621702074,0.026684356817959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0156799984652613,0.0070777136570988,-0.0295523172331749,-0.00180767969734762,0.0267487253353356
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,39638,-0.00688751974808071,0.00311102362170905,-0.0129851260466304,-0.00078991344953098,0.0268554779214091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0065109381550624,0.00294136847157614,-0.0122760203593516,-0.000745855950773172,0.0268745410001117
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.013181892128187,0.00595578074581318,-0.0248552223899808,-0.00150856186639317,0.026893979941946
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0193724553220423,0.00875641255732638,-0.036535023934402,-0.00220988670968261,0.0269578644533051
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.011289590707005,0.00510517097881379,-0.02129572582548,-0.00128345558852995,0.0270249580285062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0205072774803256,0.00927554364682499,-0.0386873430281026,-0.00232721193254862,0.0270595801729183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.01808684415045,0.00818685421680726,-0.0341330784153922,-0.00204060988550772,0.0271768707727851
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0113692460111698,0.0051476060191177,-0.0214585538086404,-0.00127993821369907,0.0272196343731868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.017249035803142,0.0078134236691972,0.00193472541151544,0.0325633461947685,0.0272916709640082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0199187740472734,0.00902512693150479,-0.0376080228330228,-0.00222952526152405,0.0273322798927173
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0067508479538406,0.00306115634934334,-0.0127507143985535,-0.000750981509127648,0.0274512227252327
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0127467731683131,0.00580768286248289,-0.0241298315787796,-0.00136371475784665,0.0281972931680746
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.00931757623567822,0.0042492739770599,-0.0176461532307156,-0.000988999240640815,0.0283459833093485
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0193905307726974,0.00884495603577702,-0.0367266446028204,-0.00205441694257449,0.0283770119992721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.019612859253646,0.00897447642142096,0.00202288546766089,0.0372028330396311,0.0288763587805803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIM,Vimentin,41900,-0.0260259178340734,0.0119366685529198,-0.0494217881977961,-0.00263004747035063,0.0292502211483557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0134703221919054,0.00618260657507487,-0.0255882310790521,-0.00135241330475863,0.0293718303512657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.0087392502734903,0.004022103085333,0.000855928226237628,0.016622572320743,0.0298155147479191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.021103967176114,0.00971441352801153,-0.0401442176910166,-0.00206371666121139,0.0298400431560943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42070,0.0125818128857439,0.00579179075249082,0.00122990301086191,0.0239337227606259,0.0298464423315783
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0193349389949103,0.00891446602263998,-0.0368072923992847,-0.00186258559053599,0.030108443689995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0215621472576869,0.00994345764947841,-0.0410513242506646,-0.00207297026470924,0.0301439439897563
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.00732648499794065,0.00337977108867377,-0.0139508363317412,-0.000702133664140067,0.0301987261512391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.00900935951758108,0.00415966069175322,-0.0171622944734174,-0.000856424561744768,0.0303408341608315
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0210319030085652,0.0097279134913569,-0.0400986134516247,-0.00196519256550563,0.0306378237351792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0224911331215882,0.0104050817209571,-0.042885093294664,-0.00209717294851233,0.0306735431112672
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00786047936785121,0.00363710537701462,0.000731752828902565,0.0149892059067999,0.0307017953625689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0120132631095767,0.00557062705700397,-0.0229316921413045,-0.0010948340778489,0.0310592787591086
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.0067305303354758,0.00312169762297428,0.000612002994446205,0.0128490576765054,0.0310972467606704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0136164513013024,0.00632530165185041,-0.0260140425389292,-0.00121886006367557,0.0313601404566195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.00446326287795444,0.0020736538462175,0.000398901339368132,0.00852762441654075,0.0313862165479206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,41780,-0.00681250868025631,0.00316539854212596,-0.0130166898228232,-0.000608327537689422,0.0314012512204504
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00621432616625981,0.0028899233999916,0.000550076302276281,0.0118785760302433,0.0315457012983105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,39560,0.00897541468648624,0.00417470889391477,0.00079298525441329,0.0171578441185592,0.0315809969851036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0148631151209843,0.00691817351773749,-0.0284227352157498,-0.00130349502621879,0.0316984914626901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.00976337759153797,0.0045444682978551,-0.018670535455334,-0.000856219727741967,0.0317029512170942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.00873013445836356,0.004065174562621,-0.0166978766011007,-0.000762392315626399,0.0317719629815464
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0110815017837247,0.00516629779978976,0.000955558096136733,0.0212074454713126,0.0319738160049622
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0200501043586705,0.00937069869002922,-0.0384166737911278,-0.00168353492621327,0.0324002114081944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0109014598722251,0.00510076980643096,-0.0208989686928297,-0.000903951051620394,0.0326015688147094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0105590454091477,0.00494434093757718,-0.0202499536467989,-0.000868137171496385,0.0327354459215544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.00726037811609879,0.00340786005764682,-0.0139397838290866,-0.000580972403111033,0.0331499807452659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,39925,0.00568422750333746,0.00267382148088327,0.000443537400806254,0.0109249176058687,0.0335347054107033
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.025837844196449,0.0121558103855617,-0.04966323255215,-0.002012455840748,0.0335584690449036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00964403425420444,0.00454059636194574,0.000744465384790794,0.0185436031236181,0.0336917027222772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0189767091398046,0.00893945326128665,-0.0364980375319264,-0.00145538074768276,0.0337924339780792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00743095592027912,0.00350515194612259,-0.0143010537346794,-0.000560858105878852,0.0340274599200354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0141159126044766,0.00666973312506183,-0.0271885895295977,-0.00104323567935539,0.0343319827027777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42230,0.0059984418956745,0.00283989544242584,0.000432246828519846,0.0115646369628292,0.0346869947058402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00689733203603744,0.00326765965561951,0.000492719111023211,0.0133019449610517,0.0348130698058209
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0147941102577436,0.00701071917436262,-0.0285351198394944,-0.00105310067599287,0.0348625881617642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.00626923195908029,0.00297103586881752,0.000446001656197951,0.0120924622619626,0.0348665576061293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0118095780126401,0.00560370020545323,0.000826325609951757,0.0227928304153284,0.0350999453130871
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.00729938045141555,0.00346741389371812,0.000503249219728039,0.0140955116831031,0.0352978095755731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TTN,Titin,39575,-0.0152199019720355,0.00723424380362799,-0.0293990198271464,-0.00104078411692464,0.0354125594673412
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00444076750631589,0.0021177893885659,0.00028990030472672,0.00859163470790505,0.0360219173309225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,39934,-0.00801683124677843,0.00382396217360127,-0.0155117971070369,-0.000521865386519934,0.0360624150784048
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0189776193579282,0.0090580885174551,-0.0367314728521401,-0.00122376586371616,0.0361805526785419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00292059243346654,0.00139535871438231,0.000185689353277215,0.00565549551365586,0.0363648005155065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPART,Spartin,39736,-0.0169922285695127,0.00813560497083485,-0.0329380143123491,-0.00104644282667643,0.0367641386396703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0111589821198485,0.0053436241555454,-0.0216324854647175,-0.000685478774979551,0.0367954446434793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0112452034809155,0.00538759652017452,-0.0218048926604576,-0.000685514301373454,0.0368854923677118
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0150100905988316,0.00720078171886455,-0.0291236227678062,-0.0008965584298571,0.0371366692009089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.0107708005160694,0.00516771655155623,0.000642076075019203,0.0208995249571196,0.0371599941274095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0181336575584975,0.00872734968292244,-0.0352392629370254,-0.00102805217996948,0.0377472330207415
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,39649,0.0145602620358436,0.00700982750498038,0.00082100012608201,0.0282995239456051,0.0378134130353975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0159772625246574,0.00770237889658554,-0.0310739251619651,-0.000880599887349764,0.0380717080097092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.0131261172408587,0.00634639585527688,0.000687181364515978,0.0255650531172013,0.0386329132540197
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0103984176236984,0.0050290814162351,-0.0202554171995192,-0.00054141804787761,0.0386949170644441
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42119,-0.014665779097723,0.00709937432120668,-0.0285805527672881,-0.000751005428157895,0.0388678198037025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.012513138903616,0.00605830095644002,-0.0243874087782384,-0.000638869028993568,0.0389027997305938
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42137,-0.0156474824822319,0.00757914869850543,-0.0305026139313025,-0.00079235103316122,0.0389852133269924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00448848918053433,0.00217493641714297,0.000225613802934107,0.00875136455813454,0.0390664442640711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0100453545378588,0.00487348811009168,-0.0195973912336385,-0.000493317842079134,0.0393049660533799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00726818545880038,0.0035268673711948,0.000355525411258566,0.0141808455063422,0.0393451686329032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00610432643515377,0.00296686182373237,0.000289277260638321,0.0119193756096692,0.0396569861552695
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,39930,-0.0221875075664589,0.0107976984766048,-0.0433509965806043,-0.00102401855231342,0.0399176554116881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.00839437154426044,0.00408840705852493,-0.0164076493789693,-0.000381093709551566,0.0400710619490494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.00728341742254867,0.00355491364031194,0.000315786687537266,0.0142510481575601,0.0404978097326942
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0109529947394317,0.0053490555561828,0.000468845849313395,0.02143714362955,0.0406172200780308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.0191009991943518,0.00932935157420523,0.000815470108909568,0.0373865282797941,0.04063722022954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0142755352265806,0.00698139798955799,-0.0279590752861143,-0.000591995167046994,0.0408983819861553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.00964419258553601,0.0047177150297261,-0.0188909140437992,-0.000397471127272859,0.0409481823958944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.00616174586819675,0.0030206627057284,-0.0120822447714244,-0.000241246964969085,0.0413872198571812
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00550753061845761,0.00270080006536639,0.00021396249033949,0.0108010987465757,0.0414473639797393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.00570739606812166,0.00279928262181963,-0.0111939900068881,-0.000220802129355185,0.0414852987777509
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00806093362908998,0.00395713647214318,0.000304946143689351,0.0158169211144906,0.0416675802997939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0136536990771375,0.006708726094524,-0.0268028022224046,-0.000504595931870465,0.0418524104839491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0163687824899038,0.0080438768958942,-0.0321347812058564,-0.000602783773951156,0.0418803890307987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.00964456975018875,0.0047456076464093,0.000343178763226532,0.018945960737151,0.0421451288054681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0189056490528511,0.00930528552406072,-0.0371440086800101,-0.000667289425692073,0.0422024963957399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0104721023244727,0.00515821835490273,-0.0205822103000821,-0.000361994348863349,0.0423623382866411
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.00666103537800334,0.00328760839336153,0.000217322927014746,0.0131047478289919,0.0427781429012006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42249,-0.00611161884676346,0.00302143125531734,-0.0120336241071854,-0.000189613586341488,0.0431177471169116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.0110728190486344,0.00548532422870884,-0.0218240545369037,-0.000321583560365045,0.0435495933204042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,39586,0.0195247453333921,0.0096841886341823,0.000543735610394773,0.0385057550563894,0.0438089267671447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0185053726775748,0.00918576939074497,-0.036509480683435,-0.000501264671714692,0.0439733371563792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,39930,-0.0165521862087474,0.00821984888525984,-0.0326630900238567,-0.000441282393638161,0.0440662154997929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0132754387494411,0.00660024434643078,-0.0262119176684454,-0.000338959830436742,0.0443074577049227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,41839,-0.0144245941990378,0.00717270513232234,-0.0284830962583896,-0.000366092139685999,0.0443415048957987
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.00518894740770123,0.00258505582342278,-0.0102556568216099,-0.000122237993792589,0.0447389463749071
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00704366111558663,0.00351409858133655,0.000156027896166984,0.0139312943350063,0.0450471330687661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.00864711600403355,0.00431971328591219,-0.0171137540444215,-0.000180477963645658,0.0453327747793289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.011720166252181,0.00585672144406855,0.000240992221806633,0.0231993402825554,0.0453963988604077
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0233932659946591,0.0117020012820956,-0.0463291885075665,-0.00045734348175161,0.0456240422060708
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.010415919707911,0.0052120357681652,-0.0206315098135148,-0.000200329602307181,0.0456898301338669
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.010200097350682,0.00510696867099549,-0.0202097559458332,-0.000190438755530877,0.0458176655202126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42310,-0.018261025360351,0.00915001664256039,-0.0361950579797694,-0.00032699274093264,0.0459823237547794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.0070602063925533,0.00355407039325071,9.42284217819072e-05,0.0140261843633247,0.0470012391892807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0215334328696185,0.010855116771577,-0.0428094617419094,-0.000257403997327554,0.0473124447532323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.00773502973495818,0.00390030113775456,-0.0153796199649571,-9.04395049592449e-05,0.0473665342107595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,39657,0.00689536567528154,0.00347858919476284,7.73308535463738e-05,0.0137134004970167,0.047478161633717
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0116706217791735,0.00588797683320051,-0.0232110563722465,-0.000130187186100465,0.0474874915478388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.00827375290809647,0.00418087205915245,-0.0164682621440353,-7.9243672157666e-05,0.0478457490565006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,39757,0.00689356206811643,0.00349282792685636,4.7619331477968e-05,0.0137395048047549,0.0484480710311456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0244769591360989,0.0124123499436212,-0.0488051650255966,-0.000148753246601293,0.0486316817244425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0137644693717319,0.00698079465715787,-0.0274468268997613,-8.21118437024388e-05,0.0486575009742195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.00725055687641183,0.0036775969834343,-0.0144586469639431,-4.24667888806107e-05,0.0486817171387104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0151386458881119,0.00768047572079375,-0.0301923783008677,-8.49134753561909e-05,0.0487424412918664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.0110008823112605,0.0055873522399665,4.96719209261958e-05,0.0219520927015949,0.0489864263653883
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.0157195642704353,0.00799372595712805,5.18613944643469e-05,0.0313872671464063,0.0492673118427663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,39575,0.0104522228824325,0.00531972562781171,2.55606519215142e-05,0.0208788851129434,0.0494620133529925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.00703894264091333,0.00358394084735449,-0.0140634667017281,-1.44185800985295e-05,0.0495480942004457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,41913,0.019220456374413,0.00979216717587626,2.78087096955183e-05,0.0384131040391305,0.049685571807924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.00719375362668648,0.00367458993884351,-0.0143959499068198,8.44265344680448e-06,0.0502894751884622
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.00811583795267453,0.00415038770301672,-0.0162505978505873,1.89219452382434e-05,0.0505520564494621
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00699246157956803,0.00357652553866518,-1.75284762157198e-05,0.0140024516353518,0.0505967637650554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,41900,-0.0159606721516778,0.00818002953790839,-0.0319935300459782,7.21857426226706e-05,0.051057154193092
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,39575,0.00933987785925367,0.00478683075084727,-4.23104124069925e-05,0.0187220661309143,0.0510632953359892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0185724516551012,0.00952281772203252,-0.0372371743902849,9.22710800825184e-05,0.0511643701196009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.00826557219704481,0.00423997877420774,-4.47862004023577e-05,0.016575930594492,0.0512641097349076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0200248958757713,0.0102839120205045,-0.0401813634359601,0.000131571684417395,0.051534646690463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0219569920257755,0.0112808814531063,-0.0440675196738638,0.000153535622312802,0.0516326492980002
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42119,-0.0174671059937603,0.00898161245768992,-0.0350710664108325,0.000136854423311954,0.0518242395589299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00392421692972386,0.00202107496039987,-3.70899926598837e-05,0.00788552385210761,0.052204332264458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0132759491353432,0.00683995970005345,-0.0266822701474479,0.000130371876761595,0.0522866741831589
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.00695098004321363,0.00358328152041613,-0.0139742118232292,7.2251736801989e-05,0.0524203154302905
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0149603705881951,0.00771417298802034,-0.0300801496447149,0.000159408468324801,0.0524816932072711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0133599621746317,0.00689182933236854,-0.00014802331681061,0.0268679476660741,0.0525851873030047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0107142365941293,0.00554257588526332,-0.0215776853292454,0.0001492121409868,0.0532477681276916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42181,-0.0140189007598376,0.0072678958162654,-0.0282639765597178,0.000226175040042556,0.0537665426895673
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00719267740776937,0.00373035320343166,-0.000118814870956682,0.0145041696864954,0.0538573428414646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0144686753097377,0.0075148827125211,-0.0291978454262791,0.000260494806803648,0.0542087144708221
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0185467399968698,0.00963322693378592,-0.0374278647870902,0.000334384793350573,0.0542145665895368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0135224245327136,0.00703637751417178,-0.0273137244604903,0.000268875395063102,0.0546576849934141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0182994591454668,0.00953864280656788,-0.0369951990463399,0.000396280755406223,0.0550790796521642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.0164122422470311,0.00855987557882156,-0.000365113887459193,0.0331895983815213,0.0552149812234618
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00321515030699011,0.00167734579284103,-7.24474469782979e-05,0.00650274806095852,0.0552830559734833
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00773125287978743,0.00403426743268008,-0.00017591128826553,0.0156384170478404,0.0553402648999343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.0061515805815893,0.00321256952517526,-0.000145055687754201,0.0124482168509328,0.055532747305971
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.00489894304571076,0.00256248216445334,-0.000123521996617793,0.00992140808803931,0.0559237181649884
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00672429172582643,0.00352167566462126,-0.0136267760284841,0.000178192576831236,0.0562362555333869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.016982396324049,0.00891639003884256,-0.0344585208001804,0.000493728152082467,0.0568545108390416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.0130549028945077,0.00685827046656887,-0.000387307219967261,0.0264971130089827,0.0569971305668105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.00845445189069351,0.0044459104754937,-0.0171684364226612,0.00025953264127414,0.0572464349822649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,39990,-0.0138709795716275,0.00729740397483447,-0.0281738913623031,0.00043193221904801,0.0573521025087796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,39657,0.0201965251318052,0.0106434491451242,-0.000664635192638343,0.0410576854562487,0.0577808139454384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0168939862949124,0.00891204754090115,-0.0343615994750786,0.000573626885253895,0.0580337848147765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.00643844931434577,0.0034109800155675,-0.0131239701448581,0.000247071516166521,0.0591057391098393
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0134923011360561,0.0071522671953235,-0.0275107448388902,0.000526142566777948,0.0592622964392835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0178090213315856,0.00944749201889289,-0.0363261056886157,0.000708063025444419,0.0594489086920486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,41913,-0.00997474935533089,0.00530653256354739,-0.0203755531798838,0.000426054469221983,0.0601692520207943
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,39649,-0.0117835015785771,0.00626953071780321,-0.0240717817854713,0.000504778628317232,0.0602043198425974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0051581681318709,0.00274772955509439,-0.0105437180598559,0.000227381796114109,0.0605056822651259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,39794,-0.00639485390996903,0.00341878926626083,-0.0130956808718403,0.000305973051902188,0.0614401423845115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00480087909782493,0.00256778331123641,-0.000231976192198429,0.00983373438784828,0.0615569968038788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00785184924400421,0.00420741791389171,-0.016098388355232,0.000394689867223548,0.0620407383754318
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.008062742370841,0.00432461380170005,-0.0165389854221731,0.000413500680491102,0.0622898601703693
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,41913,0.00931835346825565,0.00499894992791914,-0.000479588390465859,0.0191162953269772,0.0623349680392679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00671725667118283,0.00360573639544678,-0.000349986663892865,0.0137845000062585,0.0624979206241261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.00714277111538339,0.00383724315775164,-0.0146637677045766,0.00037822547380982,0.0627050956523598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,39850,-0.0191411893876556,0.0102908312716083,-0.0393112186800079,0.00102883990469671,0.0629082614624455
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.00519004753838008,0.00279220424435719,-0.000282672780560007,0.0106627678573202,0.0630823813665186
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00754620422028313,0.00406046618420267,-0.000412309500754108,0.0155047179413204,0.0631308130135047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0150651828398267,0.0081088128616788,-0.0309584560487171,0.000828090369063773,0.063212960918858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.00915983479641386,0.00493093923716475,-0.0188244757012568,0.00050480610842905,0.0632445781130567
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0100527684794577,0.00543079373776286,-0.0206971242054729,0.00059158724655751,0.0641820217720054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,41820,0.00684180893464417,0.00369842353051525,-0.000407101185165725,0.0140907190544541,0.0643465524373498
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,41839,0.00872372217414961,0.00472877215135789,-0.000544671242511861,0.0179921155908111,0.0650863960432733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42016,-0.00823744605146161,0.00447477918439386,-0.0170080132528736,0.000533121149950345,0.065664013101921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0110363578118972,0.00599967206086686,-0.0227957150511963,0.000722999427401817,0.0658650020904524
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.013197671636372,0.007180819426684,-0.000876734439928674,0.0272720777126726,0.0661030788723063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0159545697695986,0.00870482939442171,-0.0330160353826651,0.00110689584346797,0.0668480226563931
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.00691968678991658,0.00377546619131963,-0.000480226945069885,0.014319600524903,0.0668541523609575
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42262,0.00878677351285533,0.00479960467176148,-0.000620451643797159,0.0181939986695078,0.0671628328305447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0113526764880849,0.0062019670911102,-0.0235085319866608,0.000803179010491137,0.0672020449015367
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0133334241861295,0.00729313983345863,-0.0276279782597085,0.000961129887449357,0.067539666800059
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0158755200866012,0.00869392783213893,-0.0329156186375935,0.0011645784643911,0.067869958574852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00534887583878774,0.00292942184437951,-0.0110905426537716,0.000392790976196098,0.0678893466215747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.00754225929064085,0.00413646846320209,-0.0156497374785169,0.000565218897235243,0.0682760617106042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.00428726757592167,0.00235391130870757,-0.000326398589145169,0.00890093374098852,0.0685774082165799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0125273643028808,0.00688308329689433,-0.0260182075647937,0.000963478959032097,0.0687819903345991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0122314204491946,0.00672277721470449,-0.0254080637900154,0.000945222891626196,0.0688774676573156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0141079384431978,0.00777807246553901,-0.00113708358925867,0.0293529604756543,0.0697335575202686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0169550272310054,0.00935060456860181,-0.0352822121854649,0.00137215772345419,0.0698189373452233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,39990,0.00432153495584948,0.00238508253384126,-0.000353226810479387,0.00899629672217834,0.0700277197866902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0189745053291661,0.0104764606888045,-0.0395083682792229,0.00155935762089066,0.0701431939535656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00917029920388279,0.00506345085791743,-0.000754064477635371,0.019094662885401,0.0701562401837111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0081767922639128,0.00451675778960439,-0.0170296375315374,0.000676053003711798,0.0702721327564405
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0120013286107024,0.00662963100580782,-0.000992748160680899,0.0249954053820858,0.070278650023898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.00448061047360933,0.00249033836461649,-0.00936167366825765,0.000400452721038996,0.0720097015274556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.00362283155029034,0.00201359517288978,-0.0075694780891543,0.000323814988573625,0.0720116682056069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,39990,-0.0137590987254587,0.00765623395303619,-0.0287653172734097,0.0012471198224922,0.0723445539402895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0115453773345352,0.00642454645626113,-0.024137488388807,0.00104673371973663,0.0723506279350955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.00690053036137985,0.00384115848492255,-0.014429200991828,0.00062814026906834,0.0724424068852804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00461452602470722,0.00257014389432608,-0.00042295600817189,0.00965200805758633,0.0726110760915702
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.00763733027054765,0.00426260011794524,-0.0159920265017203,0.000717365960625025,0.0732023588080202
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.00840737722264907,0.00469639509722554,-0.0176123116132111,0.000797557167912976,0.0734522229745576
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00720385863256505,0.00402607548917194,-0.000687249326211952,0.0150949665913421,0.073593170994857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0119449897866333,0.00668268194952137,-0.00115306683442859,0.0250430464076952,0.0738912484945333
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42144,0.00618091955431817,0.00346020814986306,-0.000601088419413424,0.0129629275280498,0.0740754095560004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.017221744529818,0.00964719595509817,-0.0361302486018104,0.00168675954217447,0.0742588859987836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,39657,0.0103667635416853,0.00580744654935647,-0.0010158316950534,0.021749358778424,0.0742755540405165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0277902092428579,0.0155873637820437,-0.0583414422556635,0.00276102376994763,0.074630254653269
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.00985874862776484,0.00553467061811926,-0.000989205783748911,0.0207067030392786,0.0748907054746116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00566420138687438,0.00318179422400716,-0.00057211529217965,0.0119005180659284,0.0750724069126423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00562340243638657,0.00316788276611907,-0.01183245265798,0.000585647785206809,0.0758990068191914
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,39929,0.0175894341025694,0.00991265790685369,-0.00183937539486385,0.0370182436000026,0.0760169578651801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.00588398441619926,0.00331619882134497,-0.0123837341060354,0.00061576527363687,0.076038595238922
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0183327092614769,0.0103481022821087,-0.03861498973441,0.00194957121145613,0.0764885147427154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.00816231307241598,0.00460996717762231,-0.0171978487405557,0.000873222595723736,0.0766531886869386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.00522096435935214,0.00294975514258883,-0.0110024844388262,0.000560555720121974,0.0767552393112082
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.00614756985120164,0.00347527477879997,-0.000663968715246306,0.0129591084176496,0.0769256015793408
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42062,-0.00591918627249832,0.0033528529713069,-0.0124907780962598,0.000652405551263208,0.07751624276254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.00306737153961401,0.00173909344024167,-0.00647599468248769,0.000341251603259672,0.0777965045769786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00484260316831084,0.00274629570461403,-0.000540136412732648,0.0102253427493543,0.0778740482232352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0133645177393645,0.00758193057772319,-0.028225101671702,0.00149606619297292,0.0779813584129205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00735458259869766,0.00418017499459987,-0.00083856039071808,0.0155477255881134,0.078537282674934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.00754599898402182,0.00428989469870894,-0.000862194625447705,0.0159541925934913,0.078597507314182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0176585829719966,0.0100513015304428,-0.0373591339716644,0.0020419680276712,0.0789718859922659
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,41843,-0.0103851348728342,0.00593054235336063,-0.022008997885421,0.00123872813975265,0.0799471276056597
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.00805867140315377,0.00460512547595809,-0.000967374529724093,0.0170847173360316,0.0801575780384675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,41774,0.011565603619919,0.00661163710914326,-0.00139320511400178,0.0245244123538398,0.0802659411917237
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.00576646721402471,0.00329753923102878,-0.000696709678791698,0.0122296441068411,0.0803623757677273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42119,-0.00577594093884392,0.00331089059039118,-0.0122652864960106,0.000713404618322792,0.0810898090946617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0114705684180507,0.00658032729908376,-0.0243680099242549,0.00142687308815346,0.0813335394463163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.00623454317128584,0.00357770060360208,-0.000777750011774235,0.0132468363543459,0.0814285173742571
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00371331734036411,0.0021316712989732,-0.00789139308635158,0.000464758405623361,0.0815406885261999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42189,-0.00652180429263045,0.00374648259049754,-0.0138649101700056,0.000821301584744734,0.0817446734764928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0152138773203013,0.00878552318263325,-0.0324335027582625,0.00200574811765984,0.0833504451645848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.00654834661393637,0.00379468119021301,-0.0139859217467539,0.000889228518881123,0.0844308145940193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42115,0.0132254957173194,0.00766672763472231,-0.00180129044673638,0.0282522818813751,0.0845411540861432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.005343400955077,0.00310126809852839,-0.0114218864281926,0.000735084518038653,0.0849206406605494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00741379299821016,0.0043050227499489,-0.00102405159168968,0.01585163758811,0.0850749054240921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.00646162757797839,0.00376485897723133,-0.000917496017395024,0.0138407511733518,0.0861344679848869
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,41900,0.005792330498394,0.00337756650911355,-0.000827699859468561,0.0124123608562566,0.0863791646410581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.00669858641784106,0.00390944935113408,-0.0143611071460639,0.000963934310381742,0.0866599676650932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0148531874131602,0.00869924898330775,-0.0319037154204433,0.00219734059412302,0.0877686715053076
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00722619926084695,0.00423488618943757,-0.0155265761921446,0.00107417767045069,0.0879711716925341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0161276367154431,0.00945250204867537,-0.0346545407308469,0.00239926729996061,0.0880026313090242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42310,0.00305951928023909,0.00179646959486461,-0.000461561125695542,0.00658059968617372,0.0885770299017892
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42070,0.00338224186694671,0.00198988982838092,-0.000517942196679902,0.00728242593057332,0.089207986413954
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.0168447888819167,0.00991086780607439,-0.00258051201798906,0.0362700897818226,0.089223899175488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,39919,0.01857799371577,0.0109450166661537,-0.00287423894989135,0.0400302263814313,0.0896498919868406
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.010140975510622,0.00598931032601025,-0.0015980727283581,0.0218800237496021,0.0904497469701559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.00987866162362559,0.0058408366181318,-0.0213267013951639,0.00156937814791273,0.0908052382246192
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.0119890784297121,0.00710022468553844,-0.00192736195394327,0.0259055188133674,0.0913342693169184
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,39930,0.00543900822085857,0.00322930083095598,-0.000890421407815143,0.0117684378495323,0.0921574208191586
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.00752761916531542,0.00448619697343167,-0.0163205652332415,0.00126532690261065,0.0933847055294272
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.00517331985175078,0.00308535203603772,-0.0112206098423847,0.000873970138883156,0.0936224478816932
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0146706053763733,0.0087623542729286,-0.0318448197513134,0.00250360899856675,0.0941038637405264
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.00796345078440534,0.00476952200533971,-0.0173117139148712,0.00138481234606049,0.0950109768838491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,39990,-0.0161299174773149,0.00966660587017756,-0.0350764649828629,0.00281663002823315,0.0952196726008328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.00670015439581174,0.00402001153124653,-0.0145793769970549,0.00117906820543145,0.095597179504283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.00611276608979524,0.00366926664565853,-0.013304528715286,0.00107899653569548,0.0957490057518183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.00455738608187856,0.00274757443785853,-0.000827859816324149,0.00994263198008127,0.0972013211229853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,39925,0.00830457900527329,0.00501026017543687,-0.00151553093858297,0.0181246889491295,0.0974431926115433
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0111812361390182,0.00674930791846115,-0.00204740738116564,0.0244098796592021,0.0976189868114363
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.00773659951843758,0.00467904706568775,-0.0169075317671856,0.00143433273031042,0.0982657780869497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0091695110189617,0.00555728315503338,-0.0200617860028271,0.00172276396490372,0.098966479280047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.0104630434024804,0.00637120432986677,-0.00202451708405849,0.0229506038890192,0.100563638246037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0211333795737588,0.0128709476822483,-0.0463604370309655,0.00409367788344786,0.100625493619097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00418981556271883,0.0025527604597141,-0.000813594938320804,0.00919322606375847,0.100765789969867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.00534123056802536,0.0032588485428897,-0.00104611257603846,0.0117285737120892,0.101243379956468
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.00791616775503898,0.00483668343088673,-0.00156373176949901,0.017396067279577,0.101723224554854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00899836009502139,0.005500979098137,-0.00178355893732712,0.0197802791273699,0.10191060951054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0195464730201512,0.011953481267138,-0.0429752963037418,0.00388235026343933,0.102032434994928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0104064993708799,0.00638866192992374,-0.0229282767535304,0.00211527801177066,0.103362435020624
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.00433623043046398,0.00266922132815875,-0.00956790423365514,0.000895443372727165,0.104285893503599
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0111521783261822,0.00688131377412188,-0.024639553323461,0.00233519667109673,0.105116757088279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.01687911751969,0.0104254001922331,-0.0373129018964669,0.00355466685708681,0.105467852729635
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.00818800371368669,0.00505812491615924,-0.0181019285493588,0.00172592112198542,0.105517796128923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,39854,-0.00728105569705972,0.00450091474445463,-0.0161028485961908,0.00154073720207136,0.105758840081808
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.00391509610319299,0.0024209094984313,-0.00866007872011834,0.000829886513732369,0.105862754104996
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00874293480009032,0.00540683945024188,-0.00185447052238375,0.0193403401225644,0.105898985886642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00614932397114555,0.0038045792303706,-0.00130765132038084,0.0136062992626719,0.106058824204528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,39757,-0.0146078276347929,0.00903807355417824,-0.0323224518009822,0.00310679653139647,0.106067558811266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,41839,0.00751614039521293,0.0046687435812391,-0.00163459702401569,0.0166668778144416,0.107446799338291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.00673838740079323,0.0041911727547381,-0.00147631119849345,0.0149530860000799,0.107911937344489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00760842590417129,0.00473637359063839,-0.0168917181418225,0.00167486633347996,0.10821871421068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0165831859085465,0.0103311193706691,-0.036832179875058,0.003665808057965,0.108484631610019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,39575,0.00673546715239643,0.00420496519130904,-0.0015062646225693,0.0149771989273622,0.109231047215078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.00956502861795371,0.0059845085592133,-0.0212946653940118,0.00216460815810435,0.110005274451711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.00846366302204257,0.00530312459744617,-0.0188577872330371,0.00193046118895193,0.110517158263939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,41843,-0.0108701903942179,0.00681711599938003,-0.0242317377530028,0.00249135696456691,0.110838140788116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.00999537564593879,0.00626991261041572,-0.0222844043623536,0.00229365307047603,0.110924292995907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0178221366703275,0.0111819346342206,-0.0397387285533998,0.0040944552127448,0.111001335501522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0101879198682027,0.0064034208470225,-0.0227386247283668,0.00236278499196141,0.111630195665151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00766866079882738,0.0048299746676464,-0.00179808954975955,0.0171354111474143,0.112372920526296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.00920505845398155,0.00580182099244123,-0.00216651069120325,0.0205766275991663,0.112631230428924
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00490613602504632,0.00309419534125278,-0.00115848684380914,0.0109707588939018,0.112860147853801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0121283631374414,0.00765362852616011,-0.0271294750487152,0.00287274877383244,0.11306775686354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.00788524137201117,0.00498053561139691,-0.0176470911703491,0.00187660842632678,0.113397014358397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00984126544629836,0.00622013518491538,-0.00235019951613578,0.0220327304087325,0.113641070950116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.00597475201364124,0.00377941311424097,-0.00143289769027107,0.0133824017175535,0.113936238268402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0108419097270428,0.00686011205741879,-0.0242877293595836,0.00260390990549801,0.114032348282711
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42119,0.0110547064889363,0.00699534166366464,-0.00265616317184645,0.0247655761497189,0.114062619762451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00721725256774358,0.00457337985884081,-0.00174657195558441,0.0161810770910716,0.114570464312295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.00528453708726412,0.00335010412967902,-0.00128166700690675,0.011850741181435,0.114721058945233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00458876157745738,0.00291381227495438,-0.00112231048145321,0.010299833636368,0.115324094197259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00494593441577465,0.00314142613453228,-0.0111031296394579,0.00121126080790862,0.115417479075596
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESPL1,Separin,39560,0.00876634903905394,0.00557654077588545,-0.00216367088168155,0.0196963689597894,0.115978296618809
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.006562589976984,0.00419830779590824,-0.0147912732569641,0.00166609330299615,0.118044957933016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.00936930100435081,0.00600734851012474,-0.0211437040841953,0.00240510207549367,0.118873653357923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00923678638644459,0.00592503748857483,-0.00237628709116208,0.0208498598640513,0.119038913480634
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42070,-0.00485459817842087,0.00311827246249924,-0.0109664122049194,0.00125721584807763,0.119536016617326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00820405227192238,0.00527540466043274,-0.00213574086252579,0.0185438454063705,0.119938465959198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42185,-0.00586659304685332,0.00377418729053179,-0.0132640001362956,0.001530814042589,0.120112560041697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.011456835954265,0.00737113575359165,-0.0259042620313047,0.00299059012277459,0.120145130079612
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00759982134020428,0.00489290011851793,-0.00199026289209087,0.0171899055724994,0.120395992124218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42224,0.00987085874789919,0.00635872607793453,-0.0025922443648525,0.0223339618606509,0.120605853001442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.00398111812624389,0.00256565517238843,-0.00900980226412521,0.00104756601163742,0.120757968536428
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.00625133507004925,0.00404828595144785,-0.014185975534887,0.00168330539478854,0.122570237084658
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0197919610674776,0.0128413672141453,-0.0449610408072024,0.00537711867224715,0.123280707386895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.00958163392754274,0.00621706473260191,-0.0217670808034425,0.00260381294835701,0.123301145034745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.00971339930647201,0.00632983465785155,-0.00269307662291703,0.0221198752358611,0.124920071007395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00581388513096827,0.00379454490719326,-0.0132511931490671,0.00162342288713052,0.125509276855903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.00441400803524065,0.00288404837543491,-0.00123872678061178,0.0100667428510931,0.125924043205317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.00648541239554416,0.00423914599705782,-0.00182331375868917,0.0147941385497775,0.126072735935653
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,39560,0.00489678717443674,0.0032031240023794,-0.00138133587022689,0.0111749102191004,0.126354411269112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,39657,0.0117690480921817,0.00772998654417083,-0.00338172553439316,0.0269198217187565,0.127907792024494
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0176261623684468,0.011633886156953,-0.0404285792360748,0.00517625449918114,0.129778214189603
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.00943379431918941,0.00622772678939839,-0.0216401388264102,0.00277255018803143,0.129850067911337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42208,0.0175799073928827,0.0116316073355327,-0.00521804298476131,0.0403778577705268,0.130712064985032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42016,0.0200702266301279,0.0133005169573282,-0.00599878660623541,0.0461392398664912,0.13132720129169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00551572264323538,0.00367004458013951,-0.00167756473383806,0.0127090100203088,0.132887789134988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.00510295716145595,0.0034012935697118,-0.0117694925580911,0.00156357823517918,0.133560547270198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.00988438006128216,0.00659609768512628,-0.0228127315241297,0.00304397140156535,0.13402665903138
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.00936057334993547,0.00624770068319937,-0.0216060666890062,0.00288491998913529,0.134093250508592
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42296,-0.00663944001190516,0.00443385436500066,-0.0153297945673064,0.00205091454349612,0.134301315914268
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00667378942887291,0.00446009599672602,-0.0154155775824559,0.00206799872471009,0.134590208239404
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.00693565813636203,0.00463857409196588,-0.00215594708389109,0.0160272633566151,0.13488750948911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.00688645398680411,0.00461336404327852,-0.01592864751163,0.00215573953802179,0.135534185743545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00681726947789414,0.00456780134826326,-0.0157701601204901,0.00213562116470185,0.135606813373091
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0108580212524508,0.00729925839091707,-0.0251645676986482,0.00344852519374671,0.136892761636429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.00893255905230513,0.00600580652185752,-0.00283882173053562,0.0207039398351459,0.136958886781976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.0074340634066588,0.00500505469884401,-0.00237584380307545,0.0172439706163931,0.137485230049917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0136615111207066,0.00919784729697266,-0.031689291822773,0.0043662695813598,0.137494362153458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0112900050815265,0.00761003402257325,-0.0262056717657701,0.00362566160271706,0.137952176928862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00419374989406716,0.00283412774189374,-0.0097486402681789,0.00136114048004458,0.138967879862291
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0059325090987886,0.0040130242640965,-0.00193301845884054,0.0137980366564177,0.139347185812017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0163081402098004,0.011036907288248,-0.0379404784947664,0.00532419807516558,0.139542955527398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0128509992184267,0.00870158926947348,-0.00420411574974132,0.0299061141865947,0.139742754105037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_A,,39934,-0.00506085332367192,0.00343251627072922,-0.0117885852143012,0.00166687856695736,0.140405513934011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.00815399185256043,0.00553075543956061,-0.00268628880897837,0.0189942725140992,0.140429141350306
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00506848763703938,0.00344199031955267,-0.0118147886633626,0.00167781338928385,0.140902283331751
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0119365602881521,0.00810976245093652,-0.0278316946919877,0.00395857411568343,0.141082314870608
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.00591476996855004,0.00401862928490135,-0.0019617434298566,0.0137912833669567,0.141092984172777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00684323548785202,0.00465080024378052,-0.0159588039656618,0.00227233298995781,0.141208825991542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00541790845635005,0.00368847456866698,-0.00181150169823722,0.0126473186109373,0.141889905908863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAX,Protein max,41839,-0.0161995744943358,0.0110460636814926,-0.0378498593100613,0.00545071032138967,0.142523006153338
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00418874287876608,0.00286010374393129,-0.0097945462168714,0.00141706045933924,0.143073585690148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,39699,-0.00680249810970972,0.00464669529379853,-0.0159100208855548,0.0023050246661354,0.143237781144142
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,39919,-0.010762418016672,0.00735655166858487,-0.0251812592870983,0.00365642325375437,0.143503219203903
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.011898069628294,0.00814134173716765,-0.0278550994331426,0.00405896017655462,0.143918889125354
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.00690907284324956,0.00472811283538502,-0.0161761740006042,0.00235802831410509,0.143963341586641
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0148763124010708,0.0102042104533182,-0.0348765648895744,0.00512394008743279,0.144907691186295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.00773171470733812,0.00531072976377963,-0.00267731562966994,0.0181407450443462,0.145458071907764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.00888710197722612,0.00615494797989161,-0.0209508000178137,0.00317659606336143,0.148796712616807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.00914639876067665,0.00633471904348349,-0.003269650564551,0.0215624480859043,0.148808875100749
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42310,-0.00380803271424101,0.00263975015512874,-0.00898194301829333,0.00136587758981131,0.149163594053423
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00407608668474804,0.00282942441323778,-0.00146958516519801,0.00962175853469409,0.149723648152072
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0106789553905491,0.0074146163464436,-0.0252116034295786,0.00385369264848033,0.149822177408865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.00527193310799474,0.00366130059571489,-0.0124480822755959,0.00190421605960644,0.149916510572189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.00934593972165878,0.0064939832539294,-0.00338226745604284,0.0220741468993604,0.150126593776305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0171344130644299,0.0119795938993218,-0.0406144171071006,0.00634559097824076,0.152658513079929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.00427145285393558,0.00298939913043109,-0.00158776944170936,0.0101306751495805,0.153066001017578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.00539457241040085,0.00378202356858079,-0.0128073386048192,0.00201819378401751,0.15378409190324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0178522181333723,0.0125264679916183,-0.0424040953969441,0.00669965913019949,0.15413905083832
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0150752144148188,0.0106021123747447,-0.0358553546693184,0.0057049258396808,0.155076609057974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.0043553070974587,0.00307475638522792,-0.00167121541758802,0.0103818296125054,0.156665636328304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.00953678308865457,0.00673697436911681,-0.00366768667481438,0.0227412528521235,0.156924450259308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.0053927619912166,0.00381190132571345,-0.00207856460718176,0.012864088589615,0.157174489895112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,39806,0.00526783925504294,0.0037280257809792,-0.00203909127567629,0.0125747697857622,0.157672549316876
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00620210188631616,0.00439121348399628,-0.00240467654231654,0.0148088803149489,0.157863327656135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.00385910045303737,0.00273335594464711,-0.00149827719847097,0.0092164781045457,0.158020316907194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0129280715845679,0.00916438517037309,-0.0308902665184991,0.00503412334936339,0.158364656386451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0113976429625236,0.00808144052427635,-0.0272372663901053,0.00444198046505802,0.158465121271753
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0128092779769564,0.00909666554674275,-0.0306387424485722,0.00502018649465936,0.15912080977976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00667488845564132,0.00474139395361391,-0.0159680206047246,0.00261824369344195,0.159221304064207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00597357487943775,0.00425748132949203,-0.00237108852636663,0.0143182382852421,0.160621926295359
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00533810792824641,0.00380738334128485,-0.00212436342067189,0.0128005792771647,0.160931255616438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.011314095284347,0.00807348855299119,-0.0271381328482098,0.00450994227951567,0.161120726653844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00817684867335685,0.00583973742295803,-0.00326903667564089,0.0196227340223546,0.161479198137978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42015,-0.00735969555947683,0.00525799370315736,-0.0176653632176653,0.00294597209871159,0.161621638609761
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.00860042954248433,0.00615663275332432,-0.020667429739,0.00346657065403134,0.162460689990041
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.00808264750854708,0.00578656691172604,-0.0194243186555301,0.00325902363843595,0.162503271352962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,39586,0.00682319387012961,0.00488693924394235,-0.00275520704799739,0.0164015947882566,0.162679450196736
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42189,0.00659297128854276,0.00472615935114958,-0.00267030103971042,0.0158562436167959,0.163039979156345
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCN,Decorin,41900,0.00333052217906941,0.00239128905681376,-0.00135640437228556,0.00801744873042438,0.163711809007588
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,39560,0.00441755158284956,0.0031810694191816,-0.00181734447874638,0.0106524476444455,0.164952167540554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.00892116911525672,0.00642817466476089,-0.0215203914581881,0.00367805322767463,0.16521891229623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.00671621550918845,0.00484048680361113,-0.00277113862588936,0.0162035696442663,0.165310175455758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0156780192328526,0.0113082546050242,-0.0378421982586999,0.00648615979299479,0.16564127239341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.00802961057665433,0.00579177425920501,-0.0193814881246962,0.00332226697138749,0.165657649174355
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,41839,0.00686588105693353,0.00497326641215514,-0.00288172111089054,0.0166134832247576,0.16743831538153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.00652522582603732,0.00473176721537636,-0.015799489568175,0.00274903791610034,0.167914234821852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.00913585603031517,0.00662630576271335,-0.0221234153252333,0.00385170326460299,0.168002074462147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.00327731467520013,0.00238110040469927,-0.0079442714684107,0.00138964211801045,0.168724454825039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.00979116260912798,0.00715275891985636,-0.0238105700920464,0.00422824487379049,0.171064062095029
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00909758241212958,0.00664734101665783,-0.00393120598051976,0.0221263708047789,0.1711459554897
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NENF,Neudesin,39919,-0.0160671053916905,0.0117444922564444,-0.0390863102143216,0.00695209943094054,0.171322176620196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,39919,0.00379116955329449,0.00277443967336188,-0.00164673220649479,0.00922907131308378,0.171820785081115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00643353383293477,0.00472074030845255,-0.0156861848375018,0.00281911717163223,0.172965781316758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0107612587400417,0.00789902405140386,-0.0047208284007099,0.0262433458807933,0.173113630953747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0134764825738205,0.00989962792714848,-0.0328797533110315,0.0059267881633905,0.173442201363213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00363453472220231,0.0026699000036687,-0.00886753872939296,0.00159846928498835,0.17344591402823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.00881936273310941,0.00649023959377493,-0.0215402323369083,0.00390150687068945,0.174216947691255
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.00764226206611355,0.00563524312084446,-0.0186873385829687,0.0034028144507416,0.175076968313522
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42210,-0.0059624082616471,0.00439690375341959,-0.0145803396183495,0.00265552309505529,0.175106703109992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42119,0.00909615670581022,0.00671003732348974,-0.00405551644822968,0.0222478298598501,0.175247688619895
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0116400919844777,0.0085921514949105,-0.0284807089145023,0.00520052494554686,0.175524506465858
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.00830227311784921,0.00613529422793786,-0.0203274498046074,0.00372290356890899,0.176014913504157
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00458285811815429,0.00338928625717679,-0.00206014294591221,0.0112258591822208,0.176351893685309
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0118173883576768,0.0087498408515242,-0.0289670764266642,0.00533229971131063,0.176856858956656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.00342855153942041,0.00253865184764103,-0.00840430916079683,0.001547206081956,0.176865249922193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,39958,-0.00428616442155532,0.0031739652012654,-0.0105071362160355,0.00193480737292487,0.176910393304099
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.00771809351684373,0.00574504164041874,-0.00354218809837701,0.0189783751320645,0.179153989347521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00521599956402576,0.00388677787725333,-0.0128340842034423,0.00240208507539077,0.179628005272067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00354815431901406,0.00264609281267479,-0.00873449623185665,0.00163818759382853,0.179978767130274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00507965129415293,0.00378956428918828,-0.0023478947126561,0.012507197300962,0.180131972185023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00684261650652935,0.00510580568371514,-0.016849995646611,0.00316476263355232,0.180215061324881
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00697963730651375,0.00521057710689801,-0.0171923684360338,0.00323309382300635,0.180427599013623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.0108421932704424,0.00812109324146127,-0.0050751494828217,0.0267595360237065,0.181882564035456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.00411277107458938,0.00308094986812853,-0.00192589066694255,0.0101514328161213,0.181930618405685
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0156202733605459,0.0117151124246204,-0.0385818937128019,0.00734134699171004,0.18244147854489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.00680462477270747,0.00510923356860205,-0.0168187225671675,0.00320947302175256,0.182943928470484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.0085560830978662,0.0064318236162875,-0.00405029119005729,0.0211624573857897,0.183455861138439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.0176785038044031,0.0133680726369417,-0.0438799261728088,0.0085229185640026,0.186043092520244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.00657948277393195,0.00497998733301554,-0.00318129239877851,0.0163402579466424,0.186462512829633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.00427196222784555,0.00323447267163887,-0.00206760420856665,0.0106115286642577,0.186608724963674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00963784858601687,0.00729845629339682,-0.0239428229210746,0.0046671257490409,0.186683975193366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,41910,-0.0100817100159463,0.00764096051360504,-0.0250579926226121,0.0048945725907196,0.187048203370865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00363753444174439,0.00275951695353175,-0.00177111878717784,0.00904618767066663,0.187471590356541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C3,Complement C3,39445,-0.00633466266153976,0.004816061307077,-0.0157741428234107,0.00310481750033116,0.188430124003189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.00966818667726145,0.00735052548373022,-0.0240752166253727,0.00473884327084977,0.188434724938697
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.00632635530721204,0.00480985735270426,-0.00310096510408832,0.0157536757185124,0.188435073827613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.00560304444165594,0.00426046613026966,-0.0027474691736726,0.0139535580569845,0.188494511831324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42144,0.00404943365617659,0.00308104003571739,-0.0019894048138295,0.0100882721261827,0.188765042011225
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.00665252377508976,0.00507731403590777,-0.016604059285469,0.00329901173528946,0.19013523462206
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.00341588841129984,0.00260810057645079,-0.00852776554114338,0.00169598871854371,0.19031183109139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.0047102223316936,0.00360846051843992,-0.00236236028444864,0.0117828049478358,0.191808729607919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,39958,0.0134627939908192,0.0103168042794275,-0.00675814239685871,0.033683730378497,0.19194026366731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,39897,-0.0126150692300103,0.00967028178823675,-0.0315688215349544,0.00633868307493368,0.192083158260275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.00414917878493286,0.0031817624417516,-0.010385433170766,0.00208707560090028,0.192238384546907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.010868165641081,0.00833921535255206,-0.00547669644992104,0.027213027732083,0.192513395893217
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.0104992013032589,0.0080574412981931,-0.00529338364119955,0.0262917862477174,0.192586862087557
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00557755527648294,0.00428556010381742,-0.0028221425269992,0.0139772530799651,0.193117963382251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00544322728231171,0.00418432873028096,-0.0136445115936624,0.00275805702903898,0.193333613362583
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0156177909688317,0.0120168272511999,-0.0391707723811835,0.00793519044352015,0.193739992907014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00833770608300479,0.00641945551356742,-0.00424442672358736,0.0209198388895969,0.194032762153486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.00498269375043791,0.00384491537415129,-0.0125187278837744,0.00255334038289862,0.195025875925349
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.00512029813881082,0.00395962551187241,-0.0128811641420807,0.0026405678644591,0.195989250889741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.0146455145941557,0.0113330059266961,-0.00756717702216874,0.03685820621048,0.196284799066179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,41839,-0.0100089729603263,0.00777794466218443,-0.0252537444982078,0.00523579857755515,0.19817244255145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00785210021908974,0.00614763502348093,-0.00419726442693289,0.0199014648651124,0.201539102577844
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.00287089766730847,0.00224842648659093,-0.00153601824640974,0.00727781358102668,0.201677927467216
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42119,-0.00659486784116776,0.00516619276567006,-0.0167206056618811,0.00353086997954555,0.201785521087196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00509810143718378,0.00400259768566643,-0.00274699002672243,0.01294319290109,0.202796608860275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,41865,0.00987797307173088,0.0077577367860984,-0.00532719102902197,0.0250831371724837,0.202931778556151
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,39586,0.00699307788658651,0.0054927288552312,-0.00377267066966664,0.0177588264428397,0.202991103233382
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.00752325636438904,0.0059137627224469,-0.00406771857160689,0.019114231300385,0.203337918835798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.00651145339391061,0.00512234444408116,-0.0165512485043097,0.00352834171648846,0.203688523405979
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,39638,-0.0104001538023513,0.00820591386280863,-0.0264837449734562,0.00568343736875365,0.205039970036046
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.00701551452050893,0.00553914960854145,-0.00384121871223231,0.0178722477532502,0.205344679087352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.00869290823822277,0.00686563578011559,-0.00476373789080379,0.0221495543672493,0.205481779912559
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00471119254279654,0.00373597639426812,-0.00261132118996898,0.0120337062755621,0.207323471517857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00484199129881004,0.0038416048540301,-0.00268755421508896,0.012371536812709,0.207548645393178
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42216,-0.00767545998377645,0.00609081317285503,-0.0196134538025723,0.00426253383501941,0.207629642250585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42016,-0.00428886035265605,0.0034081382462924,-0.0109688113153892,0.00239109061007706,0.208262753881457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,39930,-0.00445039176050659,0.00353777257983869,-0.0113844260169904,0.00248364249597724,0.208430576546254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.00671516199450835,0.00534713316698838,-0.0171955430018056,0.00376521901278888,0.209194807079756
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,41839,-0.00801605549918247,0.00638731044738106,-0.0205351839760493,0.0045030729776844,0.209501998981823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.00498975507122466,0.00397625173256193,-0.012783208467046,0.00280369832459673,0.209545533941899
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.00530676321573326,0.00422950736413712,-0.00298307121797549,0.013596597649442,0.20960942731955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.00858875489064807,0.00685529800124893,-0.022025138973096,0.00484762919179984,0.210281961138722
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.00740890686332224,0.00593125819837008,-0.0190341729321276,0.0042163592054831,0.21163984268474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.00681234526592709,0.0054611895379784,-0.00389158622851057,0.0175162767603648,0.212269070515577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42310,0.00540973301842063,0.00434277772175473,-0.00310211131621863,0.0139215773530599,0.212901354139795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.00608336731771295,0.0048889020635721,-0.0156656153623143,0.00349888072688837,0.213403218575623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,39908,0.00793984242492094,0.00638221921001069,-0.00456930722670001,0.0204489920765419,0.213504490657794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0080197317804294,0.00647200033697451,-0.0207048524408994,0.00466538888004065,0.215313954099085
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00630686468481478,0.00509033027176323,-0.0162839120174707,0.00367018264784114,0.215371722470539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00632666990134333,0.0051068767274305,-0.00368280848442046,0.0163361482871071,0.215426384651681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.00319619278109878,0.0025815252683362,-0.00825598230703773,0.00186359674484017,0.215704404766467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,39930,0.00804345091057143,0.00651564764127661,-0.00472721846633072,0.0208141202874736,0.217048885210681
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPGN,Epigen,39919,0.00596424114751859,0.00483894064896524,-0.00352008252445328,0.0154485648194905,0.217768927011158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,39560,0.00852342744938252,0.00693293048761698,-0.00506511630634675,0.0221119712051118,0.21894379174292
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.00342795557850365,0.00279645038526483,-0.00890899833362271,0.00205308717661541,0.220290314092396
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.00587538997632283,0.00480255512171773,-0.0152883980148896,0.00353761806224392,0.221204222052266
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00499865282551668,0.0040915655560702,-0.00302081566438092,0.0130181213154143,0.221848521432649
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00527178278014039,0.00432146827593863,-0.00319829504069932,0.0137418606009801,0.222526731453925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00901979243904344,0.00739494293031373,-0.00547429570437147,0.0235138805824584,0.222595547139008
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,39657,-0.00451898710512157,0.00372045802001243,-0.0118110848243459,0.00277311061410279,0.224532443652158
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.00324568406261082,0.00267293868441432,-0.00848464388406288,0.00199327575884125,0.224663934622528
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.00722811414409561,0.00595711556680344,-0.0189040606550304,0.00444783236683914,0.225019043127968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42088,0.00914606914822657,0.00753836749006658,-0.00562913113230393,0.0239212694287571,0.225048158333631
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.00532728932887236,0.0043939932582793,-0.00328493745735507,0.0139395161150998,0.225384398131323
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.00415269619393366,0.00342587212059873,-0.0108674055503072,0.00256201316243986,0.225478085496004
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.00697204090913029,0.00578712894060454,-0.0043707318144546,0.0183148136327152,0.228325810531263
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.00636603343719933,0.00530262834877815,-0.00402711812640586,0.0167591850008045,0.229949996701477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.00509217921494203,0.00424621893923097,-0.0134147683358347,0.00323040990595067,0.230461293520849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00757702817718327,0.00633297018849971,-0.00483559339227616,0.0199896497466427,0.231550145034911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.00302858167027179,0.00253557858216443,-0.00194115235077049,0.00799831569131407,0.23232921356986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00341117530699195,0.00286650694169718,-0.00902952891271843,0.00220717829873453,0.234063239401636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0056633809222536,0.00476070340895399,-0.0149943596038034,0.00366759775929621,0.234225031528011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.00590925938083443,0.00498920856104421,-0.0156881081604811,0.00386958939881221,0.236276375199758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0031373579845929,0.0026507769791264,-0.00833288086368064,0.00205816489449485,0.236611352151867
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00894914584292657,0.00756201160362094,-0.00587239690017047,0.0237706885860236,0.236662183613378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0107631702124709,0.00909848861599748,-0.028596207899826,0.00706986747488413,0.236844800021299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00298338682078608,0.00252226533004777,-0.00196025322610755,0.00792702686767971,0.236900855447258
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00921909967240115,0.00780705529721017,-0.00608272871013078,0.0245209280549331,0.237680862349267
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00637620949861641,0.00540000396460788,-0.00420779827201503,0.0169602172692479,0.23771624829553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIT,Vitrin,39958,0.00472324685497209,0.00401230597516354,-0.00314087285634846,0.0125873665662926,0.239144308496721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,39586,-0.00528234423276513,0.0045017023574313,-0.0141056808533305,0.00354099238780021,0.240656719381514
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,41843,0.0107872949343457,0.00919650191351185,-0.00723784881613755,0.0288124386848289,0.240825703270664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00659529903806806,0.00563021091364416,-0.00443991435267449,0.0176305124288106,0.241454120820474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.00846525862650221,0.00723784874500814,-0.0226514421667182,0.00572092491371375,0.242194153028642
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.00423428967141832,0.00362656393501438,-0.00287377564120987,0.0113423549840465,0.243002324016109
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,39586,-0.0129245546842405,0.0110808305972469,-0.0346429826548444,0.0087938732863634,0.243482677561831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00320927628395794,0.0027518742510005,-0.00218439724800305,0.00860294981591892,0.24355301514201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,39736,0.0118049248607793,0.0101438503350227,-0.00807702179586514,0.0316868715174237,0.244549512869365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,39966,-0.0112449076267457,0.0096781129902979,-0.0302140090877296,0.00772419383423818,0.245304340495093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.00901751637492298,0.00776751851056118,-0.0242418526556229,0.00620681990577693,0.245696718295108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.00752422443324659,0.00648658634616683,-0.0202379336717336,0.00518948480524039,0.246087614761679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.00862765555278524,0.00745430312087372,-0.00598277856412725,0.0232380896696977,0.247131546940374
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0187776523968596,0.0162748637676157,-0.0506763853813865,0.0131210805876673,0.248609630832065
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00578990204988387,0.0050242141069702,-0.00405755759977772,0.0156373616995455,0.249182028251764
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.00520548411964211,0.00451900519705287,-0.0140627343058657,0.00365176606658151,0.249379140131344
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42262,0.00525904197284686,0.00457952105882122,-0.00371681930244273,0.0142349032481365,0.250830789428647
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00491700820338818,0.00428387119991553,-0.00347937934844625,0.0133133957552226,0.251077859742896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0100460118892606,0.00875348944687985,-0.00711082742662388,0.0272028512051451,0.251134806242848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0068175664533424,0.00595289641939776,-0.018485243435362,0.0048501105286772,0.252129034729595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0067902567716442,0.00593618847997662,-0.0184251861923984,0.00484467264910998,0.252700520269074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00497258436057381,0.00434809333943044,-0.00354967858470984,0.0134948473058575,0.252804478469482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0052177844088147,0.00457336445680761,-0.0141815787441576,0.00374600992652821,0.253932660017775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00476286820933047,0.00417616017932309,-0.0034224057421428,0.0129481421608037,0.254107208709665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,41843,0.00447050588661189,0.00393599232756094,-0.00324403907540755,0.0121850508486313,0.256060214371153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.00852174179771411,0.00751743439918842,-0.0232559132201234,0.00621242962469519,0.256987518510162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,39900,0.00622669571696189,0.00549417613308956,-0.00454188950389365,0.0169952809378174,0.257101187961182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00428165014412641,0.0037797938063464,-0.00312674571631252,0.0116900460045653,0.257333975962565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.00377320189431108,0.00333309644727463,-0.00275966714234719,0.0103060709309694,0.257641781811154
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00495863085139953,0.00438516562591442,-0.00363629377539273,0.0135535554781918,0.258174810540511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.00866365925020189,0.00766757222887182,-0.00636478231838687,0.0236921008187907,0.258538344098153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00426233397075658,0.00377811274906227,-0.00314276701740547,0.0116674349589186,0.259274805224921
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,41900,-0.00547843954081092,0.00486373189434313,-0.0150113540537235,0.00405447497210162,0.260022490697556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00334918716696478,0.00297830073873081,-0.00918665661487716,0.0024882822809476,0.260812209373096
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0103835709971509,0.00923952764525621,-0.00772590318755125,0.0284930451818531,0.261109534578358
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00524634021765478,0.00467163364065495,-0.00391006171802892,0.0144027421533385,0.261453365346053
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0102399075998259,0.00914736754428726,-0.0281687479866289,0.00768893278697715,0.262977621904248
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,39757,0.00484880662182172,0.0043349586348292,-0.00364771230244352,0.013345325546087,0.263362288075271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42016,0.0121585365756166,0.0108733601429757,-0.00915324930461576,0.033470322455849,0.263503755727505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.00978949056211707,0.00876210795760021,-0.0269632221590135,0.00738424103477934,0.263909821966745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00589612497710782,0.005277921167447,-0.00444860051108829,0.0162408504653039,0.263963126775495
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.0040678360961617,0.00365480806377212,-0.00309558770883166,0.0112312599011551,0.265724464935862
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.0033779346555391,0.00303571137706391,-0.00257205964350616,0.00932792895458436,0.265843601171379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0058932068597167,0.00529780885476671,-0.0162769122150594,0.00449049849562605,0.265996711429469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.00871009088549884,0.00783356082653265,-0.0240638701055028,0.00664368833450516,0.266207644240949
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.00715601384488151,0.00644056549351492,-0.0197795222121708,0.00546749452240774,0.266556262036111
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00579536040207187,0.00522202824311697,-0.00443981495443738,0.0160305357585811,0.26711340957999
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0137022694270064,0.0123513626932517,-0.0379109403057798,0.010506401451767,0.267288972365238
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,39649,0.00396042971671111,0.00357660500369097,-0.00304971609052319,0.0109705755239454,0.268181704075336
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0032889096814712,0.00297243426789782,-0.00911488084655094,0.00253706148360854,0.26854646117463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.0063945267716331,0.00578460372188616,-0.00494329652326379,0.01773235006653,0.268989484446934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00620220672463879,0.00561847467489953,-0.00481000363816429,0.0172144170874419,0.269662921879295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00325001525768101,0.0029487805058406,-0.00252959453376658,0.00902962504912859,0.270413568306632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00785062368988733,0.00713150055598571,-0.00612711739984467,0.0218283647796193,0.270991536521624
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0036131596501359,0.00328533074859563,-0.0100524079173833,0.00282608861711154,0.271448879878768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C5,Complement C5,39979,0.00172326354651382,0.00156842234373801,-0.00135084424721267,0.00479737134024031,0.271911640691911
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00533936181119399,0.00486998061215187,-0.00420580018862368,0.0148845238110117,0.27293542520282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0065930152536827,0.00601950043100669,-0.0183912360984558,0.00520520559109042,0.273415335084511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42196,0.00399833253829062,0.00365399142253798,-0.00316349064988382,0.0111601557264651,0.27387044189222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.00736359499422637,0.00673730684479306,-0.0205687164100208,0.00584152642156804,0.27443594937143
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0126728558349682,0.0116063724390451,-0.0354213458154967,0.0100756341455602,0.274902314431886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,41800,-0.00542967454837174,0.00499993422951984,-0.0152295456382306,0.00437019654148714,0.27752130134617
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.00793364037716085,0.00732050430946235,-0.0222818288237071,0.00641454806938536,0.278496057892395
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HLA_DRA,,42060,0.00409316335580396,0.003779809688593,-0.00331526363383831,0.0115015903454462,0.278871336111704
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00395858934370083,0.00366203818313309,-0.0111361841826417,0.00321900549524004,0.279729822750777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.00626650736365103,0.00581481534312941,-0.0176635454361847,0.00513053070888261,0.281196331084042
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,39934,-0.00866895533358592,0.00804443466735003,-0.024436047281592,0.00709813661442014,0.281220111981353
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00643807580037432,0.005979010602138,-0.00528078497981616,0.0181569365805648,0.281601753024502
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00448279663546979,0.00416730860007433,-0.00368512822067589,0.0126507214916155,0.282082681420714
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.00379898207107856,0.00353723218749272,-0.00313399301640716,0.0107319571585643,0.282846789890928
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,39510,0.00382914383625488,0.00358921631576162,-0.00320572014263791,0.0108640078151477,0.286064641434094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00407860753305448,0.00383115199398452,-0.0115876654412641,0.00343045037515517,0.287084602056285
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.00340218168504907,0.00319789097886834,-0.00967004800363102,0.00286568463353288,0.287404796399794
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00488248962625681,0.00460518748160367,-0.00414367783768637,0.0139086570902,0.289069343730426
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00518196114730349,0.00490170832481637,-0.0147893094639436,0.0044253871693366,0.290454477765975
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,39560,0.00516637389843072,0.00488774681953113,-0.0044136098678503,0.0147463576647117,0.290532502498792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0108686748942552,0.0102871150891816,-0.0310314204690512,0.0092940706805408,0.290744119411474
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0140160884552181,0.0132745071768683,-0.0400341225218799,0.0120019456114437,0.291048640797398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.00787927380331656,0.00747272301615538,-0.0225258109149811,0.00676726330834799,0.291716457505231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,39742,-0.00240431065420131,0.00228093950605362,-0.0068749520860664,0.00206633077766379,0.291865548476831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,39560,-0.00804159690394315,0.00763809635026185,-0.0230122657504564,0.00692907194257008,0.292443328118549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00365736261094807,0.00347602134903307,-0.00315563923315674,0.0104703644550529,0.292745068421127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00527866268103598,0.00501991095995437,-0.0151176881625465,0.00456036280047459,0.293031089920478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.00526321710490318,0.00501104351171887,-0.0150848623878722,0.0045584281780658,0.293591766744619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.00728690327211297,0.00694277313726533,-0.020894738621153,0.00632093207692707,0.29393657469152
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00735511753654869,0.00701198737213782,-0.00638837771284143,0.0210986127859388,0.294231259160418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.00784570448185751,0.00749416566978544,-0.022534269194637,0.00684286023092195,0.295164213306331
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.00893932641941134,0.0085657980471091,-0.0078496377529225,0.0257282905917452,0.296689884850489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.00414599965072884,0.00397427263001779,-0.0119355740055637,0.00364357470410602,0.296873444469511
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00589037654224414,0.0056560778077332,-0.0169762890454012,0.00519553596091293,0.297701466639619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0118310389251341,0.0113873831177621,-0.0341503098359478,0.0104882319856796,0.29884575985089
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.0031978727152157,0.00308538907991479,-0.00924523531184869,0.00284948988141728,0.300007454603031
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.00386396851246331,0.00373864028464496,-0.0111917034703674,0.00346376644544081,0.301381933096526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,39979,0.00218239535063573,0.00211319350354039,-0.00195946391630344,0.0063242546175749,0.301744017454073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.00455014165374997,0.00442165060765194,-0.0132165768447478,0.00411629353724784,0.303470401786392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00335496909946985,0.003273606693604,-0.00306130001999399,0.00977123821893368,0.305450694871572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.00466294037304116,0.00456812921471005,-0.0136164736338729,0.00429059288779055,0.307392899866952
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00705758742988664,0.00691970175027152,-0.00650502800064555,0.0206202028604188,0.307785418849848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.00249092180212671,0.00244464643678941,-0.00230058521398054,0.00728242881823395,0.308254776373667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00406247800719904,0.00399252467308071,-0.0118878263664372,0.00376287035203916,0.30892804036187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00360261545108268,0.00354728483220926,-0.00335006282004748,0.0105552937222128,0.309843086400243
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.00775848579690053,0.00766016143010755,-0.0227724021999113,0.00725543060611026,0.311157103346733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00332661908591444,0.00329559255219349,-0.00313274231638481,0.00978598048821368,0.312798092712852
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.00817035009078626,0.00810314314804977,-0.0240525106609638,0.00771181047939129,0.313331419809273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00543670726902138,0.00539366180359524,-0.00513486986602528,0.0160082844040681,0.31348556344842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00239202005811063,0.00237570508417675,-0.00704840202309705,0.00226436190687579,0.314016258066159
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.00918285909939393,0.00912075583958578,-0.0270595405449821,0.0086938223461942,0.314048763602245
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.00455739426672592,0.00453396059514816,-0.0134439570332163,0.00432916849976447,0.314834018060849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.00404293152466324,0.00404252446112559,-0.00388041641914292,0.0119662794684694,0.317283702968274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.00802974056440523,0.0080505063154121,-0.023808732942613,0.00774925181380248,0.318582255644392
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.00730716559868653,0.00733096151617973,-0.0216758501703988,0.00706151897302573,0.318905734018013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0198539987208997,0.0199632977982877,-0.0589820624055437,0.0192740649637442,0.319985123896639
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0109511645002329,0.0110151979745299,-0.0325409525303115,0.0106386235298457,0.320153701560562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0042255044867065,0.00425191350771846,-0.0125592549618347,0.00410824598842168,0.320347393871149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.0068557567551288,0.00690225117834871,-0.00667265555443466,0.0203841690646923,0.320603112685565
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.00726654079401662,0.00732544005321493,-0.0216244032983179,0.00709132171028464,0.321238772343656
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00633613682713369,0.00639882131767092,-0.00620555295550131,0.0188778266097687,0.322096016669537
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,41913,0.00753091266379003,0.00761484288753643,-0.00739417939578137,0.0224560047233614,0.322691842459229
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00694283054201554,0.00702888302796594,-0.0068337801927977,0.0207194412768288,0.323293152559482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00592521669540691,0.00600119640033045,-0.00583712824924077,0.0176875616400546,0.323497964490878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.00520948550549139,0.00527655038093094,-0.00513255324113326,0.015551524252116,0.323518527170689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.00410739184598983,0.00416334056611853,-0.0122675393555821,0.00405275566360249,0.323875578638332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00322534190025295,0.00327244993751869,-0.00318865997728368,0.00963934377778958,0.324348878908171
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42070,0.0195138975784913,0.019868547081755,-0.0194284547017485,0.0584562498587312,0.326043495140304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00494625026644764,0.00503744089436927,-0.0148196344194114,0.00492713388651612,0.326172056104476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00707726783859058,0.00722479796505291,-0.00708333617291313,0.0212378718500943,0.327314896498581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.00372917402631949,0.0038248581759088,-0.00376754799846176,0.0112258960511007,0.329586105839226
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00278374088244416,0.00285740575933893,-0.00838425617074847,0.00281677440586016,0.329964670689863
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00272229517268582,0.00279594108884989,-0.00820233970683161,0.00275774936145997,0.33024683112454
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,39757,-0.00439843014151348,0.00452560785948134,-0.0132686215460969,0.00447176126306996,0.331122264004894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00489994819514229,0.00505375379637329,-0.00500540924574936,0.0148053056360339,0.332284199722101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,41825,0.00567565805484244,0.00585427551820474,-0.00579872196083886,0.0171500380705237,0.332318796566564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00571326398016898,0.00591628852493304,-0.0173091894890377,0.00588266152869978,0.334219969876853
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.0048780411149503,0.00505216742135779,-0.0147802892608116,0.00502420703091096,0.334298587488087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.00763775300151827,0.00791069327987806,-0.0231427118300793,0.00786720582704273,0.334313418255102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.00485133764433402,0.00503300632014974,-0.00501335474315947,0.0147160300318275,0.335115003475074
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00361663768788885,0.00375541077240989,-0.0109772428018122,0.00374396742603454,0.335541440115211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00575061143225934,0.00597376062936906,-0.00595795940130401,0.0174591822658227,0.335746841082561
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.00553677152041276,0.00575968769129724,-0.0168257593953553,0.00575221635452982,0.336419881069595
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.00754743207897528,0.00785818160744624,-0.0229494680295699,0.00785460387161935,0.336843704042888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.0083880866269972,0.00874270470685157,-0.00874761459843188,0.0255237878524263,0.337358767377894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.00258350672244249,0.00269598856886186,-0.00270063087252675,0.00786764431741173,0.337943511541261
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00523395440783889,0.00548320721292552,-0.00551313172949513,0.0159810405451729,0.339829413513636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.00339295822304499,0.00356304684748447,-0.0103765300441146,0.00359061359802458,0.340980626871762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00294545742223985,0.0030947228751321,-0.00901111425749877,0.00312019941301906,0.34123577027737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0043486620615491,0.00457579284234009,-0.0133172160325357,0.00461989190943746,0.341945119823848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00597214235595341,0.00628704208587334,-0.00635046013235833,0.0182947448442652,0.342173853460865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.00435576143098158,0.00458579944226633,-0.0133439283378236,0.00463240547586043,0.342215423178105
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.0047954084586858,0.00507736730417651,-0.00515623145750016,0.0147470483748718,0.344951448668526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.00331645366472302,0.00354276955550237,-0.00362737466406162,0.0102602819935077,0.349228951589139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,39979,0.00266202107265474,0.00284487029281552,-0.00291392470126369,0.00823796684657316,0.349433780588108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.00365066254328442,0.00390203547843553,-0.0112986520810181,0.00399732699444922,0.349509911696467
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00627397320133659,0.00670816140705783,-0.0194219695591699,0.00687402315649677,0.349667390465362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00402151415188946,0.00432299882561424,-0.00445156354631445,0.0124945918500934,0.352256771823969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00325694932783662,0.00350205283490116,-0.0101209728842429,0.00360707422856965,0.352381905763906
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,39979,0.00320966367745125,0.0034641190337771,-0.00358000962875187,0.00999933698365437,0.354182247083373
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00303138227945852,0.00327324439210721,-0.00338417672907162,0.00944694128798866,0.354405936084132
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42145,-0.003898158785477,0.00421464420265151,-0.0121588614226739,0.00436254385171996,0.355030162448807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,41843,0.00702958147517767,0.00762411040099194,-0.00791367491076653,0.0219728378611219,0.356534994788839
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.00751833847142326,0.00815968120719656,-0.0235113136375285,0.008474636694682,0.356860715532203
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.00473009483271741,0.00513689903570118,-0.0147984169426917,0.00533822727725692,0.35716737090438
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.0045466153500134,0.00495829019993397,-0.014264864141884,0.00517163344185719,0.359177108079868
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00350914831076285,0.00383049173440579,-0.0110169121101982,0.00399861548867249,0.359629672517018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00503543227256847,0.00551514538029025,-0.00577425267280042,0.0158451172179374,0.361252655537163
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00405512326547073,0.0044437112657989,-0.00465455081549511,0.0127647973464366,0.361497434574574
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0056789285597945,0.00622787009778089,-0.00652769683185604,0.0178855539514451,0.361863257175907
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.00829657991591735,0.00916796600135807,-0.0262657932785792,0.00967263344674447,0.365506244092274
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.00999039002674806,0.0110698713260913,-0.011706557772391,0.0316873378258871,0.36681922622053
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,41668,-0.00343584701547937,0.00381107209113267,-0.0109055483140994,0.00403385428314067,0.367316066923902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,39966,0.00407887722589103,0.00452869318406918,-0.00479736141488455,0.0129551158666666,0.36778063972978
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42145,-0.0027629791399485,0.00307736507254777,-0.00879461468214213,0.00326865640224513,0.369287216024741
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.00675349744290216,0.00753652324111455,-0.00801808810968236,0.0215250829954867,0.370214026716636
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00258165834136057,0.0028889285558295,-0.00824395831078639,0.00308064162806524,0.371531298727516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,39560,0.0057148248435659,0.0063995857776712,-0.00682836328066966,0.0182580129678015,0.371877219166769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.00437583267583059,0.00490360822031521,-0.0139869047876484,0.00523523943598722,0.372213611669383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00408290840251772,0.00457819205431163,-0.0130561648289685,0.00489034802393308,0.372510563707777
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00717315140260143,0.00806275929908099,-0.0229761596288002,0.00862985682359731,0.373665542685135
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0118950066698027,0.0133703949037024,-0.0381009806810595,0.014310967341454,0.373671331978927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,41839,-0.00611446045709137,0.00687406286688798,-0.0195876236761918,0.00735870276200907,0.373752028214719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.00239058679091615,0.00269025092420935,-0.00288230502053417,0.00766347860236647,0.374227911747815
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.00436789993755179,0.00491849230785074,-0.0140081448609392,0.00527234498583566,0.374525913559771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.00327493641972688,0.00369650137396294,-0.0105200791126943,0.00397020627324048,0.375660500251497
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00535718559435459,0.00605077691597109,-0.00650233716094874,0.0172167083496579,0.375975365017469
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,39657,-0.00367885384427628,0.00415546986583693,-0.0118235747813167,0.00446586709276411,0.376011977413984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00698394516832767,0.00789944622237519,-0.00849896942752771,0.022466859764183,0.37665515591539
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00280408726890217,0.00317225698687912,-0.00902171096318525,0.0034135364253809,0.376744236604389
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00491375772653233,0.00557088944104459,-0.00600518557791505,0.0158327010309797,0.377772897042581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.0031677533632761,0.00359592531298503,-0.0102157669767268,0.00388026025017456,0.3783723982432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.00919709382785187,0.0104718883073009,-0.0297219949101616,0.0113278072544579,0.379818498748811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.0028248765921011,0.00321665447771787,-0.00347976618422592,0.00912951936842812,0.379852481423073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.00974251896362052,0.0111791024800539,-0.0121685218972852,0.0316535598245262,0.383500297914201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00396103504812375,0.00455937311932499,-0.0128974063620007,0.00497533626575323,0.384993352781122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00364606299764218,0.00421834621100166,-0.00462189557592107,0.0119140215712054,0.387422944658068
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.00262512879454559,0.00304573733862012,-0.00859477397824103,0.00334451638914985,0.388759377547022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00217428303446554,0.00252622129918575,-0.00712567678086961,0.00277711071193853,0.389429271012385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00561515008212154,0.00654082044576287,-0.0184351581558168,0.00720485799157369,0.390647213960478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42145,-0.0031282291886684,0.00364416417604853,-0.0102707909737235,0.00401433259638671,0.390674902637496
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,39575,-0.00524440794860706,0.00611575016112579,-0.0172312782644136,0.00674246236719948,0.39117359338544
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42262,0.00555656266593255,0.00651320971587412,-0.00720932837718072,0.0183224537090458,0.393606594566606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.010754171810761,0.0126347518857987,-0.0355182855069263,0.0140099418854044,0.394696592646939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.00329920579810483,0.00388446324708415,-0.0109127537623898,0.0043143421661801,0.395713559884482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,39560,-0.00630818879099715,0.00743890046227317,-0.0208884336970526,0.00827205611505827,0.396456399538446
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00494145194577617,0.00586338336151682,-0.0164336833343491,0.00655077944279681,0.399378351308513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00416957937133413,0.00497164209278769,-0.00557483913052975,0.013913997873198,0.401671394718818
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00563549003296262,0.00672377335250125,-0.0188140858038651,0.00754310573793984,0.40196798588035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00319629834761824,0.00381983013303988,-0.00429056871313993,0.0106831654083764,0.402743185279388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.0037083413775004,0.00443374939694282,-0.00498180744050754,0.0123984901955083,0.40295403547376
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00248111638108774,0.00296709221834725,-0.00829661712904836,0.00333438436687287,0.403053557149477
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00432115949815811,0.00517049329942735,-0.0058130073687195,0.0144553263650357,0.403322490347242
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,39657,-0.00409473735958344,0.00490041431204202,-0.0136995494111858,0.00551007469201893,0.403403632756081
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.00836829625851516,0.0100201594308243,-0.0280078087429308,0.0112712162259004,0.403653415287007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00408183267575865,0.00489272944027848,-0.00550791702718718,0.0136715823787045,0.404149881552551
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.00284349985305074,0.00341000491649054,-0.00384010978327071,0.00952710948937219,0.40437254871729
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.00413479580825962,0.00496240997753534,-0.00559152774770964,0.0138611193642289,0.404736914750141
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0104403992190897,0.0126027831549275,-0.0351418542027476,0.0142610557645683,0.407450062189831
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00221383550398993,0.00267494554205702,-0.00745672876642169,0.00302905775844184,0.407904249841686
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.0029679157346761,0.00359345415818794,-0.00407525441537227,0.0100110858847245,0.408865837010332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.00338267429097047,0.00410017397291738,-0.0114190152778885,0.0046536666959476,0.409385141788296
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00665064157737677,0.00806937141535883,-0.00916532639672654,0.0224666095514801,0.409853354810652
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00514217287566333,0.00626056877809245,-0.0174128876807245,0.00712854192939787,0.41145668126014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00223528987180206,0.00272507332442433,-0.00310585384406962,0.00757643358767374,0.412081303299657
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,39586,-0.00334726180211745,0.00408163676216479,-0.0113472698559604,0.00465274625172554,0.412189254768322
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.00486820926179052,0.00594539520801361,-0.0165211838694972,0.00678476534591615,0.412906740663062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00294323480859757,0.00361216780479794,-0.00413661408880639,0.0100230837060015,0.415198047537305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00363239164262437,0.00445994529042367,-0.00510910112660603,0.0123738844118548,0.415406131716318
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,41900,-0.00411741311169388,0.00506170982841036,-0.0140383643753782,0.00580353815199043,0.415978598517554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,39736,-0.00333874523302271,0.00411515432048534,-0.011404447701174,0.00472695723512856,0.417193934078361
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00259689189994809,0.00320690795637748,-0.00368864769455177,0.00888243149444795,0.418080748505765
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00397285936153748,0.00492939995809364,-0.00568876455632606,0.013634483279401,0.420287904895275
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00501208916823128,0.00622097256796647,-0.0172051954014456,0.00718101706498299,0.420447048100988
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00371234472857533,0.00463149793573406,-0.00536539122546343,0.0127900806826141,0.422831266267985
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42016,-0.00353518136401313,0.00441578322645486,-0.0121901164878646,0.00511975375983839,0.423389844985507
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00471416678496,0.00589024504353122,-0.0068307135003612,0.0162590470702812,0.423533754554058
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00696648415259345,0.00871708617535103,-0.0240519730562815,0.0101190047510946,0.424202584542222
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,41900,0.00226771533030974,0.0028376621513782,-0.00329410248639153,0.007829533147011,0.42421819706817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.00904782295671568,0.0113486508188512,-0.0312911785616641,0.0131955326482327,0.425314210017849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,39475,0.00329252480880836,0.00414950277763771,-0.00484050063536156,0.0114255502529783,0.4275187087189
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00798400946034477,0.0100738253130679,-0.0117606881532684,0.0277287070739579,0.428057209465865
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.00935561692619153,0.0118172394657131,-0.0325174062789892,0.0138061724266061,0.428553946598025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.00535865041507985,0.00678086385675214,-0.018649143574314,0.00793184274415435,0.429391968722386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.003835346648189,0.00485399795516811,-0.0133491826403185,0.0056784893439405,0.429462036321451
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00430852625428394,0.0054565795865234,-0.0150034222438698,0.00638636973530192,0.429777310830801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.009822598281634,0.0124754946092574,-0.0342745677157786,0.0146293711525106,0.431089985095321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0032847927152922,0.00417318231346191,-0.0114642300496775,0.00489464461909315,0.431228460207532
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00505834574418488,0.00643051805009861,-0.0075454696340084,0.0176621611223782,0.43152391516244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.00617012147609462,0.00785195960401471,-0.0215599622999635,0.00921971934777422,0.431997802196088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,39657,0.00213990570656487,0.00273726605337277,-0.00322513575804575,0.00750494717117549,0.434367949203397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00449882967667482,0.005788271792743,-0.00684618303710146,0.0158438423904511,0.437038697240466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00232317311850434,0.00299223772315855,-0.00354161281888641,0.00818795905589509,0.437529608703626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00696429542898587,0.0089835569884774,-0.0245720671264016,0.0106434762684298,0.438222148256018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.00581419978095826,0.00750159456648061,-0.0205173251312603,0.00888892556934374,0.438316954527797
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,41839,0.00260298988986175,0.00335977432375427,-0.00398216778469662,0.00918814756442013,0.438500403548391
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.00370748112550723,0.00479308001263873,-0.00568695569926468,0.0131019179502791,0.439235863809691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.00184847314004914,0.00239801634318234,-0.00285163889258823,0.00654858517268652,0.440821227480896
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42048,0.00464096286636199,0.00605157339955706,-0.00722012099676984,0.0165020467294938,0.443153333302106
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00340930325369328,0.00445676549181083,-0.0121445636176425,0.00532595711025594,0.444304218053644
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.00460531235933846,0.00602880616203326,-0.0164217724369236,0.00721114771824673,0.444949607149645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00402102684731469,0.0053025900366953,-0.0144141033192375,0.00637204962460809,0.448279361820025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.00441467023829914,0.00583621073268618,-0.015853643274364,0.00702430279776577,0.44940598653195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,39657,-0.00504684585659547,0.00667221144203107,-0.0181243802829764,0.00803068856978543,0.449426859804917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.00319878494239344,0.00423423882514501,-0.0114978930396777,0.00510032315489078,0.449990974835977
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.00143874079322024,0.00190516206009787,-0.00517285843101207,0.00229537684457159,0.450156940004321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.00417809440190512,0.00553588071138468,-0.0150284205962191,0.00667223179240885,0.450426781016018
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.00445651944363212,0.0059102320193268,-0.0160405742015126,0.00712753531424841,0.450841625855035
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42124,0.00451750038706856,0.00599117021867851,-0.00722519324154132,0.0162601940156785,0.450846509981758
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.00597604111433492,0.00793546988725693,-0.00957747986468866,0.0215295620933585,0.451418172131095
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.00855103011199211,0.0113580823442263,-0.0308128715066756,0.0137108112826914,0.451551012744787
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00508262715498817,0.00676840371574093,-0.00818344412786405,0.0183486984378404,0.452708131165166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00173513309224682,0.0023117643760308,-0.00279592508477356,0.00626619126926719,0.452926593858957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.00334320930952905,0.00446522944509833,-0.00540864040286367,0.0120950590219218,0.454038792379878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.00821749327951926,0.0109761104000278,-0.0132956831045353,0.0297306696635738,0.454068824498062
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00408545915614154,0.00546213625880446,-0.0147912462233983,0.0066203279111152,0.454500326216613
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.00337471107952939,0.00451330939419174,-0.00547137533308642,0.0122207974921452,0.454642008132898
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,39919,0.002687864740276,0.00359535827669678,-0.00435903748204968,0.00973476696260169,0.454721208609223
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,39757,-0.0054890396266695,0.00735105028938712,-0.0198970981938683,0.00891901894052926,0.455259551768097
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00457583414374214,0.0061427411305586,-0.00746393847215273,0.016615606759637,0.456337688115442
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.00664600284410965,0.00894200228570571,-0.0108803216358735,0.0241723273240928,0.457353026615093
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00311037433214663,0.00418572826362663,-0.00509365306456155,0.0113144017288548,0.457442901424962
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,41814,-0.00470929921925969,0.00633897553244783,-0.0171336912628574,0.00771509282433805,0.4575483360486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.00268103065683536,0.00361916239635029,-0.0044125276400112,0.00977458895368193,0.458837596295352
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.00514245222218011,0.00696021534018093,-0.0187844742889347,0.00849956984457451,0.460020161265233
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.00410915512958108,0.00557104049494466,-0.0150283944996726,0.00681008424051046,0.460778072373983
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00504700014700177,0.00684626500129441,-0.00837167925553528,0.0184656795495388,0.461019695867626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00213172804651706,0.00289229502714329,-0.00780062629971791,0.00353717020668379,0.461112994902661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00303055643094234,0.0041224803242285,-0.0111106178664302,0.00504950500454551,0.462276150697479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.00629496566856273,0.00857105918867342,-0.0230942416783626,0.0105043103412372,0.462693574335063
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00585203362425974,0.00797801126249588,-0.00978486845023218,0.0214889356987517,0.463256532345236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42249,-0.00212122032922511,0.00291610389652365,-0.00783678396641147,0.00359434330796125,0.466983696269289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00541292022913133,0.00746770160357109,-0.00922377491386801,0.0200496153721307,0.468562951733319
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.00433693089497752,0.00599401010136897,-0.0160851906936607,0.00741132890370567,0.469360813859234
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0036174957453885,0.00501489527676082,-0.0134466904878397,0.00621169899706272,0.470706808553187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00414728017805282,0.00575359945078049,-0.00712977474547694,0.0154243351015826,0.471038747996145
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,41913,0.00363126972177033,0.00504244609932294,-0.00625192463290263,0.0135144640764433,0.471451128482366
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,39649,-0.00270126235632625,0.00375344878092842,-0.010058021966946,0.00465549725429345,0.471740491109034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0034704739995708,0.00482261047645414,-0.0129227905334209,0.00598184253427931,0.471770397984735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.00147824177521479,0.00205805107918462,-0.00255553833998707,0.00551202189041665,0.47260397282679
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00348357148165978,0.00487058025556558,-0.0130299087825683,0.00606276581924874,0.474483878258079
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42116,-0.00301513896889085,0.00421602838538168,-0.0112785546042389,0.00524827666645724,0.474521933104489
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00275718958089279,0.00385702724244182,-0.00480258381429317,0.0103169629760787,0.47471740284499
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.0048559894371735,0.00679505075408734,-0.00846231004083769,0.0181742889151847,0.474849037516703
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00306678882310557,0.00434003505137118,-0.00543967987758194,0.0115732575237931,0.47981032964577
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00381766611358304,0.00541555582864046,-0.0144321555377183,0.00679682331055225,0.480860089010683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.00554357908313401,0.00787784795366638,-0.0209841610723201,0.0098970029060521,0.481636939510628
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,39649,-0.00541423601985863,0.00769510009778791,-0.0204966322115229,0.00966816017180566,0.481699684915144
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.00747163714933665,0.0106454914731999,-0.0283368004368084,0.0133935261381351,0.482781713741183
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,41843,0.0117580785740627,0.0168493473687991,-0.0212666422687836,0.0447827994169089,0.485292110665239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,39757,0.00409254045108614,0.00587439910141531,-0.00742128178768786,0.0156063626898601,0.486021419000339
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.00474030716205883,0.00681550948802488,-0.0180987057585876,0.00861809143446993,0.486745230934991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,39575,0.00420863592317513,0.00609066180462007,-0.00772906121388021,0.0161463330602305,0.489581330088447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.00667307446998115,0.00967167837022894,-0.0256295640756299,0.0122834151356676,0.490230975433645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,41883,0.00635512691134407,0.00922389501561766,-0.0117237073192665,0.0244339611419547,0.490844631679773
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.00532039003849372,0.00774636539444521,-0.0205032662116063,0.0098624861346189,0.492205501482826
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42070,-0.00588179548395324,0.00859039862031129,-0.0227189767797634,0.0109553858118569,0.493548736450663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00281158968761437,0.00412593705758252,-0.00527524694524736,0.0108984263204761,0.495605790553484
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,39657,-0.00363277930053756,0.00533301631974913,-0.0140854912872459,0.00681993268617073,0.495767685903252
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42262,-0.00223606218593262,0.00330222343835653,-0.00870842012511141,0.00423629575324617,0.498329633291324
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00398833768957221,0.00590066862952432,-0.00757697282429546,0.0155536482034399,0.49911088567205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00208684111337016,0.00308774667070182,-0.0039651423612054,0.00813882458794572,0.499150059594205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.00394956144097376,0.00585465990056659,-0.0154246948460843,0.00752557196413675,0.499942998977006
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00393426857038554,0.0058349213495242,-0.00750217727468189,0.015370714415453,0.500158637100648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00349231972061239,0.00518893439879257,-0.0136626311422458,0.00667799170102105,0.500940897835343
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00197780574663333,0.00294230346822335,-0.00774472054435109,0.00378910905108443,0.501470349221734
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42261,-0.00241878189216526,0.00359961847126562,-0.00947403409584587,0.00463647031151534,0.501623661649709
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00302328119891868,0.0045088529955888,-0.00581407067243537,0.0118606330702727,0.502539646640299
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00331507250745573,0.004950158209125,-0.0130173825973407,0.00638723758242927,0.503069380305128
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.0047393031250236,0.00712911210146183,-0.00923375659384159,0.0187123628438888,0.506204109187633
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.00467353454428735,0.00704811859554798,-0.0184878469915614,0.00914077790298668,0.50728661934955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,39586,-0.00339218476774654,0.00511929431216545,-0.0134260016195908,0.00664163208409775,0.507583107101627
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00351113314909639,0.00530268400054491,-0.00688212749197164,0.0139043937901644,0.507891340421955
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00858648516727441,0.0131261172878572,-0.0343136750514746,0.0171407047169258,0.513024785851763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,39657,0.0019380312732236,0.00296572888846559,-0.00387479734816895,0.00775085989461615,0.513463344766995
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.00222128442411359,0.00340056741744184,-0.00888639656229959,0.00444382771407241,0.513632015771976
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0017440801645185,0.00267274744859986,-0.00349450483473723,0.00698266516377423,0.51406512875156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.00343759855897295,0.0052712482355854,-0.0137692451007203,0.00689404798277444,0.514323603570556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0037677991916318,0.00577805959772601,-0.0150927960031748,0.00755719761991118,0.514355993029457
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.00366949189934767,0.0056329887068977,-0.0147101497648672,0.00737116596617183,0.514783178369007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00474524531668279,0.00730661325918447,-0.00957571667131876,0.0190662073046843,0.516061835586047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,39560,-0.0029040611815996,0.00448188898318958,-0.0116885635886512,0.00588044122545199,0.517027801480993
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.00193609284420484,0.00299691798832424,-0.00393786641291067,0.00781005210132035,0.518272291396122
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00458700366317281,0.00713996133714119,-0.00940732055762392,0.0185813278839695,0.520600108238732
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.00585999786358515,0.00915754453121503,-0.0238087851447666,0.0120887894175963,0.522242417958459
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00223744444844954,0.00350609878854928,-0.00910939807400612,0.00463450917710705,0.523384267915239
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,39934,0.00150603016748799,0.00236289600053598,-0.00312524599356253,0.0061373063285385,0.523899179871542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.00266517840091057,0.00419820708657537,-0.00556330748877716,0.0108936642905983,0.525547774985902
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.00732691845477036,0.0115486945087364,-0.0299623596918937,0.015308522782353,0.525809293496385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.0015288438362517,0.00243731865392076,-0.00324830072543299,0.00630598839793638,0.53049640220769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.00608609132057757,0.00975881527338978,-0.0252133692564215,0.0130411866152664,0.53286761093311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.00238751958538197,0.00383074111298208,-0.00989577216682684,0.0051207329960629,0.53313104750654
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42158,0.00200064407377211,0.00321215550282196,-0.00429518071175892,0.00829646885930315,0.533403185660452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.00642250336188335,0.0103208224712575,-0.026651315405548,0.0138063086817813,0.533764318371215
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00248934322099812,0.00405060023823175,-0.0104285196879323,0.00544983324593611,0.538857043723807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.00445231728666262,0.0072624054546827,-0.0186866319778407,0.00978199740451548,0.539844534881061
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00142345884242276,0.00233333266083887,-0.00599679085766694,0.00314987317282142,0.541838606013766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.00366007112156784,0.00601000407779402,-0.0154396791140441,0.00811953687090844,0.542537020419476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00213187555930005,0.00350086542821338,-0.00899357179859828,0.00472982067999819,0.542565299978147
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.00560718327267351,0.00923601563350779,-0.0237097739143488,0.0124954073690017,0.543796846524044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.00465382899331803,0.00767065579786515,-0.0196883143571337,0.0103806563704977,0.544058855406964
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42145,0.00480851180010494,0.00794356097181937,-0.010760867704661,0.0203778913048709,0.544966879814399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42119,0.00320121566380343,0.00529167976933345,-0.00717047668409013,0.013572908011697,0.545220616736994
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00246579298307525,0.00408147063584363,-0.00553388946317827,0.0104654754293288,0.545760903942386
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00306296879873954,0.00507039497370491,-0.0130009429472012,0.00687500534972208,0.545797081411766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00210916861258985,0.00349280818452837,-0.00473673542908575,0.00895507265426546,0.545948944143013
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,39649,0.0037071856770379,0.00614768234462947,-0.00834227171843587,0.0157566430725117,0.546506650175053
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.00335384706005168,0.00556918520764387,-0.0142694500670337,0.0075617559469303,0.547043031021213
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0151583562389651,0.0251816242926957,-0.0645143398526486,0.0341976273747184,0.547212131205277
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.00530775888866408,0.00885516439715073,-0.0226638811070795,0.0120483633297514,0.54891843752069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.00514169119384733,0.00859953499224579,-0.0219967797786491,0.0117133973909544,0.549914407813179
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00137052274699828,0.00229664719777884,-0.00587195125464481,0.00313090576064824,0.5506869495295
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.0064680427172087,0.010867750234863,-0.0148327477431227,0.0277688331775401,0.55174887352251
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.00490350675252524,0.00826402979734357,-0.0112939916502682,0.0211010051553186,0.552953207564919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00283867435513645,0.004792514636849,-0.00655465433308759,0.0122320030433605,0.553652337085049
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,39929,-0.00164619917502213,0.00279286137145819,-0.00712020746308019,0.00382780911303593,0.555583914960121
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,39930,0.00710557361000968,0.0120906740503574,-0.0165921475286909,0.0308032947487102,0.556751802575149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.00635885014256592,0.0108268156769299,-0.0148617085842167,0.0275794088693486,0.556998036703967
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.00139775175356892,0.00238012433541146,-0.00606279545097538,0.00326729194383754,0.557040822343981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.00269943288981719,0.00462996793935429,-0.0117741700509516,0.00637530427131722,0.559881697448916
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,39560,0.00398158210551099,0.00682963148450124,-0.00940449560411145,0.0173676598151334,0.559914466534836
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.00261628070996621,0.00449608921413514,-0.0114286155696711,0.00619605414973868,0.560645034301256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.00454452904573044,0.00781204932190616,-0.0107670876252056,0.0198561457166665,0.560758289879193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,39586,0.00291593598024372,0.00501251767173134,-0.00690859865634972,0.0127404706168372,0.560759949235925
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00166026814095423,0.00286108340283833,-0.0039474553286089,0.00726799161051736,0.561728419969476
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,41881,-0.00342063824731709,0.00590701170859631,-0.0149983811961659,0.00815710470153169,0.56254434064465
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00556167623294486,0.00960944817865937,-0.0132728421972275,0.0243961946631172,0.562755124054012
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00187297095165364,0.0032531150879677,-0.00824907652407034,0.00450313462076305,0.564798001892516
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,39919,-0.00255994881483981,0.00446079902933325,-0.011303114912333,0.00618321728265336,0.566062615173917
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BSND,Barttin,39560,-0.00201146306345435,0.00350638538922047,-0.00888397842632647,0.00486105229941777,0.566211598301572
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00350281925251406,0.00612682335229246,-0.00850575451797917,0.0155113930230073,0.567522092042236
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42087,-0.00392884699697405,0.0068798780386795,-0.0174134079527859,0.00955571395883777,0.567966137611337
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,39649,0.00285839044419025,0.00500717960815597,-0.00695568158779545,0.012672462476176,0.568107254525661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.00430943239960864,0.00756207316551179,-0.0105122310047945,0.0191310958040117,0.568772215420016
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.00313377332167255,0.00555633611983048,-0.0140241921165403,0.00775664547319519,0.572763663356289
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,39757,0.0031264796161853,0.00556645129454431,-0.00778376492112155,0.0140367241534921,0.574355719942747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00249638694499586,0.00445300665985105,-0.00623150610831219,0.0112242799983039,0.575076901148541
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,39657,0.00586108184852285,0.0104698285284266,-0.0146597820671933,0.026381945764239,0.575622523063856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.00472201852916478,0.00844974742824923,-0.0212835234885333,0.0118394864302037,0.576285341787463
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00292073356431113,0.00523404496560923,-0.0131794616969052,0.00733799456828296,0.576837950537332
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,41839,-0.00223148306844792,0.00400513268162906,-0.0100815431244409,0.00561857698754503,0.577430376473788
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.00106713226790461,0.00191613903094648,-0.0048227647685597,0.00268850023275048,0.577594426258721
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.00461288333026317,0.0083004816179959,-0.0208818273015351,0.0116560606410088,0.578400164198745
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.00402325844449393,0.00724439334931358,-0.0182222694091486,0.0101757525201607,0.57865826011823
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00407824173679132,0.00736371610802505,-0.0103546418349378,0.0185111253085204,0.579707142083915
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42246,0.00251950159622294,0.00455225036831843,-0.00640290912568119,0.0114419123181271,0.579955559924579
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.0033384194846415,0.00606367975578254,-0.00854639283669228,0.0152232318059753,0.581944587110398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,0.00348114871792402,0.0063593828425377,-0.00898324165344986,0.0159455390892979,0.584110695946282
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00154452456061277,0.00283787004395059,-0.00401770072553038,0.00710674984675592,0.586276812205039
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.00228925833605608,0.00421097672985673,-0.00596425605446311,0.0105427727265753,0.58669977795188
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00184399359718401,0.00339409051334778,-0.00480842380897763,0.00849641100334566,0.586935611768169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0052134543435356,0.00964686745314496,-0.0241213145516997,0.0136944058646285,0.588911649654901
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00440376916955884,0.00817881135086036,-0.0204342394172451,0.0116267010781275,0.590286784984421
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42224,-0.0038651872075638,0.00722849921670619,-0.0180330456723079,0.0103026712571803,0.592855649778126
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,39736,0.00327576518651998,0.00612715119991809,-0.00873345116531947,0.0152849815383594,0.592915692596205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.00201385582019894,0.00378426525485727,-0.00943101571971918,0.0054033040793213,0.594622008586737
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0038571588860584,0.00725258507215657,-0.0180722256274853,0.0103579078553685,0.59485292512435
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.00166221688649194,0.00314442016292511,-0.00450084663284127,0.00782528040582514,0.597074966016148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00153245960855587,0.00292392681225879,-0.0072633561605831,0.00419843694347135,0.600212461329447
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.00271648464605834,0.00519093366520188,-0.00745774533773733,0.012890714629854,0.600766809799743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.00462884795375251,0.008858898927641,-0.0127345939444239,0.0219922898519289,0.601325082925066
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00119499053774662,0.00229209775205207,-0.00329752105627545,0.00568750213176868,0.602131784182963
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42137,-0.00659739151481206,0.012667870438807,-0.0314264175748738,0.0182316345452496,0.602516568737735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.00159074261634783,0.00306012125551696,-0.00440709504446541,0.00758858027716107,0.603190625701407
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.00249763995433473,0.00480711995583377,-0.00692431515909945,0.0119195950677689,0.603371323048856
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.00354619012257623,0.00683580747601153,-0.00985199253040636,0.0169443727755588,0.60393381623304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00320971144740818,0.00619677571400098,-0.00893596895203375,0.0153553918468501,0.604492979989204
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42239,0.00326163881677934,0.00630544145632796,-0.00909702643762346,0.0156203040711821,0.604973522902594
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00107936137864126,0.00209554754428762,-0.005186634565445,0.00302791180816248,0.606511591802606
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00353080536687867,0.00687400984886462,-0.0170038646706533,0.00994225393689599,0.607509917590259
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00136308087615009,0.00265535103391281,-0.00384140715031901,0.00656756890261919,0.607728339178675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00222747170425613,0.00435604294100293,-0.0107653158686219,0.00631037246010961,0.609114490725148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00133483709666681,0.00262306685876555,-0.00380637394651366,0.00647604813984727,0.61084167798164
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42181,-0.00284454223472457,0.00559288442030749,-0.0138065956985273,0.00811751122907811,0.611040737794619
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.0101657355757483,0.0199907201865413,-0.0290160759898727,0.0493475471413693,0.611095122668923
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00310362357821591,0.00611922461134426,-0.0150973038164507,0.00889005666001884,0.612030080713283
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.00152266854493092,0.00301017228465878,-0.00437726913300029,0.00742260622286213,0.612976484298303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,41538,-0.00148511166100534,0.00295122897436201,-0.00726952045075489,0.0042992971287442,0.614819549062198
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.00465251295786412,0.00924616365199326,-0.0227749937157709,0.0134699678000427,0.614843903532611
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,39657,0.00173459800915424,0.00344785601065559,-0.00502319977173071,0.00849239579003919,0.614907729387227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.00237897270274211,0.00475893166953862,-0.0117064787750378,0.00694853336955358,0.617156163622493
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.00221357253982575,0.00446599602012032,-0.0109669247392616,0.00653977965961008,0.620149296196687
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0036335113229656,0.00733458960666813,-0.0107422843061039,0.0180093069520351,0.620331687703308
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00318557146784957,0.00644470444950432,-0.00944604925317889,0.015817192188878,0.621109178585231
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.00389746658747731,0.00791690454821283,-0.0116196663270198,0.0194145995019745,0.622519396127211
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00416916674498979,0.0085277894400783,-0.0125453005575637,0.0208836340475433,0.624928049394478
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.0136080170300231,0.0278390081226718,-0.0409564388904136,0.0681724729504599,0.624985128826087
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00198835067381164,0.00408199830623708,-0.00601236600641303,0.00998906735403632,0.626195508189674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.0057487495445589,0.0118125043703364,-0.0174037590213004,0.0289012581104182,0.626504303605273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00443068586914154,0.00918877619384666,-0.022440687209081,0.0135793154707979,0.629684415569182
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.00308383943465746,0.00639579012811953,-0.0156195880857717,0.00945190921645682,0.629696546861385
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00415137235126212,0.0086132148331805,-0.0210332734242959,0.0127305287217717,0.629831839881398
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00233320277995423,0.00484321511171185,-0.007159498839001,0.0118259043989095,0.629995519840726
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00221665700480104,0.00463536550243263,-0.011301973389569,0.00686865937996692,0.632513213528112
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.0129383929491171,0.0271464027897231,-0.0402685565187401,0.0661453424169743,0.633645224449578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00247611220987578,0.00520124735905467,-0.0126705570336229,0.00771833261387136,0.634040233646181
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42137,-0.00168830255859613,0.00354786428590313,-0.00864211655896626,0.005265511441774,0.634178615129022
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.00479549444999184,0.0100793566258677,-0.0149600445367089,0.0245510334366926,0.634244664576894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,41913,-0.00194230873498388,0.00409299433106269,-0.00996457762386676,0.00607996015389899,0.63511931932731
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00230450463461759,0.00485833914048941,-0.0118268493499768,0.00721784008074167,0.635266831958116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00259950059950128,0.00549353726709163,-0.0133668336430009,0.00816783244399832,0.636085109946664
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00406655242077348,0.00860252078760326,-0.0209274931644759,0.0127943883229289,0.636424934970014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00143585639324185,0.00303779004599672,-0.00451821209691173,0.00738992488339543,0.636461680140803
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.00153349927238546,0.00325152896104154,-0.00790649603602688,0.00483949749125595,0.637204459765023
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00266578259916477,0.00565998738325622,-0.00842779267201742,0.013759357870347,0.63765904227873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.00621298905436722,0.0132104145011998,-0.0321054014767187,0.0196794233679843,0.638142817987313
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00137450140116139,0.00295841566227627,-0.00442399329690011,0.00717299609922289,0.642220141624624
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00300931829059789,0.00648496542768757,-0.00970121394766975,0.0157198505288655,0.64262430394795
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.0016401025145096,0.00353749126059087,-0.00857358538526772,0.00529338035624851,0.642917308768529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,39757,-0.00162754116899873,0.003510502905942,-0.00850812686464506,0.00525304452664759,0.642928697059747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.00282659630914076,0.00609812089725937,-0.0091257206494876,0.0147789132677691,0.642999642025195
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00128678824778063,0.00277633770323666,-0.00415483365056323,0.00672841014612449,0.64302492632409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00233640240859101,0.00505404341395465,-0.0122423274999421,0.0075695226827601,0.643886977456194
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00255072453069442,0.00553946127858714,-0.0134080686367252,0.00830661957533636,0.645191788283026
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00249519481712799,0.00546316920204232,-0.0132030064531309,0.00821261681887497,0.647872414541127
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00745484384544049,0.0163361194342529,-0.0245639502456953,0.0394736379365763,0.648153407644677
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.00225397523479714,0.00494341530570194,-0.011943069233973,0.00743511876437866,0.648431032511939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42145,0.00318601419028099,0.00700222026879283,-0.010538337536553,0.0169103659171149,0.649116123542629
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.00166845075545062,0.00368057448456703,-0.00554547523430077,0.008882376745202,0.65033235741739
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,41843,-0.00367416311340152,0.00814006514737174,-0.0196286908022501,0.0122803645754471,0.651731894185789
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.00337226490620986,0.00748605527453247,-0.0180449332442935,0.0113004034318738,0.652376792011817
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00198178470549025,0.00440679602195475,-0.00665553549754107,0.0106191049085216,0.652927440372689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.00255686976705933,0.00568914869982925,-0.008593861684606,0.0137076012187247,0.653130640287365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,39649,-0.00277549411285913,0.00622587962827639,-0.0149782181842809,0.0094272299585626,0.65575080779668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00242752709749341,0.00544645640269096,-0.0131025816467677,0.00824752745178087,0.65581726645556
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.00067142589684182,0.00151003252043763,-0.00363108963689958,0.00228823784321594,0.656585996466218
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42264,-0.000950105792085836,0.0021415362435321,-0.00514751682940876,0.00324730524523708,0.657298205266458
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00249535996140381,0.00563493572575647,-0.0135398339838865,0.00854911406107887,0.657892130630991
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00173224016110116,0.00392060481298797,-0.00941662559455758,0.00595214527235526,0.658621023146482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.00310532913116916,0.00708921532298223,-0.0170001911642143,0.010789532901876,0.661367416695848
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00142128610198127,0.00325902604424676,-0.00780897714870491,0.00496640494474237,0.66276575536944
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,39586,-0.00237957089605177,0.00546600124580933,-0.0130929333378381,0.00833379154573451,0.663323952892814
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.00319858593679376,0.00743476815412519,-0.0177707315188791,0.0113735596452916,0.667042617244044
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,39586,0.0040592004280302,0.00953339751361862,-0.0146262586986623,0.0227446595547227,0.670271118633379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.0029093644505906,0.00683340411203592,-0.016302836510181,0.0104841076089998,0.670293688191139
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.0016177423813468,0.00381631544651968,-0.00586223589383177,0.00909772065652537,0.671645799271744
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.00297861210017908,0.00703654248014738,-0.0108130111609098,0.0167702353612679,0.672078537624912
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,41913,-0.00214147508972354,0.00514174420909147,-0.0122192937395428,0.00793634356009574,0.67705961429107
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.00174512083517238,0.0042004255415441,-0.00648771322625405,0.00997795489659881,0.677811169362663
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.00258892027239783,0.00625695221210244,-0.0148525466081186,0.00967470606332296,0.679051242685156
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,39586,0.0019972637297929,0.00486324881498812,-0.00753470394758381,0.0115292314071696,0.681311477971578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.00165529018524569,0.00404203981052598,-0.00957768821387661,0.00626710784338522,0.682165799433205
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.00206725197697713,0.00505773669291615,-0.0119804158950928,0.00784591194113853,0.682745074966763
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00250703874784342,0.00614632730455543,-0.0145538402647721,0.00953976276908523,0.683360743122402
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.00127188558012419,0.0031284874930493,-0.00485994990625243,0.00740372106650081,0.684345138183187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.00242614878793598,0.00603501214282489,-0.0142547725878728,0.0094024750120008,0.687681526995149
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.00287330813144897,0.0071596298947998,-0.0111595664623586,0.0169061827252566,0.688191664889959
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00374344271256927,0.00934080559821898,-0.0145645362599399,0.0220514216850785,0.688601450899581
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00302220617476664,0.00756451008318022,-0.0118042335882666,0.0178486459377999,0.689514632565342
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.00223293567691696,0.0056086374329373,-0.0132258650454741,0.00875999369164015,0.690546190834116
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.00102117539680943,0.00256524757766296,-0.00400670985540996,0.00604906064902882,0.690578430532623
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42296,-0.00327367145616378,0.00823933925452247,-0.0194227763950278,0.0128754334827002,0.691136154630854
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.00224687810408388,0.00566090359165633,-0.00884849293556252,0.0133422491437303,0.691440403882811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00240320439282965,0.00607455197683546,-0.00950291748176786,0.0143093262674272,0.692394260212418
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.0018708704876077,0.00473634469837671,-0.0111541060964261,0.00741236512121065,0.692848274306834
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.00147980767253426,0.00374705217375592,-0.00882402993309585,0.00586441458802734,0.692903956969466
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42262,0.00100787877111815,0.00255638748535085,-0.00400264070016951,0.00601839824240582,0.693395984541169
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.00146526756661076,0.00372002540597499,-0.00875651736232173,0.00582598222910022,0.693671085548784
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,39929,0.00402585787425546,0.0102326952027119,-0.0160302247230599,0.0240819404715709,0.694008698552113
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,39649,-0.00237369882007004,0.00603806200612753,-0.01420830035208,0.00946090271193993,0.694236494672792
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.00321497911099951,0.0081915205308644,-0.0128404011294947,0.0192703593514937,0.694713569712861
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00128012493322233,0.00327479160467097,-0.00769871647837743,0.00513846661193277,0.695876683112025
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00284759117583054,0.00729232153323502,-0.0114453590293101,0.0171405413809712,0.696180505185974
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00256516235587951,0.00662479601386612,-0.0155497625430571,0.0104194378312981,0.698610916424101
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.00275590114634116,0.00714790583850065,-0.0167657965898024,0.0112539942971201,0.699833464531326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.00398226495933625,0.0103379883440898,-0.0242447221137523,0.0162801921950798,0.700091325663886
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00333257889542721,0.00879425580991716,-0.0205693202828648,0.0139041624920104,0.704731501541651
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00144533348396321,0.00382252553286871,-0.00893748352838588,0.00604681656045947,0.705356512310742
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPL,Periplakin,39657,-0.00126243941366946,0.00337373341729076,-0.00787495691155935,0.00535007808422043,0.708265264118688
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.00224242818193215,0.00600455599820217,-0.00952650157454411,0.0140113579384084,0.708816184051166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.00244695885544897,0.00655422705230108,-0.0103993261670611,0.0152932438779591,0.708902155644054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,41913,0.0019829598142903,0.00531370900854311,-0.0084319098424542,0.0123978294710348,0.709021838451689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,39560,-0.00163094221691379,0.00437650072426657,-0.0102088836364763,0.00694699920264868,0.709409489371009
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00139163721221302,0.00374088129229148,-0.00872376454510433,0.00594049012067828,0.709894137755989
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.000712615055448319,0.00191560031563095,-0.00446719167408497,0.00304196156318833,0.709895214332227
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00137218459464484,0.0037175948091971,-0.00865867042067116,0.00591430123138149,0.712056012878674
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.00236563812904548,0.00644931804836535,-0.0150063015038416,0.0102750252457506,0.71377067863632
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00154274471039279,0.00421205241673061,-0.00671287802639921,0.00979836744718479,0.714171333615743
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42070,0.00162334361290405,0.00443219856040203,-0.00706376556548393,0.010310452791292,0.714175720875951
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,41913,0.00183201404529154,0.00500952939232634,-0.00798666356366808,0.0116506916542512,0.714590414506984
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,39966,0.00318521954259164,0.00878721112713746,-0.0140377142665978,0.0204081533517811,0.716997448788028
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42119,0.00252470948543049,0.00704909443792381,-0.0112915156129002,0.0163409345837612,0.720228553682019
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,39575,-0.00208506023449731,0.00582357436325413,-0.0134992659864754,0.00932914551748079,0.720321849597425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,41913,0.00223712806565251,0.00632132814127232,-0.0101526750912412,0.0146269312225462,0.723418241572968
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42123,0.00470314906972692,0.0133871202213476,-0.0215356065641143,0.0309419047035681,0.72535455032798
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42123,0.000849639399077059,0.00243362770674614,-0.00392027090614538,0.0056195497042995,0.727001174172335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.00335160609445136,0.00961563289952017,-0.0221982465775109,0.0154950343886082,0.72742778614675
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ARTN,Artemin,41913,0.00162736369111306,0.00469041826507948,-0.00756585610844272,0.0108205834906688,0.728630670546513
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00203377493991781,0.00586822108463193,-0.0135354882657964,0.00946793838596077,0.728917767906578
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00194530713796238,0.00561315665319377,-0.0129470941782222,0.0090564799022974,0.728926794468317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00147601375158133,0.0042614243011614,-0.00982840538185767,0.00687637787869502,0.729074041710934
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.00151003884433324,0.00436217311580577,-0.0100598981513126,0.00703982046264607,0.729224069489486
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,39757,0.0018557488966782,0.00540296958666389,-0.00873407149318302,0.0124455692865394,0.731252640310317
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00139174150035462,0.00405928498715049,-0.00656445707446034,0.00934794007516957,0.731713851138304
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,39934,0.0012440892251758,0.00363744254762846,-0.00588529816817599,0.00837347661852759,0.732339880896201
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.00104987393064662,0.00307515751303059,-0.00497743479489334,0.00707718265618658,0.732805252913378
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42310,0.00259829998609998,0.00769885642585875,-0.0124914586085832,0.0176880585807831,0.735751450062199
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42119,0.00273973803329058,0.00818623449975796,-0.013305281586235,0.0187847576528162,0.737874532388094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00299993755751594,0.00901485104298153,-0.0206690456017597,0.0146691704867279,0.739308666410032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00114361795010168,0.00344102383811817,-0.00560078877260994,0.0078880246728133,0.739631613772724
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,39757,0.00202266484971032,0.0061036281075708,-0.00994044624112845,0.0139857759405491,0.740358179236011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00591516781930205,0.0179815199842769,-0.0411589469884847,0.0293286113498806,0.742193389294878
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00158081737739592,0.0048124653798488,-0.0110132495218996,0.00785161476710772,0.742551012190271
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.00217939530166088,0.00663572063932214,-0.0151854077547323,0.0108266171514105,0.742589924220919
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00102467793833879,0.00314417542138396,-0.00718726176425135,0.00513790588757376,0.744508312643207
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00171337037254733,0.00526456638655295,-0.00860517974509646,0.0120319204901911,0.744844253029807
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00203682292278702,0.00627549622661863,-0.0143367955269595,0.0102631496813855,0.745514329030037
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.000964111048126203,0.00298235561451306,-0.00488130595631939,0.0068095280525718,0.746495449912772
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.00119492142983461,0.00369646631343538,-0.00605015254449872,0.00843999540416795,0.746504148988872
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.00187039205713826,0.00580014975971894,-0.00949790147191086,0.0132386855861874,0.747100383899598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,41913,0.00142680550781627,0.00443793675762329,-0.00727155053712539,0.0101251615527579,0.747835050225102
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.00198676858251411,0.00620272860916404,-0.0141441166564756,0.0101705794914474,0.748741644181667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,39560,0.0019979813587396,0.00627141022883186,-0.0102939826897708,0.0142899454072501,0.750046800540316
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00205623818751569,0.00656768234728782,-0.0149288955881998,0.0108164192131684,0.754222570844782
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,39657,0.00186709074420202,0.00597107586087049,-0.00983621794310414,0.0135703994315082,0.754522722741929
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,39638,0.00287060077310953,0.00920951180983088,-0.015180042374159,0.020921243920378,0.755274749831806
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00121952498737327,0.00391407154798715,-0.00889110522142808,0.00645205524668154,0.755369627184992
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PTTG1,Securin,39757,0.00134817243738425,0.0043538452287285,-0.00718536421092361,0.00988170908569211,0.756832167563368
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00097583035560602,0.00316395804170595,-0.00522552740613765,0.00717718811734969,0.757766992994328
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00118595305274439,0.00385225807616733,-0.00873637888203236,0.00636447277654358,0.758195120968491
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00160680293097103,0.00522551850844565,-0.00863521334558243,0.0118488192075245,0.758475061384001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.00202075512792265,0.00657486968675809,-0.0108659894581232,0.0149074997139685,0.758586209152755
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.000744180090038076,0.00242439548939008,-0.00549599524924263,0.00400763506916648,0.758882362867017
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,41913,-0.0010154452764927,0.00331830401351689,-0.00751932114298579,0.0054884305900004,0.759599277937875
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00183690808720491,0.00601476201891005,-0.0136258416442686,0.00995202546985879,0.760066232468032
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.00169718582538555,0.00561465719115572,-0.0127019139200508,0.00930754226927965,0.762445003134877
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,41913,0.00106905125453328,0.00353709941251719,-0.00586366359400042,0.00800176610306698,0.762474195390521
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.00106462487500398,0.00353534635872361,-0.0058646539880943,0.00799390373810226,0.763315451154523
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.00242586613504659,0.00807217977816378,-0.0182473385002476,0.0133956062301544,0.763784817202733
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,39958,-0.000847250110336946,0.00283924435714239,-0.00641216905033603,0.00471766882966214,0.765398081225805
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.000648365908645115,0.00217281145278165,-0.00490707635609715,0.00361034453880692,0.765402853156774
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00106002077901291,0.00355371252476063,-0.00590525576951791,0.00802529732754374,0.765490767788801
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0024317807484383,0.00816396724355469,-0.0184331565458055,0.0135695950489289,0.765808944489401
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.000820057644961987,0.00276113849286734,-0.00623188909098197,0.004591773801058,0.766472059742986
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00112209233414306,0.00377934000827718,-0.00628541408208022,0.00852959875036633,0.766547172929431
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.00186194820342416,0.00629009239754067,-0.0104666328957555,0.0141905293026039,0.767225823928835
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.00118179315249116,0.00399722758013076,-0.00901635920954744,0.00665277290456513,0.767500365383219
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.000654681377357627,0.00223093724526931,-0.00502731837808547,0.00371795562337022,0.769178333541505
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,39736,0.0011223026406271,0.00382642941286462,-0.00637749900858755,0.00862210428984176,0.7692961431088
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00207564434412,0.0072140784668902,-0.0162152381392248,0.0120639494509848,0.773565447513362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.00220147529235912,0.00771410873004328,-0.0173211284032439,0.0129181778185257,0.775355213175281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.00129209117049357,0.00460074518142499,-0.00772536938509941,0.0103095517260866,0.778834503184432
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.00128088915560156,0.00459755364595463,-0.00773031599046952,0.0102920943016726,0.78055528086379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.0018946436532562,0.00680872038062746,-0.0114504482927736,0.015239735599286,0.780811563305409
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,41839,-0.00170304792786249,0.00613016878834533,-0.0137181787530193,0.0103120828972944,0.781159329486301
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.002469431481834,0.00902760658443308,-0.0201635403873228,0.0152246774236548,0.784441557172626
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00199268280494031,0.00729764140688504,-0.0123106943525544,0.016296059962435,0.78481240043676
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00286934801336519,0.0105738121384283,-0.0178553237779543,0.0235940198046847,0.786116477979888
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.000834407434430431,0.00308424820343778,-0.00521071904430762,0.00687953391316848,0.786750186229762
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.00138125090029672,0.00511954923669907,-0.0114155674042269,0.00865306560363345,0.787319718839279
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.00101552731681765,0.00377217966540758,-0.00637794482738121,0.0084089994610165,0.787769321869388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.00121222324620343,0.00451744358315963,-0.0100664126691963,0.00764196617678946,0.788439680292683
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,39649,-0.0011142886570964,0.0041909818362798,-0.00932861305620481,0.00710003574201202,0.79033835230894
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.00173804434427263,0.00654862295248437,-0.0110972566425967,0.014573345331142,0.790700719571625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.00152224595168816,0.00576812182258875,-0.0128277647239621,0.0097832728205858,0.791856773538719
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42137,-0.00147596038179964,0.00561005259042851,-0.0124716634590395,0.00951974269544023,0.792483615426997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.00266912101756225,0.010198798693541,-0.0226587664569027,0.0173205244217782,0.793550434669775
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.00141775935993979,0.00542266252983219,-0.00921065919853131,0.0120461779184109,0.793749812679689
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00119725712563672,0.00460876454895452,-0.0102304356415876,0.00783592139031415,0.795039497520847
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.00167083103972431,0.00643270420977213,-0.0109372692114291,0.0142789312908777,0.795068231958506
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.00128633389958622,0.00500363416319838,-0.00852078906028261,0.0110934568594551,0.797121893013305
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.000975096495519415,0.00380513645734371,-0.00648297096087425,0.00843316395191308,0.79775555279246
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.000773549906127261,0.00302331951872919,-0.00515215635058195,0.00669925616283648,0.798062055428473
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.00316933615453582,0.0125141880652416,-0.0276971447624093,0.0213584724533377,0.800071575591591
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.00195010717365684,0.00771581271158994,-0.0131728857410594,0.0170731000883731,0.800472595281001
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.0010768699983276,0.0042961824107655,-0.00949738752342797,0.00734364752677278,0.80208359945244
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,39586,0.00196177954180671,0.00784895108633454,-0.013422164587409,0.0173457236710224,0.802637170442383
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00122428891116943,0.00492528955408536,-0.0108778564371767,0.00842927861483788,0.803696404903462
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.000785653682752122,0.00316162835202377,-0.00541113788721447,0.00698244525271871,0.8037548675684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00101568820885446,0.00413488837497594,-0.0091200694238073,0.00708869300609838,0.805966595933191
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.000945950920940305,0.00391511634121744,-0.00672767710784587,0.00861957894972648,0.809082990482998
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.000957292777685846,0.00397340121350016,-0.00874515915614615,0.00683057360077446,0.809616826729939
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00138402197423505,0.00575146832915152,-0.00988885595090194,0.012656899899372,0.809840177967668
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00110830227759023,0.0046696297868808,-0.0102607766598766,0.00804417210469613,0.812395379587981
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.000643630653222429,0.00271699491019323,-0.00596894067720117,0.00468167937075631,0.812745903533094
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.000849366291492984,0.00360094735899973,-0.00790722311513246,0.00620849053214649,0.813534840850811
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00116141175715552,0.00493150664068471,-0.00850434125858651,0.0108271647728975,0.813817721043648
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.00225051361494852,0.00957032676102369,-0.0165073268366579,0.0210083540665549,0.81409250840646
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00221997688081694,0.00956463099857991,-0.0209666536380336,0.0165266998763997,0.816462564930303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.000751942187977002,0.00326031009270477,-0.00714214996967834,0.00563826559372434,0.817602543445857
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,39934,0.000725227838995119,0.00315726717448832,-0.00546301582300198,0.00691347150099222,0.818328161485691
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00282034951375242,0.0122844035452836,-0.0268977804625084,0.0212570814350035,0.818416341138174
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.000638755533458727,0.00278315419695904,-0.00609373775949844,0.00481622669258099,0.81847852170699
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.00124376321195455,0.00543393385312443,-0.00940674714016933,0.0118942735640784,0.818959965423609
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.00146363233920537,0.00651724954255537,-0.0113101767642031,0.0142374414426139,0.82231145923175
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.00134351832823431,0.00600011015962734,-0.0131037342411039,0.0104166975846353,0.822827142425479
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.000737340426510293,0.00334816033794778,-0.00729973468888795,0.00582505383586736,0.825701225489738
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NEB,Nebulin,39575,-0.000914834819967117,0.00415875491766878,-0.00906599445859792,0.00723632481866368,0.825892336643598
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.00108412894526709,0.00496003638807961,-0.0108058002659031,0.00863754237536894,0.826986120411667
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.00315818387046311,0.0144632123020015,-0.031506079982386,0.0251897122414598,0.827152719806615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.000670078498136727,0.00308695114134581,-0.00672050273517452,0.00538034573890107,0.828159309242397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.00103756853984529,0.00478460791072555,-0.0104154000448674,0.00834026296517678,0.828324861424054
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.000869258660267704,0.00400886989478955,-0.00872664365405522,0.00698812633351981,0.828341741842549
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42075,0.00129086718850249,0.00612404813195143,-0.0107122671501223,0.0132940015271273,0.833056994736488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00128617254618303,0.00614167533183009,-0.01332385619657,0.0107515111042039,0.834126437698064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.000681426286197731,0.00328660425989437,-0.00576031806319523,0.00712317063559069,0.835752496247957
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.00224922085415071,0.010932505533427,-0.0191784899913662,0.0236769316996676,0.837000145167768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.000986720727247715,0.00485694545476146,-0.00853289236408474,0.0105063338185802,0.839015629415615
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.000835315400348637,0.00427054871791415,-0.00753496008676309,0.00920559088746037,0.844926897630552
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.00112763583252924,0.00584580615210958,-0.012585415890664,0.0103301442256055,0.847042933161064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.00213088790323432,0.0112085504274278,-0.0198378709345241,0.0240996467409928,0.849224207604587
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.00180872944349141,0.00951639496866273,-0.0168434046950875,0.0204608635820703,0.849261392771982
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,41913,-0.00268329231761004,0.0143340927057498,-0.0307781140208796,0.0254115293856595,0.85150940338508
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.000774356819387507,0.00424207104477296,-0.0075401024283675,0.00908881606714251,0.855160618744293
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,39657,0.000797741460395357,0.00437252433228035,-0.00777240623087413,0.00936788915166485,0.855237529652254
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.00113016209930526,0.00629294939486025,-0.0112040187146208,0.0134643429132313,0.85747577707645
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.000887323262521622,0.00497163998880152,-0.00885709111552936,0.0106317376405726,0.858351121080684
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42145,0.000709171119728334,0.00397389448161288,-0.00707966206423291,0.00849800430368958,0.858366394940413
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0017086568579641,0.00969171672961183,-0.0172871079320751,0.0207044216480033,0.860060828392791
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.000552932085317776,0.00316835881376198,-0.00676291536029125,0.0056570511896557,0.861462484173419
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42027,0.000832163395765022,0.00481841193048107,-0.00861192398797788,0.0102762507795079,0.862885987752482
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.000971643354333163,0.00564614380027386,-0.0100947984942036,0.0120380852028699,0.863370139418735
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.000575423548336439,0.00334558415293554,-0.00598192139141721,0.00713276848809009,0.863444056313909
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000737181298801122,0.00441284209188133,-0.00791198920128628,0.00938635179888852,0.867330877012416
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,39586,0.00128356087075755,0.00771391689440711,-0.0138357162422804,0.0164028379837955,0.867848796377625
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00152402040909746,0.00931972961459331,-0.0197906904537003,0.0167426496355054,0.870107028489534
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.00112765862362405,0.00690550458601477,-0.014662447612213,0.0124071303649649,0.870286310738965
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,39750,-0.00167759505658373,0.0103675330107607,-0.0219979597576746,0.0186427696445071,0.871456545835379
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.000717453757054166,0.00447483244647647,-0.00805321783803971,0.00948812535214804,0.872623397301585
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,39624,0.00111743714594769,0.00701753073733596,-0.0126369230992308,0.0148717973911262,0.873486574942488
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.000739094626124103,0.00464565123001499,-0.00984457103695348,0.00836638178470527,0.87359779853841
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.000417869577381716,0.0026701617637468,-0.00565138663432545,0.00481564747956202,0.875644421559115
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.000454592864774703,0.00294427642275237,-0.00531618892381994,0.00622537465336935,0.877298088128456
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,0.000857229533300103,0.00562723925928724,-0.0101721594149029,0.0118866184815031,0.8789249521558
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42119,0.000874563290006142,0.00575206670203354,-0.0103994874459796,0.0121486140259919,0.879155041108311
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,41843,-0.00208870228402253,0.0138672306249335,-0.0292684743088922,0.0250910697408471,0.880276639477529
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.00177970947108948,0.011926895113508,-0.0215970049513862,0.0251564238935651,0.881384126957256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.00100672441848328,0.00675466798861291,-0.0142458736761646,0.012232424839198,0.88152331098365
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,39979,-0.000401211883626581,0.00269583661814587,-0.00568505165519248,0.00488262788793932,0.881693189926256
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.00110127662334217,0.00742706107614149,-0.0156583163325795,0.0134557630858951,0.882125352963073
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.000685481673365014,0.00466721707576337,-0.00846226379513118,0.00983322714186121,0.883236016665067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.00073760215477625,0.00503420306790009,-0.0106046401678604,0.00912943585830793,0.88351459157014
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,39919,0.000591716785919155,0.00407677823554079,-0.00739876855574079,0.0085822021275791,0.884600366542153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.000747642517041514,0.0051536883468817,-0.00935358664284662,0.0108488716769297,0.884658651236439
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,39560,0.001404417339933,0.00968212302824252,-0.0175725437954223,0.0203813784752883,0.884671991323166
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.000438161122330746,0.00302402976401547,-0.00636525945980108,0.00548893721513958,0.884797448051766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.000521102350430875,0.00359880741759097,-0.00757476488890917,0.00653256018804742,0.884872009337584
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00053856064096623,0.00379241833271902,-0.00689457929116305,0.00797170057309551,0.887074837168842
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,41913,0.000398585093205038,0.0028386331527285,-0.00516513588614283,0.00596230607255291,0.888334671259196
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.00100483449184546,0.00724628202741481,-0.0131978782818876,0.0152075472655785,0.889714278208011
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42262,-0.000424081258162744,0.0030750282570485,-0.00645113664197781,0.00560297412565233,0.890312522842403
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00042814942164301,0.00315704793319973,-0.00661596337071448,0.00575966452742846,0.892126454132397
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.00123477456993535,0.00911309226313733,-0.0190964354056845,0.0166268862658138,0.892223296990326
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.000655618359378651,0.00505141295976857,-0.010556387760525,0.00924515104176775,0.896735590379148
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.000666435267461689,0.00525455180182952,-0.00963248626412417,0.0109653567990475,0.899077204680827
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.000906735159090983,0.00726037715674554,-0.0133236040681303,0.0151370743863122,0.900614377605235
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000301184705235519,0.00242152860144677,-0.00444501135360014,0.00504738076407118,0.901018290784927
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00110302150303048,0.00895410111825331,-0.016447016688746,0.018653059694807,0.901961928548766
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.000961126758922053,0.00781959223862464,-0.0162875275466263,0.0143652740287822,0.902178106630873
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42107,0.000510461482299904,0.00418352594307367,-0.00768924936612449,0.0087101723307243,0.902887332658768
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.000775184966275169,0.0064228713159707,-0.0133640127455777,0.0118136428130274,0.903937689310819
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,0.000216958569039131,0.0018274245230043,-0.00336479349604929,0.00379871063412755,0.905496033814273
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00143511891600405,0.0122254262154346,-0.025396954298256,0.0225267164662478,0.906554706120294
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.00150550068660877,0.0128657745617699,-0.0237114174544602,0.0267224188276778,0.906849197514193
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,39586,-0.000751267821453253,0.00642821059838868,-0.0133505605942951,0.0118480249513886,0.906964856859187
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.000568466056940632,0.0049306639416499,-0.0102325673825744,0.00909563526869317,0.908215435210015
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.000356735871028198,0.00309810144893043,-0.00571554296887545,0.00642901471093184,0.908331009129771
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.000630797096245102,0.00548495603321582,-0.0101197167288579,0.0113813109213481,0.908443271739047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42107,0.00107754656123715,0.00950823499892432,-0.0175585940366545,0.0197136871591288,0.909772428373047
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.000477291430097329,0.00430749185378903,-0.00796539260332917,0.00891997546352383,0.91177303258804
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00071465689166786,0.00646586891390369,-0.0119584461795834,0.0133877599629191,0.911992991252036
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42310,-0.000223449399028348,0.00204646973749592,-0.00423453008452035,0.00378763128646365,0.913055184761849
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.0005774852520105,0.00529443240831673,-0.00979960226829029,0.0109545727723113,0.913145727896425
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.000541514437589736,0.00497306246225425,-0.0102887168636081,0.00920568798842859,0.9132921012472
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.000792992749992173,0.00728675179626082,-0.013489040770679,0.0150750262706634,0.913341582408562
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42145,0.000440184294621665,0.0040529229380564,-0.00750354466396888,0.00838391325321221,0.91351415500492
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,41864,-0.000545961389253637,0.00517063729291331,-0.0106804104833637,0.00958848770485646,0.915910207694265
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.00120281841346022,0.0114020571765904,-0.021145213652657,0.0235508504795774,0.915987499233796
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.000591734642132459,0.00562587505280932,-0.0104349804613738,0.0116184497456387,0.916234151263007
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.000437629679651037,0.00417365534510839,-0.00861799415606348,0.0077427347967614,0.916492255485526
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.000623267140763033,0.00612234111553403,-0.0113765214456837,0.0126230557272097,0.918915610119997
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,39649,0.000328953248729705,0.00328352857274488,-0.00610676275385027,0.00676466925130968,0.920200979269582
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.000639838350534032,0.00645810876207979,-0.0120180548231424,0.0132977315242104,0.92108006260281
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.000443518050261906,0.00467223506098871,-0.00960109876979978,0.00871406266927597,0.924374792355545
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.000234027858847678,0.00246592357148002,-0.00459918234125316,0.00506723805894852,0.924392206696793
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.000615655401297511,0.00650834373559453,-0.0133720091230628,0.0121406983204678,0.924638403266312
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.000301759067811239,0.0034271512030554,-0.00701897542579982,0.00641545729017734,0.929838912671165
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.000725608669275199,0.00875710845021568,-0.0164383238931475,0.0178895412316979,0.933964596902799
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42249,0.000540075964050739,0.00677137270636181,-0.0127318145404184,0.0138119664685199,0.936430332187034
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.000401256584737906,0.00510851731734446,-0.0104139505267331,0.00961143735725724,0.937394709873064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.000435604882112825,0.00554836969491201,-0.0104391997199147,0.0113104094841404,0.937423443046069
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,39929,-0.000175477674068372,0.00228151968665887,-0.00464725625991975,0.00429630091178301,0.938694410100303
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.000212997675234518,0.00278699323459119,-0.00567550441503324,0.00524950906456421,0.939081885406958
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.000272183499175696,0.0038293129955099,-0.00723326997202372,0.00777763697037511,0.943336217609388
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.000715154954408894,0.0105099915366538,-0.0198844284574326,0.0213147383662504,0.945750837126429
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.000470964282690423,0.00697479683164542,-0.0131996375073346,0.0141415660727155,0.946166001870335
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.000310533358616891,0.00510265896397216,-0.00969067821076855,0.0103117449280023,0.951474071652162
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.000282883141547131,0.00471827966344411,-0.00896494499880332,0.00953071128189759,0.952192780587593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.000995135859205982,0.0173506272991593,-0.0330120936471462,0.0350023653655581,0.954263850317566
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.000279279955767665,0.0048876672142217,-0.0098591076956422,0.00930054778410687,0.954434754952593
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,39575,0.000188460151980608,0.00334299571116806,-0.00636381144190879,0.00674073174587001,0.955044392005822
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.000307912125589098,0.00560584249109455,-0.0112953634081344,0.0106795391569562,0.956197449698247
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.000490219137292188,0.00933358745039517,-0.0187840505400667,0.0178036122654823,0.958113669102341
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.000279132068075177,0.0053605824146895,-0.0107858736008666,0.0102276094647162,0.95847270680665
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.000144888745269583,0.0028923559330379,-0.00581390637402387,0.0055241288834847,0.960048644435747
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.000352427700203314,0.00721483542437686,-0.014493505131982,0.0137886497315753,0.961041588741098
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.000216828093039229,0.00507685558381042,-0.0101674650373076,0.00973380885122919,0.965934151021067
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.000321241943662052,0.00766080983915614,-0.0153364292284081,0.014693945341084,0.966552734325662
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.000217253926870775,0.00520619060149291,-0.0104213875057969,0.00998687965205533,0.966714629646384
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,39757,-0.000118135501166373,0.00288390253781065,-0.00577058447527525,0.0055343134729425,0.967325517213452
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.000105891836308951,0.00274293419121874,-0.00527025917847977,0.00548204285109768,0.969205757342321
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.000109532605517799,0.00288021569553697,-0.00553569015773466,0.00575475536877026,0.969664985765554
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.000345545997457734,0.0092630456400306,-0.0178100234570022,0.0185011154519177,0.970243518317778
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000148154176409476,0.00422245736023245,-0.00842417060246507,0.00812786224964612,0.972010847438936
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.000217833770692454,0.00655958371824891,-0.0130746178584603,0.0126389503170754,0.97350894464542
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.000253736264496075,0.00837625701172632,-0.0166712000074797,0.0161637274784875,0.975834462703866
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.000106393374020601,0.00355021424695167,-0.00706481329804588,0.00685202655000468,0.976092892205362
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,41913,-0.000125648915818882,0.00500356128410718,-0.00993262903266896,0.00968133120103119,0.979966087078064
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.000136446358637301,0.00570259837339548,-0.0113135391704924,0.0110406464532178,0.98091122944661
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.000219011775888362,0.0099716266169375,-0.0193253763933091,0.0197633999450859,0.98247739819769
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,39657,6.89100308004998e-05,0.00346760135817036,-0.00672758863121341,0.0068654086928144,0.984145412952786
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-8.24152098041553e-05,0.00445212785962724,-0.00880858581467354,0.00864375539506523,0.985231203587104
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-3.89473730785546e-05,0.00257083073068767,-0.00507777560522639,0.00499988085906929,0.987913003795399
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-5.9992766179261e-05,0.00446013739669572,-0.00880186206370287,0.00868187653134435,0.989268319827155
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,39575,-7.07661879370014e-05,0.00682571332142293,-0.0134491642979259,0.0133076319220519,0.991728197714108
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,5.78915789191528e-05,0.00596539811693931,-0.0116342887302819,0.0117500718881202,0.992257176021078
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,39649,-3.1501426789638e-05,0.00422308923207505,-0.00830875632165673,0.00824575346807746,0.99404850361969
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,39575,4.33657920208016e-05,0.00862216324056328,-0.0168560741594832,0.0169428057435248,0.995987090374136
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,39757,1.502311541575e-05,0.00371198413497274,-0.00726046578913082,0.00729051201996232,0.996770888534153
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-2.49151629172793e-05,0.00638755074033416,-0.0125445146139722,0.0124946842881377,0.996887864539564
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,9.50725532685093e-06,0.0074120697248344,-0.0145181494053486,0.0145371639160023,0.998976599273553
NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-5.62287771153626e-06,0.00544781428869833,-0.0106833388835603,0.0106720931281372,0.999176494059844
